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This thesis describes an investigation of the cell surface levels and membrane 
trafficking of the glucose transporter isoforms GLUT1 and GLUT4. A new method 
has been developed to compare the cell surface pool of transporters with the total 
cellular pool. The impermeant bis-mannose photolabel ATB-BMPA was used to 
photolabel the cell-surface transporters. Digitonin was used to permeabilize the cells 
and allow ATB-BMPA to label the total cellular pool of GLUT1 and GLUT4. ATB- 
BMPA labelling showed that only GLUT1 was present in preconfluent fibroblasts and 
that most of the transporters were distributed to the cell surface. The insulin- 
responsive reserve pool of transporters developed when the fibroblasts reached 
confluence. In the insulin-stimulated state approximately half of the total of both 
GLUT1 and GLUT4 was recruited to the plasma membrane. Measurements of the 
changes in the distribution of both GLUT1 and GLUT4 throughout the differentiation 
of confluent fibroblasts into adipocytes showed that both transporters were 
sequestered in parallel. Basal levels of transport and photolabelling remained low 
throughout the differentiation period when the total pool of transporters (GLUT1 plus 
GLUT4) was increased by * 5  fold. These results suggest that the sequestration 
process was present before new transporters were synthesized.
At 27°C the half times for the appearance of GLUT1 and GLUT4 at the cell- 
surface were 5.7 min and 5.4 min respectively and were slightly faster than the 
observed rate of stimulation of transport activity (tVfc = 8 . 6  min). This lag may be due 
to a slow dissociation of surface transporters from trafficking proteins responsible for 
translocation. The reversal of insulin action on glucose transport was associated with 
loss of cell-surface GLUT1 and GLUT4 when reversal was induced by incubation 
with a low pH buffer. The levels of GLUT1 and GLUT4 decreased with half times 
of 9.2 and 6 . 8  min respectively with the low pH treatment. These times correlated 
well with reduction of transport activity (tVi =6.5 min). Phenylarsine oxide (PAO)
treatment has been examined. This also reversed the insulin stimulation of transport 
activity. The cell-surface level of GLUT1 remained high throughout the PAO 
treatment. But however recycling of GLUT1 and GLUT4 to the light microsome 
membrane pool occurred when cells were maintained in the presence of insulin for 60 
min even with PAO treatment. These results suggest that both transporters are 
recycled but that PAO may inhibit this recycling at a stage which involves the re- 
emergence of internalized GLUT4 at the plasma membrane. The redistribution of 
these ATB-BMPA labelled transporters from the plasma membrane to the low-density 
microsome membrane fraction has then been followed while cells were maintained at 
either insulin-stimulated or basal steady states. In both these steady states GLUT1 and 
GLUT4 were continuously recycled. Calculations of endocytosis and exocytosis rate 
constants for GLUT1 and GLUT4 in insulin-stimulated and basal states have 
indicated that the main effect of insulin is to increase glucose transporter exocytosis 
and that the unique feature of the GLUT4 isoform is the very low rate of exocytosis 
in the basal state.
The effect of insulin on the translocation of glucose transporters and glucose 
transport activity has been studied in different pH buffers ( pH 7.4, pH 8.0 and pH
6.5 ) and these stimulations have been correlated with the amount of insulin binding 
at these pHs. At pH 7.4 and at submaximal insulin concentrations, the levels of 
GLUT1 and GLUT4 that were detected by Western blotting were higher than the 
levels detected by ATB-BMPA labelling and these levels were both higher than the 2- 
deoxy-D-glucose transport activity. At pH 8.0, the levels of transport activity, ATB- 
BMPA labelling and Western blotting were very similar and were very similar to the 
levels detected by Western blotting at pH 7.4. The differences in the dose responses 
in these parameters may indicate the possibility of the presence of occluded on 
inactive glucose transporters in the cell membrane at pH 7.4.
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1.1 THE MAMMALIAN GLUCOSE TRANSPORTER FAMILY
Transport of glucose across the plasma membrane in mammalian cells is a 
very important cellular nutrient transport event, since glucose plays a central role in 
cellular homoeostasis and metabolism. The defects in glucose transport may be 
associated with diseases such as diabetes mellitus and this has led to an increased 
interest in mechanisms involved in glucose transport.
In mammalian cells, glucose is not freely permeable across the lipid bilayer, 
its uptake requires specific carrier proteins. Two types of glucose transport protein 
have been described.
The active uptake of glucose from the lumen of the small intestine and 
proximal tubule of the kidney requires a Na+ -linked glucose transport protein and 
transport of glucose is against its concentration gradient ( Wright et al. , 1991).
The glucose transport across the cell membrane in most cells is via facilitative 
glucose transporters. Transport is bidirectional, but net transport occurs from a high 
to a low sugar concentration.
Molecular cloning studies have revealed a family of facilitated diffusion 
glucose transporter proteins which are structurally related but are encoded by distinct 
genes that are expressed in tissue specific manner (Mueckler, 1990; Bell et al., 
1990). Currently, seven genes for members of the facilitative glucose transporter 
family have been identified. The proteins they encode have been named GLUT1- 
GLUT7 (Gould and Bell, 1990; Pilch, 1990). The GLUT6  is a facilitative glucose
2transporter pseudogene-like sequence and this sequence cannot encode a functional 
protein (Kayano et al. , 1990).
1.1.1 Structure of the facilitative glucose transporter
Computer analyses of the predicted amino acid sequence of human GLUT1, 
including hydropathy and secondary-structure determinations have indicated that this 
protein is an extremely hydrophobic protein and suggested approximately 50% of the 
protein lies within the lipid bilayer. Based upon this analysis, Mueckler et al. (1985) 
proposed a model for the topology of GLUT1 in the plasma membrane. In this 
model, the protein spans the plasma membrane 12 times with its NH2 - and COOH 
termini internally orientated. A large extracellular segment links transmembrane 
domains Ml and M2 and a very hydrophilic intracellular segment joins M6  and M7. 
Short regions of 7-14 amino acids connect the remaining membrane-spanning 
regions.
Infrared spectroscopic analysis indicates that the a-helix is the predominant 
structure of the native glucose transporter, although an appreciable amount of 13- 
structure and random coil conformation is also present (Lienhard et al., 1992).
Analysis of complementary DNA from human HepG2 hepatoma cells 
(Mueckler et al. , 1985) and rat brain libraries (Bimbaum, 1986) has deduced that the 
predicted sequence of the 492 amino acid GLUT1 protein is highly conserved, with 
98% sequence identity between the human and rat.
It is important to study the conserved regions of the glucose transporters 
because the regions that are significantly different may be responsible for the 
presence of distinct catalytic properties of each isoform.
3Carruthers, (1990) have reported that homology analyses have indicated that 
hydrophobic regions M5, M10 and M il are >90% conserved between transporter 
isoforms, and M l, M2, M4, M7, M8  and M12 share >80% sequence homology. 
The hydrophobic regions M6  and M9 share >70% and M3 >60%.
There is 39-65% sequence identity and 50-76% sequence similarity between 
isoforms; 26% of the residues are invariant in all seven proteins, and another 13% 
represent conservative amino acid replacements (Gould et al. , 1991).
From multiple sequence alignment data, Hodgson, Osguthorpe and Holman 
(unpublished results) have shown M7, M8 , M10 and M il have a high degree of 
conservation of certain hydrophilic and aromatic side chains. Membrane-spanning 
regions M9 and M12 are less conserved and have fewer hydrophilic amino acids. 
This finding and also the photoaffinity labelling results (see below) all indicate that 
the C-terminal half of the protein is important in ligand binding.
The basic model of GLUT1 (Fig. 1) is also applicable to the other isoforms. 
All members of this family have similar size (* 5 0 0  amino acids) and similar 
orientation in the plasma membrane, including 1 2  membrane-spanning segments, 
intracellularly oriented N and C-termini, a large extracellular loop joining 
transmembrane segments Ml and M2, which contains a single consensus site for N- 
linked glycosylation, and a large hydrophilic segment joining transmembrane domains 
M6  and M7. (Pessin and Bell, 1992). Despite their structural and functional 
similarity, the amino acid sequence of the mammalian facilitative glucose transporters 
vary considerably.
1.1.2. Mechanisms for facilitative glucose transport
To account for the accumulated data on sugar transport in cells, a number of
4OUTSIDE
^©®
5 l 0  < £ l 1  ©  12
) © ©
F ig.l A model for the arrangement of GLUT1 in the membrane.
Numbered rectangles indicate membrane-spanning a-helices. 
(From Baldwin and Henderson, 1989)
5models have been proposed. An altemating-conformer model is widely accepted as 
being the best model currently available. This model is also called the mobile carrier, 
the simple carrier, the cyclic carrier or the one-site carrier.
In this model (Widdas, 1952), the glucose carrier was proposed to contain 
mutually exclusive saturable sugar influx and efflux sites. Thus at any point in time, 
a carrier can be available for sugar influx or sugar efflux but not for both 
simultaneously (Carruthers, 1990). When sugar binds to one of these sites to form the 
carrier-sugar complex, a conformational change is promoted that results in sugar 
translocation, dissociation of sugar from the carrier at the opposite side of the 
membrane, and the exposure of a glucose transport site at the opposite side of the 
membrane. The carrier is now available for transport in the opposite direction or can 
isomerize back to its original side of the membrane.
Baker and Widdas (1988), Naftalin et al. (1985) proposed a model called a 
fixed site model. In this model, the glucose carrier is proposed to have saturable 
sugar influx and efflux sites that exist simultaneously.
Transport in human erythrocytes is asymmetric and transport in rat adipocytes 
is symmetric. Either model can account for these properties.
1.1.3 Characteristics of the tissue specific glucose transporter isoforms
The facilitative glucose transporters have distinct physiological and 
biochemical properties that allow them to serve the specific functions in the tissues in 
which they are expressed. A summary of the glucose transporter isoforms are shown 
in table 1 .
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Mueckler et al. (1985) 
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(1989)
Gould */tf/.(1991) 





(Apparent Mr from 
SDS-PAGE 
55-61)
Liver, Pancreatic G-cells, Kidney, 
Intestine
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Foetal skeletal muscle
10.6 ±  1.3
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53 Liver microsomes Not determined
?
Waddell et a l  (1992)
Table 1 The facilitative glucose transporter family
71.1.3.1 GLUT1 - the erythrocyte-type glucose transporter
The first member of the glucose transporter family is GLUT1. Mueckler and 
co-workers (1985) screened a cDNA library prepared using RNA from the human 
hepG2 hepatoma cell line and isolated a cDNA encoding a 492 amino acid glucose 
transport protein. This perhaps is the best studied glucose transporter (Gould and 
Holman, 1993).
Utilising both cDNA and antibodies probes, many subsequent studies have 
demonstrated that both the GLUT1 protein and mRNA is present in many tissues and 
cells (Mueckler et al., 1990; Flier and Kahn, 1990). It is expressed at highest levels 
in brain, but is also enriched in the cells of the blood-tissue barriers, such as the 
blood-brain/nerve barrier, the placenta, the retina etc (Froehner et al., 1988). The 
mRNA and protein for this transporter have also been demonstrated in muscle and fat 
tissue. Only very low levels of GLUT2 were found in the liver, the major tissue 
involved in the whole body glucose homoeostasis (Mueckler et a l., 1990).
Gould et al. (1991) have investigated the kinetics of isolated GLUT1 by 
functional expression of the protein in Xenopus oocytes. Transport rate is determined 
by both the Vmax, maximal velocity, and Km which inversely reflects the affinity for 
glucose. Under equilibrium exchange conditions a Km for 3-0-methyl-D-glucose of 
about 17 mM has been obtained. This agrees well with the results that Carruthers 
reported (1990) who studied human erythrocytes. They found the range of Km values 
under equilibrium exchange conditions for D-glucose was 17-38 mM.
Low levels of GLUT1 are expressed in adipose, muscle, kidney, colon and 
liver tissue (Gould and Bell, 1990). This indicates that GLUT1 plays a role in 
supplying the basal glucose requirements of cells (Mueckler, 1990).
81.1.3.2 GLUT2 - The liver-type glucose transporter
The inability to detect GLUT1 in hepatocyte membranes, and also the 
observation that the kinetics of glucose transport in hepatocytes were radically 
different from erythrocytes, indicated that a distinct transporter may be expressed in 
hepatocytes.
1988, Thorens et al. cloned and sequenced GLUT2 from rat. This isoform has 
been also cloned and sequenced from mouse (Asano et al., 1989) and human liver 
(Fukumoto et al. , 1988).
The rat gene codes for a protein with 522 amino acids which shares 82% 
sequence identity with the 524 amino acid human protein (Gould and Bell, 1990).
Further analysis of the sites of expression of GLUT2 demonstrated that this 
isoform is expressed at highest levels in the liver, pancreatic fl-cells, kidney and small 
intestine (Thorens et al. , 1988; Fukumoto et al. , 1988).
The apparent molecular weight of GLUT2 for different tissue is slightly 
different. The rat GLUT2 varies from 55-61 kDa, the liver GLUT2 is about 53 kDa, 
the islet B-cells is about 55 kDa, in kidney it is 57 kDa and in intestine it is 51 kDa 
(Thorens et al. , 1988).
The big different between GLUT2 and other transporter isoforms is that it has 
a high Km and Vmax and therefore it has a much lower affinity but has a higher 
capacity for transport at high concentrations of substrate. This means that the rate of 
flux through this transporter will be directly proportional to concentration over a wide 
range. It has been suggested that this property allows GLUT2 to participate in 
glucose sensing by the pancreatic 6 -cell and is favourable for the transepithelial
9movement of glucose in the small intestine and kidney, and the regulation of 
circulating glucose levels by the liver (Okuno and Gliemann, 1986).
1.1.3.3 GLUT3 - The brain-type glucose transporter
The development of the low-stringency hybridization approach to cloning 
transporter-like cDNAs was subsequently applied to other tissues. Using this 
approach, Kayano et al. (1988) screened a human foetal muscle library for the 
expression of transporter-proteins and isolated a novel transporter-like cDNA. This 
protein is GLUT3. Its predominant site of expression is brain, and its lower levels 
have been found in fat, kidney, liver and muscle tissue (Gould and Holman, 1993).
The human GLUT3 gene codes for a 496 amino acid protein which shares 
64% and 52% identity with GLUT1 and GLUT2, respectively, with 83% amino acid 
sequence identity between the sequences of human and mouse GLUT3 (Nagamatsu et 
al., 1992).
Gould et al. (1991) have reported that under equilibrium exchange conditions 
a Km for 3-O-methyl-D-glucose uptake is * 1 0  mM for GLUT3 expressed in 
Xenopus oocytes.
The expression of GLUT3 in brain indicates that two facilitative glucose 
transporters, GLUT1 and GLUT3 are involved in the uptake and disposal of glucose 
in this tissue. GLUT1 is primarily responsible for the transport across the blood-brain 
barrier, whereas GLUT3 probably controls glucose uptake into neuronal cells 
(Gerhart et al. , 1992; Nagamatsu et al, 1992).
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1.1.3.4 GLUT4 - The insulin-responsive glucose transporter
Following the success in utilizing a GLUT1 cDNA probe to obtain the 
homologous sequence of GLUT2 and GLUT3, the fourth glucose transporter isoform 
has been cloned by 5 independent groups in 1989 (James et al., 1989; Bimbaum, 
1989; Fukumoto et al., 1989; Charron et al., 1989; Kaestner et al., 1989). The 
putative topology of the rat GLUT4 glucose transporter protein shows in Fig. 2. This 
isoform is the insulin-responsive glucose transporter isoform. It only occurs in muscle 
and adipose tissue and it is in these tissues that insulin produces an *  30 fold increase 
in glucose transport.
James et al. (1989) have reported that the rat gene encodes a 509 amino acid 
protein with an apparent molecular mass of 43 kDa, or when deglycosylated, the 
molecular mass is 38 kDa. Other groups have reported an apparent molecular mass of 
50-55 kDa (Bimbaum, 1989; Fukumoto et al., 1989; Charron et al., 1989).
It has been found that human GLUT4 has 65 % sequence identity with human 
GLUT1, 54% with GLUT2 and 58% with GLUT3. The sequence of GLUT4 is 
highly conserved, and there is 95 and 96% identity between the sequence of human 
and rat or mouse GLUT4, respectively. GLUT4 mRNA is found at highest levels in 
brown and white adipose tissue, and also in cardiac and skeletal muscle (Bimbaum, 
1989; James et al. , 1989; Kaestner et al. , 1989).
Expressing GLUT4 in Xenopus oocytes has indicated that a Km for 3-0- 
methyl-D-glucose transport is 1.8 mM. This was measured under equilibrium 
exchange conditions (Keller et al. , 1989).
Studies using isoform-specific antibodies have demonstrated that in rat 
adipocytes 90% of the glucose transporters are GLUT4 and about 3-5% are GLUT1
11
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Fig.2 Putative topology of the rat GLUT4 glucose transporter Protein.
The transporter is drawn with the cytoplasmic surface of the plasma membrane 
facing downward. The probable single site of N-linked glycosylation is indicated 
(CHO), as are the amino and carboxy termini. Amino acids that are identical in the 
rat GLUT1 and GLUT4 glucose transporters are represented by black circles and 
conservative differences are shown as shaded circles. The precise locations of the 
borders of the transmembrane segments are arbitrary and drawn for convenience of 
representation. The overall sequence identity between the two transporters is 63.5%. 
However, the identity between the putative membrane-spanning domains is 73.0%, 
and the identity between the three large cytoplasmic domains of GLUT1 and GLUT4 
is 40.5%. (Form Birnbaum, 1989)
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(Oka et al., 1988; Zorzano et al., 1989). Under basal conditions, GLUT4 is 
predominantiy localized to an intracellular vesicle population with little being present 
in the plasma membrane. In contrast, GLUT1 is distributed approximately equally 
between plasma membrane and intracellular low density microsomal fractions. In 
response to insulin, the amount of GLUT4 present at the cell surface increases 15-20 
fold, while GLUT1 increases only 3-5 fold (Holman et al., 1990). This indicates that 
GLUT4 is the major isoform to response to insulin. The proposed translocation of 
GLUT4 has become know as the "recruitment hypothesis" (Cushman and Wardzala, 
1980; Suzuki and Kono, 1980). This will be introduced later.
In insulin-resistant states such as diabetes mellitus, obesity and fasting, 
GLUT4 expression is decreased in adipocytes and muscle tissue which results in 
decreased glucose uptake in response to insulin (Kahn and Flier, 1990).
1.1.3.5 GLUT5 - The small-intestine glucose transporter
Kayano et al. (1990) isolated a glucose transporter cDNA from human small 
intestine. Northern blot analysis has suggested that this isoform is mainly in small 
intestine, but detectable levels of GLUT 5 mRNA have also been reported in human 
fat and muscle tissue. The protein appears to be localised exclusively to the apical- 
brush-border on the luminal side of the epithelial cells. (Davidson et al. , 1992).
Human GLUT5 shares 42, 40, 39, and 42% identity with human GLUT1, 
GLUT2, GLUT3, and GLUT4, respectively (Kayano et al., 1990).
Its role is at present unclear. Since the transport of glucose from the lumen 
into the epithelial cell is normal mediated predominantly by the unrelated Na+ 
dependent glucose transporter, the presence of a facilitative glucose transporter in the 
brush-border is not easily explained (Gould and Holman, 1993). Recent evidence
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(Burant et al., 1992) suggests GLUT5 is a fructose transporter.
1.1.3.6 The pseudogene-GLUT6
Kayono et al. (1990), have sequenced a facilitative glucose transporter-like 
cDNA and designated this as GLUT6 . The gene has been identified in a number of 
tissues but the sequence cannot encode a functional transporter protein.
1.1.3.7 A hepatic microsomal glucose transporter-GLUT7
GLUT7 is the most recently identified member of the glucose transporter 
family. It is found in the liver endoplasmic reticulum and nuclear envelope but not in 
the plasma membrane. GLUT7 codes for a 528 amino acid protein and is 6 8 % 
identical to GLUT2 (Waddell et a l , 1992).
1.2 PHOTO AFFINITY LABELLING OF THE FACILITATIVE GLUCOSE 
TRANSPORTER
Mueckler et al. (1985) have cloned and sequenced a hepatoma cDNA for the 
facilitative glucose transporter and the molecular weight of this transporter is about 
55 kDa. It occurs in the 4.5 band of SDS-polyacrylamide gels of the erythrocyte 
membrane. The availability of this sequence for the transporter is a major 
breakthrough in the investigation of glucose transport. To understand which regions 
of the transporter are involved in glucose transport, photoaffinity labelling of the 
glucose transporter has been used in such studies.
There are a number of compounds which have been reported to be affinity or 
photoaffinity labels for the hexose transporter in human erythrocytes. These include 
D-maltosylisothiocyanate (Mullins and Langdon, 1980) and 6-N-(4-azido-2-hydroxy-
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3, 5-diiodobenzoyl-D-glucosamine (Weber and Eichholz, 1985). The most widely 
used compound is the fungal metabolite, cytochalasin B.
Cytochalasin B is a potent inhibitor of facilitative glucose transport (Jung and 
Rampal, 1977; Deves and Krupka, 1978; Axelrod and Pilch, 1983) and is thought to 
bind to an internal site on the transporter (Basketter and Widdas, 1978; Baldwin and 
Lienhard, 1980). It binds the transporter between membrane spanning regions M10 
and M il (Holman and Rees, 1987). In the presence of high intensity ultraviolet light 
cytochalasin B can bind covalently to the erythrocyte transporter and rat adipocytes 
(Carter-Su et al., 1982; Oka and Czech, 1984).
A number of bis (D-mannose) compounds have been reported by Holman and 
associates (Midgeley et al. , 1985; Holman et al., 1986; Holman et al., 1988; Clark 
and Holman, 1990). They are l,3-bis-(D-mannos-4'yloxy) propyl-2-amine (BMPA) 
derivatives. These compounds have been considered as photoaffinity labels for the 
external site of the transporter. These compounds are synthesized from two D- 
mannose moieties joined at their C-4' positions by a 2-propylamine bridge. The 
photolabel substituent is attached through the amino group. They have high affinity 
for the hexose transporter of both the human erythrocyte and the rat adipocyte. 
During a period of 90 min time, the compounds have not been found to be taken up 
into either type of cells.
A 4-azidosalicylate derivative of BMPA (ASA-BMPA) has been shown to 
successfully label the band 4.5 transporter peptide of erythrocytes (Holman et al. , 
1986) and binds to the exofacial surface of the transporter, probably between 
membrane-spanning regions M9 and M10 (Holman and Rees, 1987). It has been 
shown that it is a good photoaffinity label for the erythrocyte hexose transporter 
(Holman et al., 1986). But with ASA-BMPA, Holman et al. (1986) have observed 
some labelling (about 10-15% of total) in an additional band at about 75 kDa and also
15
it was found to be unsuitable for labelling adipocytes in which the transporter was 
present in low abundance.
The ligands containing precursor groups such as benzophonone or 
azitrifluoroethyl benzoyl groups, which produce carbenes, on irradiation, were found 
to be more effective (Holman et al., 1988). The benzophenone derivative of 1,3- 
bis(D-mannos-4-yloxy)-2-propylamine(BB-BMPA) and 2N-4(l-azi-2,2,2- 
trifluoroethyl)benzoyl-l,3 bis(D-mannose-4-yloxy)2-propylamine (ATB-BMPA) both 
label the erythrocyte and adipocyte transporters (Holman et al., 1988; Clark and 
Holman, 1990; Holman et al., 1990). The structure of ATB-BMPA is shown in 
Fig.3.
The advantage of ATB-BMPA is that this compound is impermeable and 
photolabelling can be confined to the discrete plasma membrane pool of glucose 
transporters. Also ATB-BMPA is very stable in the dark and is soluble in 
physiological buffers. Using this compound to estimate the levels of glucose 
transporter on the cell surface is independent of the homogenization protocol. 
Because microsomal glucose transporters will not be exposed to or bind the exofacial 
ligand during the photolabelling procedure the problem of contamination of the 
plasma membrane by microsomal transporters can be avoided by this approach. Thus 
the cell physiology of insulin's stimulation of glucose transport can be studied 
directly in the intact adipose cell. This in situ labelling allows cellular processing of 
the transporter to be followed. Thus the impermeable bis (hexoses) may be a good 
tool for studying the recruitment hypothesis for transporter activation by insulin 
(Holman et al. , 1990).
Recently, Davies et al. (Davies, Preston, Clark, Holman and Baldwin- 
unpublished work) have shown ATB-BMPA binds to GLUT1 on the exofacial surface 








Fig.3 Structure of ATB-BMPA. (From Clark and Holman, 1990)
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erythrocyte transporter on the exofacial surface of the transmembrane regions M9 and 
M10 (Holman and Rees, 1987). This suggest that transmembrane segments M7-M10 
are involved in ligand binding.
ATB-BMPA has successfully been used as an exofacial probe for the human 
erythrocyte glucose transport system (Clark et al., 1991) and also has been used for 
identifying cell surface glucose transporters in isolated rat adipose cells (Holman et 
al., 1990; Clark et al., 1991; Kozaka et al., 1992) and 3T3-L1 adipocytes (Kozka et 
al., 1991; Calderhead et al., 1990; Palfreyman et al., 1992 and present studies).
1.3 MURINE 3T3-L1 CELLS-A GOOD MODEL FOR THE STUDY OF 
GLUCOSE TRANSPORT
Green and colleagues (Green and Kehinde, 1974; 1975; 1976; Green and 
Meuth,1974) established a coloned line of murine 3T3-L1 cells. This cell line 
exhibits fibroblastic characteristics during rapid proliferation. Growth arrest occurs 
on attaining confluence and the cells undergo a spontaneous morphological change. 
Although the adipocyte conversion process can occur spontaneously over a period of 
2 to 4 weeks following confluence (Green and Meuth, 1974) conversion can be 
accelerated by treatment of the confluent cells with either 20 to 30 % serum (Green 
and Meuth, 1974), 0.18 /xM insulin (Green and Kehinde, 1976), 0.5 mM 
isobutylmethylxanthine (Russell and Ho, 1976), 0.3 juM prostaglandin F2 (Russell 
and Ho, 1976), 33 /xM biotin and combinations of insulin with any of the other 
agents or with 12.5 /xM indomethacin (Williams and Polakis, 1977).
Initially this cell line was used for testing the effect of drugs on lipid 
metabolism (Mackall et al., 1976), currently 3T3-L1 cells have been used as a good 
model to investigate the regulation of glucose transport. This cell type was chosen for 
several reasons:
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These cells can be differentiated to produce a reserve of internal glucose 
transporters which can be translocated to the cell surface in response to insulin. Like 
the rat adipocyte, it exhibits a 10-15 fold increase in the rate of hexose transport upon 
exposure to insulin (Frost and Lane, 1985).
The amount of transporter per 3T3-L1 adipocyte is almost as large as that per 
rat adipocyte (Schroer et al. , 1986).
GLUT1 is more abundant than GLUT4 in these cells. Quantitative 
immunoblotting studies indicate that there are about 950000 and 280000 molecules of 
GLUT1 and GLUT4, respectively, per cell (Calderhead et al. , 1990).
3T3-L1 cells growth as a monolayar allows a convenient and accurate assay of 
the rates of endocytosis and exocytosis (Gibbs et al. , 1986).
Preadipocyte 3T3-L1 cells transport glucose at low rates but after 
differentiation into mature adipocytes become insulin responsive and express a 
markedly elevated transport capacity (Rubin et al., 1978; Rosen et al., 1978; Reed 
and Lane, 1980). The GLUT4 is expressed in differentiated adipocytes but not in 
undifferentiated preadipocytes (Kaestner et a l ,  1989; Garcia de Herreros and 
Bimbaum, 1989; Tordjman et a l ,  1990; Weiland et al., 1990), while GLUT1 is 
expressed in both undifferentiated and differentiated 3T3-L1 adipocytes (Kaestner et 
al., 1989; James et a l ,  1989; Kaestner et al., 1989; Garcia de Herreros and 
Bimbaum, 1989; Tordjman et a l ,  1990; Reed et al., 1990; Weiland et a l ,  1990). A 
study of the subcellular distribution of glucose transporters revealed that the GLUT4 
was preferentially inserted into the intracellular compartment of the adipocytes, since 
90% of the total GLUT4 was found in the low-density microsomes (Weiland et a l ,
1990). In the fibroblasts, GLUT1 was almost exclusively located in the plasma 
membrane, whereas in differentiated cells it appeared to be re-distributed to the
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intracellular compartment, since approximately 60% of the total GLUT1 was detected 
in the low-density microsomes (Weiland et a l., 1990 and present study).
It is known that both GLUT1 and GLUT4 mRNA and total cellular protein 
rise in concentration during differentiation. By days 8-11 days after initiation of 
differentiation, the concentrations of these transporters within the cells reach a 
maximum.
The changes in transporter protein expression elicited by differentiation were 
attributed primarily to increased rates of transporter synthesis, while the 
disproportionate changes in mRNA and protein expression from chronic insulin 
treatment and starvation suggested these conditions increase synthesis and decrease 
turnover rates in regulating transporter protein expression (Reed et al., 1990). 
Chronic insulin exposure of differentiated adipocytes also increased cellular 
transporter mRNA and protein concentration (Reed et al., 1990). Glucose starvation 
increased transporter mRNA and protein levels in both undifferentiated preadipocytes 
and differentiated adipocytes.
It has been reported that large changes in cell-surface levels of glucose 
transporters occur in 3T3-L1 cells.
Piper et al., (1991) have reported that the ratio of the GLUT1:GLUT4 ratio 
was 5:1 in basal state. Using membrane impermeant bis-mannose photolabel ATB- 
BMPA, Calderhead et al., (1990) and Kozka et al., (1991) have reported that in 
basal cells the GLUT1:GLUT4 ratio was 3.5:1. Acute insulin treatment increases the 
cell-surface availability of both GLUT4 and GLUT1, so that both are present at the 
surface in equal amounts. The GLUT1:GLUT4 ratio is 1:1. Acute insulin treatment 
increase GLUT4 15-17 fold and GLUT1 3-7 fold.
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Chronic insulin treatment (24 hours) on 3T3-L1 adipocytes has been reported 
to increase GLUT1 by 4-5 fold, GLUT4 is down-regulated by 50%, as measured by 
surface ATB-BMPA labelling. The GLUT1:GLUT4 ratio increases to 10:1. This 
large increase in total concentrations of cell-surface transporters (the sum of GLUT1 
and GLUT4 concentrations) was not reflected in a large increase in 3-O-methyl-D- 
glucose transport, this suggesting that, compared to GLUT4, the GLUT1 makes a 
smaller contribution to transport (Kozka et al. , 1991).
To examine the proportion of newly synthesized transporters which become 
available at the cell surface, both cell surface and the total cellular pool of 
transporters have been measured with ATB-BMPA in this thesis. Permeabilization of 
3T3-L1 cells with digitonin can allow the normally impermeant photolabel access to 
those transporters that are sequestered within the cell.
1.4 INSULIN STIMULATION OF GLUCOSE TRANSPORT
One important area of insulin action is the stimulation of glucose transport. 
Insulin's effect to stimulate the transport of glucose into cell was first demonstrated in 
intact animals over 40 years ago, but the molecular basis of this insulin effect was not 
understood.
Insulin increase the Vmax of glucose transport in adipocytes without affecting 
the Km (Whitesell and Glieemann, 1979; Luvigsen and Jarett, 1980; Taylor and 
Holman, 1981). This could be either by increasing the number of active transporters 
in the plasma membrane, or by increasing the Vmax of already existing transporters. 
The former possibility could occur in one of two ways: either by conversion 
(activation) of a pre-existing, functionally inactive transporter system already in the 
plasma membrane, or by recruitment of functionally active transport systems to the 
plasma membrane from a separate, intracellular site.
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1.4.1 The translocation hypothesis
In 1980, Cushman, Kono, and their colleagues proposed a novel molecular 
mechanism by which insulin increased glucose transport in adipocytes (Cushman and 
Wardzala, 1980; Suzuki and Kono, 1980). These two groups independently 
demonstrated that the major effect of insulin on isolated rat adipocytes was to induce 
the translocation of an intracellular pool of glucose transporters to the plasma 
membrane; i.e. insulin increased the number of functional transport proteins at the 
surface of the cell.
Cushman and Wardzala (1980) using the cytochalasin B binding assay, found 
that the number of transporter-specific cytochalasin B binding sites associated with 
the microsomal fraction decreases in cells stimulated by insulin, by exactly the same 
amount as the number of sites associated with the plasma membrane fraction 
increased.
In a separate series of studies, Suzuki and Kono (1980) reconstituted the 
adipocyte glucose transporter (from plasma membrane and microsomal fractions) into 
liposomes, and assayed the transport activity directly. In agreement with the results 
of Cushman and Wardzala (1980), they were able to show directly that glucose 
transport activity in the subcellular, microsomal fraction decreased when the 
adipocytes were incubated with insulin, while that in the plasma membrane fraction 
increased.
Using the specific D-glucose-inhibitable [^H] cytochalasin B-binding assay, 
Kamielli et al., (1981a) have studied the time course, reversibility, and insulin 
concentration dependency of an insulin-induced translocation of glucose transport 
systems and they proposed a hypothetical mechanism of insulin's stimulation action 
on glucose transport in the isolated rat epididymal adipose cell (see Fig. 4).
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As illustrated, insulin associates with its receptor inducing a signal which is 
still unknown. In response to this signal, intracellular vesicles containing the glucose 
transporter are translocated by an exocytic-like mechanism to the plasma membrane 
in a manner comparable to the various secretory processes (Pollard et al. , 1979; 
Mehler et al., 1980). Following fusion of these vesicles with the plasma membrane, 
glucose transporters are then exposed to the extracellular medium and the glucose 
transport activity is increased.
In the reversal of this process (following dissociation of insulin from its 
receptor) glucose transporters are translocated back to the same intracellular pool by 
an endocytic-like mechanism similar to receptor-mediated endocytosis (Silverstein et 
al., 1977). This recycling process could occur continuously if the insulin receptors 
were occupied.
Since this translocation or so called recruitment hypothesis was proposed there 
has been considerable evidence to support this hypothesis.
Studies were also carried out on the insulin-resistant states that accompany 
streptozotocin-induced diabetes and maturity obesity in rats. In these animals, 
stimulation of adipocyte glucose transport by insulin is impaired, though insulin 
binding is increased. It now appears that this impairment is due to depletion of 
intracellular transport systems (Kamielli et al., 1981b) such that full stimulation can 
not occur.
Studies on isolated rat diaphragm using the cytochalasin B binding technique 
have shown that glucose transport in this tissue is also stimulated by recruitment of 
transporters from an intracellular site (Wardzala and Jeanrenaud, 1981,1983), and the 

















Schematic representation of a hypothetical mechanism of insulin's 
stimulatory action on glucose transport in the isolated rat 
epididymal adipose cell.
(From Kamielli et al., 1981)
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Watanabe et al. (1984) studied the insulin action on glucose transport in 
cardiac muscle. In this study, rat heart were perfused either in the presence or 
absence of insulin and then homogenized. The homogenate was fractionated, and the 
glucose transport activity in subcellular fractions was assayed by the reconstitution 
method. They found insulin appears to increase the glucose transport activity in rat 
hearts at least in part, by inducing translocation of the glucose transport mechanism 
from the unidentified vesicles (in fraction p 6 ) to the plasma membrane (in fraction p-
5).
Klip et al. (1987) used glucose-inhibitable cytochalasin B binding to estimate 
the number of glucose transporters in membrane fractions from insulinized and 
control muscles. Insulin treatment caused an approx. 2 fold increase in cytochalasin 
B-binding sites in the plasma membrane fraction and an approx. 70% decrease in 
cytochalasin B - binding sites in an intracellular membrane fraction.
Although the transport of glucose itself does not need ATP, the translocation 
of glucose transporters in response to insulin and reversal of this process are ATP- 
dependent (Klip et al., 1987; Simpson and Cushman, 1986).
The above findings indicate that the mechanism by which insulin stimulates 
facilitated glucose transport may be similar in both adipose and muscle tissue.
James et al 1988 isolated and characterized a monoclonal antibody, 1F8, that 
recognizes the insulin-regulated glucose transporter of adipocytes. The results using 
this antibody showed a marked translocation from the LDM to the plasma membrane 
in response to insulin and they named this protein as insulin regulatable glucose 
transporter. Subsequently, Zorzano et al. (1989) reported that rat adipocytes possess 
two immunologically distinct glucose-transporters; one recognized by 1F8, now 
known to be GLUT4 and one reactive with antibody raised against the human
25
erythrocyte glucose transporter-GLUTl. Immunoadsorption experiments indicate that 
these glucose transporters reside in different vesicle population and that both 
transporter isoforms translocate from intracellular sites to the plasma membrane in 
response to insulin.
Evidence for translocation has also come from use of the membrane 
impermeant photoaffinity labelling technique. Holman et al. (1988) have reported 
that photoincorporation of cell impermeant, exofacial photoaffinity reagent(BB- 
BMPA) into a 50-kDa plasma membrane protein of intact insulin treated adipocytes is 
blocked by cytochalasin B and 3-O-methylglucose. This plasma membrane protein 
has the characteristics expected of the glucose transporter. The photoincorporation of 
BB-BMPA into this protein is at least seven fold greater in insulin-treated versus 
basal intact adipocytes. Approximately 30% of plasma membrane carrier labelled in 
insulin treated intact cells recycles to the LDM fraction within 40 min. These 
experiments demonstrate that carrier recruitment is at least seven fold, and turnover 
(recycling) of carrier in insulin treated cells is much faster than in basal cells. The 
GLUT1 and GLUT4 antibodies were not available for this study.
Holman et al. (1990) synthesised another impermeant photoaffinity label 
(ATB-BMPA) (see 1:2). They have used this reagent to photolabel the GLUT4 and 
GLUT1 on the surface of the intact adipose in order to estimate the relative 
abundance of these two transporters on the cell surface following insulin stimulation. 
In response to insulin, GLUT4 increases 15-20 fold and GLUT1 increases 5 fold 
compared to basal state while 3-O-methyl-D-glucose transport is stimulated 20-30 
fold. The « 2 0  fold increase in the recruitment of the GLUT4 glucose transporter 
isoform can explain most of insulin's stimulation of glucose transport activity.
Calderhead et al. (1990) used ATB-BMPA to label the surface transporters 
GLUT1 and GLUT4 in 3T3-L1 adipocytes. They found the increases in GLUT1 and
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GLUT4 averaged 6.5-and 17- fold respectively, whereas there was a 21 fold in 
hexose transport. These results indicate that the translocation of GLUT4 could largely 
account for the insulin effect on transport rate, but only if the intrinsic activity of 
GLUT4 is much higher than that of GLUT1.
Widnell et al. (1990) reported using an immunofluorescence technique to 
localize the glucose transporter protein in BHK cells, they found that hyperthermia, 
treatment with arsenite, infection with vesicular stomatitis virus or Semliki Forest 
virus, and treatment with insulin cause the transporter to move from an intracellular 
site in the perinuclear region to the plasma membrane; the degree of translocation 
correlates approximately with the increase in glucose uptake. They conclude that 
stress induces an insulin-like distribution of certain membrane proteins.
Studies investigated by using electron microscopy give direct evidence to 
support the translocation hypothesis.
Blok et al. (1988) used immunocytochemistry and a GLUT1 antibody with a 
protein A-gold technique to study the effect of insulin on the cellular distribution of 
the GLUT1 in 3T3-L1 adipocytes. They reported that insulin induced a threefold 
increase in the number of these transporters in the plasma membrane and that these 
transporters were recruited from an intracellular compartment located mainly at the 
trans side of the Golgi complex.
Slot et al. (1991a) studied on cardiac myocytes of the rat. The insulin 
regulated glucose transporter GLUT4 was immunolocalized in rat cardiac muscle 
under conditions of basal and insulin stimulated states. In basal myocytes there was 
very little (<1% ) GLUT4 in the different domains of the plasma membrane. Upon 
insulin stimulation about 42% of GLUT4 was found in the plasma membrane.
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A very elegant study by Slot et al. (1991b), has clearly shown that insulin 
produces a very large increase in GLUT4 in the plasma membrane of brown adipose 
tissue as detected by immunogold electron microscopy. The increase in plasma 
membrane transporter was paralleled by a decrease in glucose transporter in a 
cytoplasmic pool associated with tubulo-vesicular structures. They conclude that 
translocation of GLUT4 to the cell surface is the major mechanism by which insulin 
increases glucose transport.
1.4.2 The intrinsic activation hypothesis
It is believed that translocation of glucose transporters from an intracellular 
pool to the plasma membrane can account for most of the effect of insulin on glucose 
transport. In addition to recruitment, glucose uptake may also be regulated by 
altering the intrinsic activity of the glucose transporter.
Clark et al. (1991) have used ATB-BMPA to photolabel the glucose 
transporter isoform GLUT4 and GLUT1 in rat adipose cells. They labelled both the 
plasma membrane fractions and light microsome membrane fraction using this 
reagent. The labelling of GLUT4 in the plasma membrane fraction from insulin 
treated cells was about 3 fold higher than that of basal cells and corresponded with a 
decrease in the labelling of the light microsome fraction. The cell surface labelling of 
GLUT4 from insulin treated intact adipose cells was increased about 15-20 fold above 
basal levels. Insulin stimulated glucose transport activity increased about 30 fold. 
Thus the cell surface labelling, but not the labelling of membrane fractions, closely 
corresponded with the stimulation of transport. The remaining discrepancy may be 




The discrepancy between glucose transporter number and activity is even 
more pronounced when the actions of hormones such as catecholamines, 
adrenocorticotrophin (ACTH) and glucagon are studied. These hormones are 
mediated by Gs-coupled receptors (Rs). Adenosine, prostaglandins and nicotinic acid, 
agents whose actions are mediated by Gi-coupled receptors (Ri), are superimposed 
upon insulin stimulation (Kuroda et al., 1987; Joost et al., 1987). Rs receptors 
therefore mediate inhibition and Ri receptors mediate augmentation of insulin- 
stimulated glucose transport activity and these changes are independent of changes in 
cAMP-dependent protein kinase activity (Kuroda et al., 1987). The changes in 
insulin-stimulated glucose transport induced by Rs and Ri receptors occurred without 
a major change in the subcellular distribution of glucose transporters. This has been 
detected by cytochalasin B binding (Kuroda et al. , 1987) and ATB-BMPA labelling 
(Vannucci et al., 1992). This had led to the hypothesis that these hormones alter the 
intrinsic activity of the glucose transporter in the plasma membrane (Kuroda et al.,
1987).
The mechanism responsible for modulating the intrinsic activity of the 
facilitative glucose transporters is still not clear. There is some evidence that both 
GLUT1 and GLUT4 can be phosphorylated. GLUT1 by protein kinase C (Gibbs et 
al., 1986) and GLUT4 by protein kinase A (Lawrence et al., 1990a). The site of 
protein kinase C-mediated phosphorylation of GLUT1 has not been determined. The 
site of phosphorylation of rat GLUT4 by protein kinase A is restricted to the region 
of the putative intracellular COOH-terminal domain at S e r ^  and is conserved in the 
sequences of rat, human and mouse GLUT4 (Lawrence et al., 1990a).
Czech and co-workers (1980) proposed that an activation of transporters 
already in the membrane must play a significant role in transport stimulation. Studies 
on 3T3-L1 cells in their group, have indicated that GLUT1 and GLUT4 present in 
these cells is already largely present on the cell surface in resting cells. However, its
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catalytic activity is markedly suppressed by a mechanism that blocks its binding to 
extracellular sugar molecules. They propose that in 3T3-L1 cells, the restraint on 
GLUT1 catalytic activity is released by known glucose transport activators, including 
insulin itself, cholera toxin, cadmium and protein synthesis inhibitors (Harrison et al. 
1991a, Clancy et al. 1991, Harrison et al., 1991b).
A stimulation of glucose transport by incubation at alkaline pH has been 
reported in rat adipocytes and an apparent translocation of glucose transporters to the 
plasma membrane has been suggested as a possible mechanism (Sonne et al., 1981; 
Toyoda et al. , 1986)
To investigation the translocation mechanism, in this thesis, studies on dose 
response of insulin-stimulated translocation of GLUT1 and GLUT4 have been carried 
out in 3T3-L1 adipocytes at different pH conditions.
1.5 REGULATION OF GLUCOSE TRANSPORT
1.5.1 Insulin signalling
Stimulation of glucose transport is one of the fundamental responses to 
insulin. The signals that mediate between insulin binding to stimulation of transport 
are still not very clear. However, considerable progress in the last few years has 
suggested that at least two possible routes may be involved in this response. These 
are from the tyrosine-specific kinase activity of the insulin receptor, and from insulin 
receptor activation of the serine and threonine-specific kinase which possibly does not 
involve the tyrosine kinase activity of the receptor (Klip and Douen, 1989).
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1.5.1.1 The insulin receptor kinase
The insulin receptor is an integral membrane glycoprotein consisting of two 
a-subunits (Mr *135000) and two B-subunits (Mr *95000) linked by disulphide 
bridges to yield a symmetrical Ba-aB complex (Massague et al. , 1980). The a- 
subunit contains the insulin binding domain and the fi-subunits contains an insulin 
tyrosine-specific kinase (Ebina et al., 1985; Ullrich et al., 1985).
It is believed that insulin-induced conformational changes of the receptor 
transfer a signal from the extracellular to the cytoplasmic receptor domains, leading 
to the activation of the B-subunit associated tyrosine kinase (Ebina et al. , 1985; 
Ullrich et al., 1985).
Insulin induces phosphorylation of several endogenous proteins on tyrosine 
residues, which differ from tissue to tissue. In 3T3-L1 adipocytes, insulin-induced B- 
subunit phosphorylation was complete within 1 min (tj/ 2  =  8  sec), while a 1 min 
latency period preceded insulin activation of hexose transport (Kohanski et al., 
1986). Removal of insulin from the medium resulted in rapid loss of phosphorylation 
( *1/2 = 2.5 min), while hexose transport decreased with a tj / 2  of 8  min. The 
observation that the time course of stimulation and reversal of receptor kinase activity 
precedes effects on glucose transport suggests that tyrosine kinase activation is rapid 
enough to elicit slower down-stream signalling processes (Klip and Douen, 1989).
1.5.1.2 Post-receptor signalling
White et al. (1985, 1987) have reported that insulin stimulates the tyrosyl 
phosphorylation of a 165-185 kDa protein in intact cells. This phosphoprotein, called 
ppl85, is barely detectable in cells expressing few insulin receptors, strongly detected 
in cells expressing high levels of receptors and weakly detected in cells expressing
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mutant receptors defective in biological signaling (White et a l., 1988; Backer et al., 
1991; Wilden et al., 1992). Thus, ppl85 appears to be a substrate of the insulin 
receptor which plays a significant role in the early stages of post-receptor insulin 
signal transduction.
Rothenberg et al. (1990) have purified a protein from rat liver in the ppl85 
band. The complementary DNA sequence encodes a 131 kDa hydrophilic protein 
called insulin receptor substrate-1 (IRS-1) (Sun et al., 1991). IRS-1 contains a 
kinase-like ATP-binding site, many potential serine and threonine phosphorylation 
sites and at least 14 potential tyrosine phosphorylation sites. Six of these tyrosyl 
residues are located in YMXM motifs and three others are in YXXM motifs. 
Synthetic peptides based on the sequence of these YXXM motifs are excellent 
substrates of the insulin receptor, with Km values between 24 and 100 nM (Shoelsone 
e ta l., 1992).
Backer et al. (1992) have found that during insulin stimulation, the IRS-1 
protein undergoes tyrosine phosphorylation and binds phosphatidylinositol 3 kinase 
(PI3-kinase). Purification of PI-3 kinase has demonstrated that the kinase is a 
heterodimer consisting of 85-kDa (p85) and 110-kDa (pi 10) subunits (Carpenter et 
al., 1990; Morgan et al., 1990; Shibasaki et al., 1991). The amino acid sequence of 
p85 showed that the protein contains (SH) Src homology regions: two SH-2 domains 
and one SH-3 domain (Otsu et al. , 1991; Escobedo et al., 1991; Skolnik et al.,
1991). The SH-2 domains are involved in interactions with tyrosine-phosphorylated 
proteins (Koch et a l ,  1991). Binding to IRS-1 increases the specific activity of PI3- 
kinase in insulin stimulated cells and overexpression of IRS-1 potentiates insulin 
stimulation of PI3-kinase. This activation occurs both in vivo and in vitro. These 
finding suggest that tyrosyl phosphorylation of IRS-1 by the insulin receptor and the 
subsequent association of IRS-1 with p85 activates PI3-kinase (Backer et al., 1992).
32
Kelly et al. (1992) have reported that upon stimulation of rat adipocytes with 
insulin, the majority of IRS1 precipitatable PI3-kinase is found in the low-density 
microsomes. The significance of this in terms of coupling to glucose transporter 
vesicular trafficking is at present unclear.
1.5.2 Role of protein kinase C in glucose transport
Protein kinase C is a Ca 2 +  and phospholipid-dependent enzyme that is 
activated by diacylgycerol (Kishimoto et al., 1980). There is some evidence to show 
that protein kinase C plays a role in glucose transport.
The activators of protein kinase C, such as phorbol 12-myristate 13-acetate 
(PMA) have been show can increase glucose transport. Saltis et al. (1991) found that 
both insulin and PMA increased GLUT1 in the plasma membranes about 1.5 fold, 
but the latter effected only about 35% of the six fold stimulation by insulin of 
GLUT4 translocation. Vogt et al. (1991) reported that PMA had no effect on GLUT1 
but caused a 2.5 fold stimulation of the redistribution of GLUT4. In both studies, the 
PMA-dependent change in transport roughly correlated with the translocation of 
GLUT4 to the cell surface. Using the impermeant glucose transporter photolabel- 
ATB-BMPA, Holman et al. (1990) have reported that PMA stimulated approximately 
four and five fold increases in cell surface GLUT4 and GLUT1 respectively in rat 
adipocytes. This is concomitant with an approximate three fold increase in 3-O-MG 
uptake. Similar results were obtained in 3T3-L1 adipocytes (Gibbs et al., 1991). In 
any case, the protein kinase C activators are less effective than insulin and this 
suggests that non-protein kinase C dependent mechanisms may be operative during 
insulin stimulation.
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1.5.3 Cyclic AMP and phosphorylation
In 1986, Joost et al. have reported that isoproterenol, in the presence of 
adenosine deaminase, inhibited the stimulation of glucose transport by insulin (Joost 
et al., 1986). The inhibitory effect is thought to be due to a decrease in the intrinsic 
activity of the glucose transporter of the plasma membrane rather than a change in 
subcellular distribution of the glucose transporter (Joost et al., 1987). There is some 
evidence that the inhibitory effect of B-adrenergic agents is not mediated by an 
increase in cyclic AMP, but is related to direct interactions of G-proteins with the 
transporter or an associated regulatory protein (Kuroda et al. , 1987).
James et al. (1989) have reported that the inhibitory effects of B-adrenergic 
agents on glucose transport in rat adipocytes are a result of a cyclic AMP-dependent 
phosphorylation of GLUT4. In metabolically labelled rat adipocytes, isoproterenol 
stimulated the incorporation of ^ P  into GLUT4 by about twofold in both plasma 
membranes and low-density microsomes. This was mimicked by analogs of cyclic 
AMP and occurred in broken cells in the presence of the catalytic subunit of cyclic 
AMP-dependent protein kinase and [t^PJATP.
The amino acid phosphorylated in response to an elevation in cyclic AMP has 
been mapped to Ser*8 8 , located at the carboxyl terminus of GLUT4 (Lawrence et 
al., 1990a). Because Ser^^ is unique to GLUT4, they suggest that GLUT4 may be 
uniquely regulated by phosphorylation. Derivatives of cAMP also stimulated 
transporter phosphorylation, suggesting that the response to the B-adrenergic agonist 
occurred via a cAMP-dependent pathway (James et al. , 1989).
Okadaic acid, an inhibitor of protein phosphatase-1 and -2A, has been shown 
to stimulate 2-deoxy-D-glucose uptake in rat adipocytes (Haystead et al. , 1989) and 
this suggested that there is a role for phosphorylation in regulating glucose transport
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activity in insulin-responsive cells. Lawrence et al. (1990b) reported that okadaic acid 
was about 50% as potent as insulin in stimulating hexose uptake in adipocytes. When 
it is present with insulin, it slightly inhibited the stimulation by a maximal 
concentration of insulin. Measurements of GLUT4 levels in subcellular fractions of 
adipocytes, indicated that both the stimulatory and inhibitory effects of the 
phosphatase inhibitor correlated reasonably well with the amount of GLUT4 protein 
in the plasma membrane and suggested that the inhibition effect on insulin-stimulated 
glucose transporter translocation by okadaic acid may be due to phosphorylation of 
GLUT4 which promotes its internalization (Lawrence et al. , 1990b).
1.6 RECEPTOR-MEDIATED ENDOCYTOSIS
To better understand the effect of insulin on translocation of GLUT1 and 
GLUT4 to the cell surface, it is important to study the cellular-trafficking pathways 
of GLUT1 and GLUT4.
Immunocytochemical studies suggest that glucose transporter trafficking is a 
regulated process similar to the receptor-mediated endocytosis that occurs in the 
processing of receptors such as the transferrin, asialoglycoprotein and insulin receptor 
(Goldstein et al., 1985; Stoorvogel et al., 1987; Tanner and Leinhard, 1987; Sonne,
1988).
1.6 .1 Outline of receptor-mediated endocytosis
In most animal cells, clathrin-coated pits and vesicles provide an efficient 
pathway for taking up specific macromolecules from the extracellular fluid, this 
process is called receptor-mediated endocytosis.
The studies on the internalisation of low-density lipoproteins (LDL) outlined
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some of the early events in the pathway (Anderson et al. , 1977). (see Fig. 5).
Ligands bind to specific membrane-spanning receptors located on the cell 
surface and the receptor/ligand complexes become clustered into coated pits. The 
major component of the coat is a protein, termed clathrin, which was first identified 
by Pearse (1975, 1976). The basic structural unit of clathrin is a complex of three 
molecules of clathrin heavy chain (180 kDa) and three molecules of clathrin light 
chain (30-40 kDa) in a three-legged structure termed a triskelion ( Kirchhausen and 
Harrison, 1981; Ungewickell and Branton, 1982). Clathrin interacts with the 
cytoplasmic tail of a receptor probably via adaptor proteins (Pearse, 1988). Clathrin 
forms lattices on the plasma membrane and growth and rearrangement of this lattice 
causes invagination of the pit. Scission of the deeply invaginated coated pit results in 
the release of a coated vesicle from the plasma membrane which carries the ligand 
into the cell.
Some receptors like the LDL-receptor, are clustered in coated pits and 
internalized even when unoccupied. Other receptor, for example of some growth 
factors and hormones, migrate into the pit and are internalized only after binding of 
their respective ligands (Goldstein et al., 1985). In the latter example, protein kinase 
C-mediated phosphorylation and auto-phosphorylation events have been proposed as 
regulatory mechanisms (Carpenter, 1987).
The coated vesicles are rapidly uncoated and these vesicles fuse to form the 
early endosome system.
In part of the early endosome system the receptor and ligands are sorted for 
directing to different destinations. They may be targeted to the lysosome for 
degradation (Stoscheck and Carpenter, 1984) or recycled back to the cell surface.
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Fig.5 Outline of receptor-mediated endocytosis.
Ligands to be internalised bind to specific receptors on the cell surface. These 
receptor/ligand complexes become clustered in specialised areas of the plasma 
membrane, termed coated pits. After invagination and scission to form a coated 
vesicle, the coat is rapidly removed. Fusion with the early endosome exposes the 
receptor/ligand complexes to reduced pH which causes dissociation of ligand and 
receptor. Ligands may be transferred through late endosomes while those receptors 
which recycle are returned to the cell surface. (From Anderson et a l. , 1977)
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The techniques of site-directed mutagenesis, cell-free assays and cell 
fractionation have been used to elucidate the endocytic mechanism.
1.6.2 Adaptors in coated pits and vesicles
A family of 100-kDa and 50-kDa proteins termed adaptors have been found 
which can recognise a signal in the cytoplasmic tail of receptors (Pearse, 1988). 
Because of their ability to enhance the assembly of clathrin lattices in vitro they have 
also been named assembly proteins (Zaremba and Keen, 1983).
The role of the adaptor proteins is to link clathrin to the membrane (Unanue et 
al., 1981). The isolated adaptor proteins bind specifically to an integral membrane 
protein in alkaline-extracted membranes from bovine brain. The binding of clathrin to 
these membrane was adaptor dependent (Virshup and Bennett, 1988). In order to link 
the selected components into the clathrin, the adaptors must possess a clathrin binding 
site. There is some evidence to suggest that it is the fi subunit of the adaptor complex 
which is involved in the interaction with clathrin (Ahle et al. , 1988).
1.6.3 Early endosomes
(1). Docking and fusion
Coated vesicles are very rapidly (< 1  min) uncoated yielding an endocytic 
vesicle (Pearse and Brescher, 1981). Once uncoated, the endocytic vesicle docks and 
fuses with its target in the endosome system. The reconstitution studies in vitro have 
measured the fusion between early endosomal elements (Gruenberg and Howell, 
1986). Very recently the cytosol-dependent fusion between purified vesicles and early 
endosomes has been demonstrated (Woodman and Warren, 1988). From this assay it 
has been shown that fusion in vitro is energy-dependent and requires cytosolic 
components. One of these cytosolic components is N-ethylmaleimide-sensitive fusion
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protein (NSF) (Diaz et al., 1989). This protein has been shown to be required for 
intra-Golgi (Malhotra et al., 1988; Block et al., 1988) and endoplasmic reticulum to 
Golgi transport (Beckers et al., 1989). Fusion was inhibited when membranes and 
cytosol were treated with ^-ethylmaleimide (NEM).
(2). Sorting of ligands and receptors
Early endosomes are located close to the plasma membrane and they may 
become part of a more specialized tubulo-vesicular structure. Early endosomes appear 
to be the site where those receptor/ligand complexes which recycle to the plasma 
membrane are sorted. The reduction of pH encountered in this compartment is 
sufficient for the dissociation of these ligands from their receptors. The receptor are 
recycled back to the cell plasma membrane (Brown et al., 1982). Reappearance of 
receptors on the plasma membrane is rapid, the measured half-times for recycling of 
the asialoglycoprotein and transferrin receptors in HepG2 cells are 4 min and 7 min 
respectively (Ciechanover et a l., 1983)
1.7 FLUID PHASE ENDOCYTOSIS
Fluid phase endocytosis (pinocytosis) is the nonspecific form of endocytosis in 
which any extracellular material is taken up at a rate proportional to its concentration 
in the extracellular medium.
In 1986, Gibbs et al. studied fluid-phase endocytosis using monolayers of 
3T3-L1 adipocytes followed by measuring [^C ] sucrose uptake. They found that 
insulin, at maximal stimulatory concentration, increased the pinocytic rate by 2 -fold 
within 5 min of its addition and this activation persisted for at least 2 hours. The 
dose-response curve for the enhancement of fluid-phase endocytosis by insulin was 
identical with that for the stimulation of 2-deoxy-D-glucose. The concentration of 
insulin eliciting half-maximal effects was 6  nM. Their results suggest that activation
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of endocytosis and hexose uptake by insulin are triggered by the same signalling 
event.
Studied on 3T3-L1 cells by Fan et al. (1982); Ronnett, (1983); Reed, (1984) 
have reported that occupied insulin receptors are rapidly internalized via coated pits 
and vesicles and then, after dissociation of the bound insulin, rapidly return to the 
plasma membrane. Marsh et al. (1980) and Robinson et al. (1983) studied other types 
of animal cells in culture. They found that a large fraction of fluid-phase endocytosis 
occurs by the pathway of coated pits and vesicles. So the hypothesis to account for 
the effect of insulin on fluid-phase endocytosis is that when insulin is bound to its 
receptor, the receptor possesses a conformation that induces either the more rapid 
assembly or internalization of coated pits.
1.8. SUBCELLULAR TRAFFICKING OF GLUT1 AND GLUT4
It is well documented that in the basal state, there is a significant intracellular 
pool of both GLUT1 and GLUT4 glucose transporter. According to these data, there 
are two questions to ask: whether GLUT1 and GLUT4 reside in the same 
intracellular compartments and the nature of the compartment(s) in which the 
transporters exist in unstimulated insulin-responsive cells.
Zorzano et al. (1989) have utilized a monoclonal antibody (1F8) directed 
against GLUT4, to immunopurify transporter-containing vesicles from the low- 
density microsome fraction of homogenates of isolated rat adipocytes. Vesicles 
absorbed to 1F8 contained over 90% of GLUT4 but less than 5% of the cellular 
GLUT1. They concluded that the GLUT1 and GLUT4 are located in distinct cellular 
compartments and GLUT4 probably resides in a distinct, differentiated organelle.
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Piper et al. (1991) examined the immunoadsorption of glucose transporter 
vesicles from 3T3-L1 adipocytes to isoform-specific anti-peptide antisera linked to 
acrylamide beads. They found that adsorption of low-density microsomes removed 
90% of the GLUT4 but only 30% of the immunoreactive GLUT1 from solution. The 
distribution of vesicles containing each of the transporters was partially overlapping 
but distinct on equilibrium sucrose density centrifugation. They suggest that GLUT1 
and GLUT4 are in different intracellular locations in murine adipocytes.
Calderhead et al. (1990) have reported a study in which GLUT4-containing 
vesicles were immunopurified from 3T3-L1 adipocytes. Adsorption by anti-peptide 
antisera directed against the carboxyl termini of either GLUT1 or GLUT4 removed 
almost all of the isoforms from the "low speed" supernatant. They suggest that the 
GLUT1 and GLUT4 reside in the same intracellular compartment.
These seemingly contradictory results have been explained. One explanation is 
that there is partial overlap between the distribution of transporters, such that there 
exists a population of vesicles rich in GLUT1 but containing a few GLUT4 
molecules, and vice versa. In addition, the much higher ratio of GLUT1 to GLUT4 
in 3T3-L1 adipocytes compared to rat fat cells might alter the apparent colocalization. 
The other explanation is that the degree of colocalization is dependent on the 
fragmentation during cell homogenization of a single organelle. A continuous 
endosomal reticulum with distinct, connected domains has been postulated; the degree 
of intermixing of proteins in such an organelle during cell disruption might be very 
dependent on the cell type (Hopkins et al. , 1990).
The other strategy for assessing the colocalization of glucose transporter 
isoforms is morphological studies, but most studies have looked at the separate 
location of either GLUT1 or GLUT4.
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Blok et al. (1989) have used the immunogold technique to localize the glucose 
transporters in basal and insulin-treated 3T3-L1 adipocytes. Using immunoelectron 
microscopy to determine the cellular distribution of GLUT4 in brown adipose tissue, 
Slot et al. (1991b) demonstrated that in the basal state GLUT4 is localized almost 
entirely to small tubulo-vesicular (T-V) structures in the Golgi area and elsewhere 
throughout the cytoplasm, these glucose transporters are often in clusters. Upon 
insulin treatment, GLUT4 display a marked shift from these sites to the plasma 
membrane. The amount of GLUT4 at the cell surface increases by at least 40-fold. 
GLUT4 is seen to enter the coated pit/coated vesicle/early endosome pathway typical 
of receptor-mediated endocytosis (Slot et al., 1991b). This finding has indicated that 
the glucose transporter a multispanning membrane protein undergoes recycling by the 
pathway that has been well established for cell surface receptors.
The effect of insulin is to allow GLUT4 to relocate from tubulo-vesicular (T- 
V) structures to the plasma membrane and to participate in the recycling pathway. 
Upon insulin withdrawal the positive signal driving movement of GLUT4 to the cell 
surface is removed such that GLUT4 appear to be withdrawn from early endosomes 
and accumulates again in the T-V structures. This proposed mechanism is consistent 
with the observation that after insulin removal GLUT4 rapidly disappears from the 
cell surface of adipocytes and reappears in the same subcellular fraction where it was 
found in basal cells (Kamielli et al. , 1981a).
To establish the identity and the location of the sorting factors that determine 
the intracellular targeting of GLUT4 and GLUT1 it is important to understand the 
insulin action on glucose transport. The early endosome or the trans-Golgi reticulum 
(TGR) are the most likely locations for specific sorting (Slot et al. , 1991b).
Another strategy to resolve the problem of whether GLUT1 and GLUT4 are 
targeted to distinct cellular compartments is to express the two transporters in
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identical cellular contexts, and define their subcellular distributions. GLUT4 was 
found to have an intracellular, perinuclear punctate distribution, resembling that 
visualized in 3T3-L1 adipocytes (Garcia de Herreros and Bimbrum, 1989; Piper et 
al.t 1991; Hudson et al. , 1992). In contrast, GLUT1 was present predominantly on 
the plasma membrane, and to a lesser extent in a juxtanuclear distribution. However 
expression systems may result in unusual targetting.
There are two models for intracellular trafficking of GLUT1 and GLUT4. 
One has been referred as the "secretory" model. The other one is referred to as the 
"receptor" model (see Fig. 6 ).
In the "secretory" model, GLUT4 resides in a mature storage organelle, and it 
is actively sorted at the trans-Golgi network into the equivalent of the regulated 
pathway, whereas GLUT1 follows a default route to the cell surface (Griffiths and 
Simons, 1986; Burgess and Kelly, 1987). This would account for the difference in 
relative distribution of the two isoforms between plasma membrane and intracellular 
compartments.
The small synaptic vesicles (SSVs) of neurons are thought to be first 
synthesized by a regulated secretory pathway (Cutler and Cramer, 1990; De Camilli 
and Jahn, 1990). After depolarization-induced release of neuro-transmitter, the 
integral membrane proteins of SSVs are sorted out of early endosomes and used to 
reconstruct synaptic vesicles which exist as a mature organelle awaiting another 
exocytotic event. As is apparently the case with insulin-responsive vesicles, SSVs are 
capable of undergoing multiple rounds of exocytosis and resynthesis. Calderhead et 
al. (1990); De Camilli and Jahn (1990); Slot et al. (1991b) examined 
immunoadsorption of GLUT4 or its localization by immunoelectron microscopy, they 
reported that GLUT4 did not appear to reside in vesicles of uniform size resembling 

















Fig.6 Alternative models for the cellular trafficking of glucose
transporters in rat adipocytes.
GLUT1 is represented by closed symbols and GLUT4 by open symbols. (A) 
The "secretory" model, in which GLUT4 is sorted into a distinct storage organelle. 
(B) The "receptor" model, in which insulin regulates the rate of GLUT4 recycling 
though a ubiquitous organelle. (From Bimbaum, 1992)
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model, it does not exclude one. Navone et al. (1986); Slot et al. (1991b) have 
localized SSV markers in endocrine cells to tubulovesicular structures. These 
resemble the GLUT4-containing compartment of brown adipose tissue. Thus this 
"neuronal-like" structure does indeed represent an authentic secretory compartment. 
A precedent exists for a pleiomorphic tubulovesicular organelle that obeys the rules 
of regulated secretion. (Reetz et al., 1991).
Recently, there are some experiments in a-toxin-permeabilized rat adipose 
cells which are consistent with a secretory model. In such cells, nonhydrolyzable 
analogs of GTP mimicked insulin in inducing the translocation of GLUT4 from low- 
density microsomes to the plasma membrane (Baldini et al., 1991).
A family of small GTP binding proteins has been shown to have a role in 
membrane traffic (Bourne, 1988; Balch, 1990) and in the fusion of early endosomes. 
Mayorga et al. (1989) have reported that GTP[7 S] can inhibit fusion of early 
endosomes at saturating cytosol concentrations. The effect of GTP[yS] appears to be 
mediated through the rab family of GTP binding proteins. These proteins are part of 
the ras superfamily.
There are numerous sites in the insulin signal transduction pathway at which 
G proteins might influence translocation. There is some evidence to show that 
nonhydrolyzable GTP analogs stimulate the production of diacylglycerol, which can 
activate glucose transport via protein kinase C (Farese et al., 1985; Stralfors, 1988; 
Bader et al. , 1989) and that GTP7 S inhibits the fusion of endosomes, which might 
increase the abundance of GLUT4 in the plasma membrane by slowing its 
internalization (Chavrier et al., 1990; Gorvel et al., 1991). The simplest and most 
likely explanation is that a small G protein is associated with the insulin-responsive 
compartment and is required for fusion to the plasma membrane. Thus this would 
provide a potential site of regulation that could be modulated by phosphorylation or
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dephosphorylation. Bailly et al. (1991) have reported that phosphorylation of the 
endosomal small G protein Rab4 by p3 4 cc*c  ^ can cause the inhibition of vesicular 
fusion during mitosis. It will be interesting to determine where an analogous protein 
is expressed in insulin-responsive tissues.
Robinson et al. 1992 have reported that in streptolysin-0 permeabilized 
adipocytes, insulin, and GTP7 S increased plasma membrane levels of GLUT4 to a 
similar extent as observed with insulin in intact cells. In the absence of an exogenous 
ATP source the magnitude of these effects was considerably reduced. Removal of 
ATP per se caused a significant increase in cell surface levels of GLUT4 suggesting 
that ATP may be required for intracellular sequestration of these transporters. When 
insulin and GTP7 S were added together, in the presence of ATP, plasma membrane 
GLUT4 levels were similar to levels observed when either insulin or GTP7 S was 
added individually. Addition of GTP7 S was able to overcome this ATP dependence 
of insulin-stimulated GLUT4 movement. GTP7 S had no effect on constitutive 
secretion of adipsin in permeabilized cells. There was no effect of insulin or GTP7 S 
on GLUT4 movement to the plasma membrane in noninsulin sensitive streptolysin-O- 
permeabilized 3T3-L1 fibroblasts overexpressing GLUT4. This indicated that insulin- 
stimulated movement of GLUT4 to the cell surface in adipocytes may require ATP 
early in the insulin signaling pathway and a GTP-binding protein at a later step.
In the "receptor" model, GLUT4 constitutively recycles through the 
endocytotic pathway, in the basal state residing predominantly in an intracellular 
location. At all times GLUT4 is located in nonspecialized cellular compartments. It 
will be either in the plasma membrane or components of the endosomal system. 
Insulin would alter the distribution by increasing the rate constant determining 
extraction of GLUT4 from the endosome to the cell surface.
In 1987, Tanner and Lienhard studied transferrin receptor in 3T3-L1
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adipocytes upon insulin treatment. They found that incubation of 3T3-L1 adipocytes 
with insulin at 37°C resulted in a 2 fold increase in specific binding of transferrin to 
cell-surface receptors, as measured by a subsequent incubation of cells at 4°C with 
*25 i-transferrin. The results they have got are similar to results obtained in rat 
adipocytes (Davis et al., 1986 ). They showed that the increased number of 
transferrin receptors is due to translocation of the receptor from an intracellular 
location to the plasma membrane. Insulin increased the rate constant for 
extemalization of transferrin receptors and had no significant effect upon the rate 
constant for receptor internalization. The insulin-like growth factor II (IGF-H) 
receptor, like the transferrin receptor, continuously recycles. Insulin has no effect on 
the rate constant for internalization of photoaffinity-labelled IGF-II receptor (Oka et 
al., 1985; Oka and Czech, 1986).
It is clear that insulin also elicits a redistribution of transferrin receptors in 
both rat adipocytes (Davis et al., 1986) and 3T3-L1 adipocytes (Tanner and 
Lienhard, 1987).
In 1989, Tanner and Lienhard studied the effect of insulin on the subcellular 
distributions of the glucose transporter, transferrin receptor and IGF-II receptor in 
3T3-L1 adipocytes using a binding assay. They demonstrate that the insulin- 
responsive pools of GLUT1, transferrin receptor and IGF-II receptor reside largely in 
the same intracellular membranes. Insulin stimulated a 2-3 fold increase in the level 
of each protein at the cell surface and in each case the decrease in the content of the 
protein in the microsomal membranes can account for the increase at the cell surface.
Although 85-100% of these three membrane proteins in the microsomal 
fraction are contained in the glucose transporter vesicles, insulin's effect on the 
content of the proteins in this fraction was not uniform. In response to insulin, a 50% 
decrease in GLUT1 content occurred while only a 16% decrease in the IGF-II
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receptor content occurred (Tanner and Lienhard, 1989). The GLUT1 may have a 
higher probability of being incorporated into plasma-membrane targetted vesicles than 
does the IGF-II receptor.
As discussed by Piper et al. (1991), the sequestration of GLUT4 could be due 
either to a very rapid removal of this protein from the plasma membrane or to a very 
slow rate of exocytosis in the basal state. This could lead us to find out if the GLUT4 
protein sequence results in a unique cellular processing by vesicle trafficking and 
sequestration machinery. If endocytosis is unusual, then the unique cellular 
processing may occur in the plasma membrane, if exocytosis is slow, the targeting 
recognition events may occur intracellularly. In the insulin-stimulated state the 
proportion of GLUT4 associated with coated pits increased 3 fold in early endosomes 
it increased 4 fold, and in the plasma membrane it increased 40 times that of the basal 
state (Slot et al., 1991b). This result indicated that the main insulin effect was to 
increase exocytosis of GLUT4 from tubulo-vesicular structures to the plasma 
membrane and thence into the endosome pathway. The studies on the steady-state 
level of the glucose transporters cannot clearly distinguish between an increased 
exocytosis or decreased endocytosis or show a modification of both these steps in 
cycling.
Kinetic studies rather then steady-state distribution studies of transporter 
cycling can directly determine and quantify the site of insulin action on trafficking. 
Using a photoreactive probe (B3-GL) to study insulin's effect on GLUT4 
translocation kinetics in rat adipocytes, Jhun et al. (1992) have reported that insulin 
has equal effects on endocytosis and exocytosis. The former is reduced and the latter 
increased by 3 fold. They suggested that the insulin dependent phosphorylation 
influenced internalization as it has been shown to regulate the internalization of many 
cell surface receptors, including epidermal growth receptor (Chen et al., 1989), 
insulin receptor (McClain et al., 1988) and IGF-II receptor (Covera and Czech,
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1985). They suggested phosphorylation may also regulate internalization of GLUT4. 
They interpreted the results of James et al.( 1989) as showing that GLUT4 in basal 
adipocytes is more phosphorylated in the plasma membrane than in the intracellular 
compartment and insulin reduces the GLUT4 phosphorylation in the plasma 
membrane. So they propose that this insulin-induced dephosphorylation of GLUT4 at 
the plasma membrane may prevent the association of GLUT4 to the clathrin-coated 
pits, resulting in reduced GLUT4 internalization rate.
This finding is different from the previous studies of GLUT4 trafficking 
kinetics in rat adipocytes (Clark et al. , 1991; Satoh et al., 1991) and the hypothesis 
(Kamielli et al., 1981a; Piper et al., 1992; Robinson et al., 1992) that the main 
effect of insulin is to increase exocytosis of GLUT4.
To resolve the site of insulin action on GLUT1 and GLUT4 trafficking, in 
part of this thesis, a study similar to that described by Jhun et al. (1992) was carried 
out. GLUT1 and GLUT4 present in 3T3-L1 cells were labelled in the insulin- 
stimulated and the basal states with ATB-BMPA. The redistributions of these labelled 
transporters from the plasma membrane to the low density microsome membrane 
fraction were followed while cells were maintained at either insulin-stimulated or 
basal steady states.
Very recently, Piper et al. (1992) have shown that the GLUT4 NH2  terminus 
contains important targeting information. Replacement of the GLUT4 NH2  terminus 
with that from GLUT1 resulted in an increase in cell surface expression whereas 
replacement of the GLUT1 NH2  terminus with that from GLUT4 resulted in an 
increase accumulation of the chimera in an intracelluar compartment. In contrast, 
Asano et al. (1992) reported that replacement of the GLUT4 NH2  terminus with that 
from GLUT1 did not alter the subcellular distribution of the protein. In these studies 
the dominant targeting domains were localized to a region spanning trans-membrane
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domains 7 and 8 . This discrepance emphasizes the potential pitfalls in studying the 
targeting of a complex protein such as the glucose transporter which is thought to 
have 1 2  membrane spanning domains and three hydrophilic cytosolic domains 
(Mueckler et al. , 1985).
Piper et al. (1993) have used a different strategy to further study the targeting 
role of the GLUT4 NH2  terminus. The amino acid constituents of the GLUT4 NH2  
terminal targeting domain have been identified. GLUT4 constructs containing NH2 - 
terminal deletions or alanine substitutions within the NH2  terminus were expressed in 
CHO cells using a Sindbis virus expression system. Deletion of eight amino acids 
from the GLUT4 NH2  terminus or substituting alanine for phenylalanine at position 5 
in GLUT4 resulted in a marked accumulation of the transporter at the plasma 
membrane. Mutation at other amino acids surrounding Phe5 also caused increased 
cell surface expression of GLUT4 but not to the same extent as the Phe5 mutation. 
GLUT4 was also localized to clathrin lattices and this colocalization was abolished 
when either the first 13 amino acids were deleted or when Phe5 was changed to 
alanine. They concluded that NH2  terminus of GLUT4 contains a phenylalanine- 
based targeting motif that mediates intracellular sequestration at least in part by 
facilitating interaction of the transporter with endocytic machinery located at the cell 
surface.
1.9 EFFECT OF PAO ON TRAFFICKING OF GLUT1 AND GLUT4
Kinetic and immunocytochemical studies suggest that some trafficking of 
GLUT1 and GLUT4 occurs via a common pathway, but that GLUT4 can be excluded 
from the common pathway in the absence of insulin and is sequestered in a distinct 
vesicle pool. An approach to examining the possible separate processing of the two 
transporters is to inhibit their trafficking.
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Phenylarsine oxide (PAO) is known to inhibit receptor endocytosis (Knutson 
et al. , 1986; Wiley et al. , 1982) and fluid-phase endocytosis in 3T3-L1 cells (Frost et 
a l.t 1985). 1983, Knutson et al. have observed that phenylarsine oxide was an 
effective inhibitor of rapid insulin-induced internalization of cell-surface insulin 
receptors to a trypsin-resistant cell compartment. It was also found that this inhibitor 
has no effect on the recycling of internalized receptor to the cell surface when insulin 
was withdrawn. In contrast to these inhibitors of internalization, PAO has been 
shown to inhibit the insulin stimulation of glucose transport in 3T3-L1 cells and in 
adipocytes (Frost and Lane, 1985) and as discussed in section 1.8 this is probably an 
exocytotic process (Satoh et al. , 1991).
1985, Frost and Lane have shown that insulin-activated deoxyglucose uptake 
by 3T3-L1 adipocytes is inhibited by phenylarsine oxide (20 /xM) but the basal 
transport was not inhibited and this blocking is reversed by 2,3 -dimercaptopropanol 
but not mercaptoethanol. The inhibitory site is postreceptor because neither insulin 
binding to the receptor nor tyrosine kinase activity of the receptor (Frost and Lane, 
1987; Bernier et al., 1987) are affected by PAO. They have also shown that in the 
absence of insulin, low levels of PAO actually activated basal deoxyglucose uptake.
Douen and Jones (1988) have reported that PAO concentration from 1-10 /xM 
can inhibit the stereospecific uptake of D-glucose in basal and insulin-stimulated rat 
adipocytes. The inhibition they observed was dose dependent and was partially 
reversed by dithiothreitol. At 1 and 5 /xM PAO, recovery of transport activity is of 
the order of 90% after 20 min. At 10 /xM PAO treatment, little or no recovery is 
observed.
1989, Gould et al. reported that at 10 fiM PAO activates transport threefold, 
but at higher concentration an inhibition of transport is observed. Quantitative 
immunoblotting showed that the GLUT1 content of the plasma membrane fraction
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increased with increasing PAO concentrations. The GLUT4 antibody was not 
available at this time.
1989, Frost et al. , using (^C ) sucrose as an endocytotic marker, found that 
phenylarsine oxide immediately blocked insulin-stimulated fluid phase endocytosis 
and exocytosis. Unlike the selective effect of PAO on insulin-stimulated glucose 
transport, PAO blocked both basal and insulin-stimulated endocytosis in an identical, 
concentration-dependent manner (Ki- 6  /xM). PAO inhibited all of the specific 
endocytosis immediately upon addition to cells, even with prior exposure to insulin. 
This immediate effect contrasts with PAO-induced inhibition of insulin stimulated 
glucose transport, which is time dependent. They also studied the effect of PAO on 
exocytosis, and they reported that PAO reduced fluid efflux from both basal and 
insulin-treated cells by 50%. Thus while endocytosis was completely inhibited, 
exocytosis was only partially inhibited.
1.10 AIMS
The major aims of this thesis are listed below:
1) To determine the development of an intracellular pool of glucose transporters in 
3T3-L1 cells by measureing 2-deoxy-D-glucose transport and to photolabel the cell 
surface and digitonin-permeabilized total cellular pool of glucose transporters.
2) To investigate the insulin-stimulation of glucose transport in 3T3-L1 adipocytes 
by measuring the glucose transport activity. To study the glucose transporters GLUT1 
and GLUT4 trafficking by using the cell-impermeant, glucose transporter-specific, 
photoaffinity ligand 2-N-[4-(l-azitrifluoroethyl) benzoyl]-l,3-bis-(D-mannos-4- 
yloxy)-2-propylamine (ATB-BMPA). To examine the possibly separate processing of 
GLUT1 and GLUT4 by treating the cells with Phenylarsine oxide (PAO) and to 
determine the site of action by PAO by monitoring the appearance (exocytosis) and
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loss (endocytosis) of these transporters.
3) To determine the dose response of insulin-stimulated translocation of GLUT1 and 
GLUT4 from different pH treated 3T3-L1 adipocytes by measuring 2-deoxy-D- 
glucose, using Western blotting and the ATB-BMPA photolabelling technique.
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2.0 MATERIALS AND METHODS
2.1 GENERAL REAGENTS
Unless otherwise stated all standard laboratory reagents were obtained from 
BDH laboratory supplies (Poole, Dorset, UK), Sigma Chemical Co. (Poole, Dorset, 
UK) or Aldrich Chemical Co. Ltd (Gillingham, Kent, UK). All radioactive 
compounds were from Amersham International.
2.2 BUFFERS AND SOLUTIONS




1.25 mM MgS04  
10 mM Hepes
Buffer stock solutions were prepared as lOx concentrated. Stored at 4°C and 
were replaced every 14 days.




1.25 mM MgS04  
10 mM MES
Phosphate buffered saline (PBS) pH 7.2 
140 mM NaCl
2.7 mM KC1
1.5 mM KH2HP04  
8.1 m M N a2H P 04
Sodium phosphate buffer pH 7.2 
5 mM Na2HP04
TRIS-buffered saline (TBS) pH 7.4 
154 mM NaCl (0.9%)
10 mM TRIS
TRIS/EDTA/sucrose buffer (TES) pH 7.2 
10 mM TRIS
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0.5 mM EDTA 
255 mM sucrose




2 0 % (v/v) methanol
In double distilled water
Electrophoresis stock reagents
30% (w/v) Acrylamide Stock 
60 g acrylamide
1.6 g N'N methylene bis acrylamide 
60 g sucrose
adjust volume to 2 0 0  ml with double distilled water
Resolving gel buffer pH 8 . 8
1.5 M TRIS 
0.4% (w/v) SDS
Stacking gel buffer pH 6 . 8  
0.5 M TRIS 
0.4% (w/v) SDS
Electrophoresis buffer pH 8.3 
25 mM TRIS 
192 mM glycine 
0.1% (w/v) SDS
Electrophoresis sample buffer 
6  M urea 
10% (w/v) SDS
1 0 % (v/v) mercaptoethanol (added before use)
Preparation of Insulin Solution
Porcine monocomponent insulin was a gift from Dr. Ronald Eli Lilly's 
laboratories. A stock was prepared at 0.5 mg/ml. The final concentration is 100 fiM. 
5 mg of insulin was first dissolved in 1 ml of 0.3 M hydrochloric acid (sterile) and 
the solution was then diluted to 10 ml with PBS (pH 7.2) and gently hand mixed to 
try to avoid air bubbles. The final concentration was 0.5 mg/ml (0.03 M 
hydrochloric acid) and the resulting insulin solution ( 1 0 0  pM) was aliquoted into 
sterile eppendorf tubes and stored at -20°C until required. The solution was not 
refrozen if it had been thawed.
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2.3 MURINE 3T3-L1 CELL CULTURE
2.3.1 Culture of 3T3-L1 fibroblasts
The cells used in these studies were Murine 3T3-L1 cell and these were 
obtained from the American tissue culture association. All cell culture was performed 
under sterile conditions. The 3T3-L1 cells were grown in Dulbecco Modified Eagle's 
medium (DMEM) (from Flow Labs) supplemented with 10% Newborn calf serum 
(NCS) - heat inactivated at 56°C for 30 Minutes, 100 U/ml penicillin, 100 /*g/ml 
streptomycin and 2 mM glutamine (from Sterilin). Cultures were maintained in a 
humidified incubator at 37°C in an atmosphere of 1 0 % C(> 2  /90% air.
Cells were routinely seeded at a density of 0.1-0.2x10^ cells /175 cm^ plastic 
flask and fed every 48 hours. The cells were allowed to reach 80-90% confluent. The 
cells were never allowed to become too confluent. Subconfluence was reached after
4-5 days and the cells were washed with phosphate buffered saline (PBS - NaCl 0.14 
M, KC1 2.7 mM KH2 PO4  1.5 mM, Na2 HPC>4 8.1 mM at pH 7.2). Cells were 
detached by incubation with 0.05% trypsin/0.02 % EDTA (Flow labs) for 1 min at 
room temperature. When the cells started to detach the trypsin was taken off and 20 
ml of medium was added to the flask. After washing by centrifugation (3 min. 1500 
rpm) the cells were gently mixed using a 21 G needle attached to a 5 ml syringe. Cell 
counts were made using a neubauer haemocytometer and using the viability indicating 
dye, trypan blue. The cells were then seeded in 0.03-0.08x10^/35 mm petri dishes 
with routine changes of the medium every 48 hours. The cells reached confluence at
5-7 days depending on cell density. If seeded at a high density the cells reached 
confluence more quickly.
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2.3.2 3T3-L1 cell differentiation
The differentiation procedure was carried out after the fibroblast 3T3-L1 cells 
attained full confluence for 2 days. To induce differentiation, monolayers were 
maintained in DMEM +  10% fetal calf serum, 100 unit/ml penicillin, 100 mg/ml 
streptomycin, 2 mM glutamine and were treated for 48 hours with 
isobutylmethylxanthine (IBMX) (0.55 mM), dexamethasone (0.25 ^M), insulin (0.2 
/iM) and then insulin (0.2 /*M) alone for another 48 hours. The medium then was 
replaced with fresh medium every 48 hours. The cells reached full differentiation on 
day 8  and during days 8 - 1 2  the glucose transport response to insulin reached a steady 
state so usually experiments were carried out at this time.
The insulin stock was 0.5 mg/ml and was diluted 500 times to 1.0 /xg/ml. 
(100 ml medium plus 200 /ti stock). The dexamethasone stock was 2.5 mM in 
ethanol and was then diluted 2 0  times with medium ( 2 0 0  /tl of solution were diluted 
into 100 ml medium). The isobutylmethylxanthine was prepared freshly each time. 
10-20 mg was dissolved first in 3.5 mM KOH ( 24 mg IBMX /50 yii KOH ) and then 
diluted 8  times with medium ( 2 0 0  /xl were diluted in 1 0 0  ml medium).
2.3.3 Storing 3T3-L1 cells
Cells from early passages were trypsinised, washed and resuspended at a 
density of 0.5 x 10  ^ cells/ml in culture medium with 10% NCS and 10% 
Dimethylsulphoxide (DMSO). After slow cooling overnight at -70°C in sterile 
Cryotubes (NUNC), the cells were transferred to liquid nitrogen for storage.
High passages number cells have less ability to differentiate, so in the studies 
described in this thesis, cell passage number was always kept under Passage 10. 
When required, the low passage cells were rapidly defrosted at 37°C and washed
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immediately in 2 0  ml culture medium before plating out as usual.
2.4 PROTEIN DETERMINATION
Protein was either estimated using the protein-dye (BIO-RAD) assay based on 
the Coomassie Brilliant Blue dye-binding method of Bradford (1976) or the 
bicinchonic acid (BCA) protein assay according to the manufacturer's instruction.
The Bio-rad protein assay used a standard curve of 0-15 /xg BSA in 775 /xl 5 
mM sodium phosphate buffer, pH 7.2. Membrane proteins were solubilized by the 
addition of 25 /xl sodium hydroxide (0.1 M) and the colour was developed by 10 
minutes incubation at room temperature with 200 /x 1 Biorad solution. Absorbance was 
measured at 595 nm in a spectrophotometer.
The BCA protein assay was carried out in microtitre plates. 10 ml of reagent 
A {containing 1% BCA detection reagent (bicinchoninc acid, sodium salt, pierce); 
2% disodium carbonate; 0.16% sodium tartrate; 0.4% sodium hydroxide; 0.95% 
hydroxide and filtered through a 0.7 /xm filter (Millipore)} was mixed with 200 /xl of 
reagent B {containing 4% copper sulphate, filtered through a 0.7 /xm filter 
(Millipore)}. 100 /xl of standard bovine serum albumin (BSA) solution (2 mg/ml in 
double-distilled water) was mixed with 100 /xl of 0.2 M sodium hydroxide. For the 
standard protein curve, 0, 2, 4, 6 , 8 , and 10 /xl of this solution was made to 10 /xl 
with 0.1 M sodium hydroxide. 200 /xl of reagent A and B solution (containing 
reagent A 10 ml and reagent B 200 /xl) was added to the standard protein and samples 
and incubated in 37°C for 30 minutes. The absorbance was measured at 450 nm and 
540 nm in a microtitre plate reader.
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2.5 PREPARATION OF ALKALI-STRIPPED ERYTHROCYTE 
MEMBRANES (PROTEIN DEPLETED)
Erythrocytes from 1-3 week old transfusion blood were washed four times in 
PBS (154 mM NaCl, 12.5 mM sodium phosphate, pH 7.2) at 0-4°C. When 
aspirating off the supernatant care was taken to remove the white cells and platelets. 
To obtain erythrocyte membranes ghosts, the cells were lysed for 20 minutes at 0- 
4°C in haemolysis buffer (5 mM sodium phosphate, 1 mM EDTA, 1 ^g/ml PMSF, 
pH 7.8 ). The membranes were centrifuged at 16000 gav (11000 revs GSA Rotor) for 
20 minutes. The pellets were resuspended and washed once in haemolysis buffer then 
once in 5 mM sodium phosphate buffer pH 7.2. The ghosts were then washed once in 
5 mM sodium phosphate buffer pH 7.8 at 16000 g for 20 minutes and resuspended in 
this buffer to give a protein concentration about 4 mg/ml (BCA protein assay). The 
membranes then treated with 5 volumes of freshly prepared solution containing 15.4 
mM NaOH, 2 mM EDTA, 0.2 mM DTT for 15 minutes at 4°. The membranes were 
harvested at 16000 gav for 20 minutes at 4°C and resuspended in Tris-HCL buffer 
(pH 6 .8 ), then spun again once. The protein concentration was determined by BCA 
protein assay and the membranes stored at 4 mg/ml in aliquots at -70 °C (Gorga and 
Lienhard, 1981).
2.6 PREPARATION OF ANTIBODIES
Anti-GLUTl and GLUT4 antibodies were kindly prepared by Dr. Avril, E. 
Clark (University of Bath, Department of Biochemistry).
Antisera against the GLUT1 and GLUT4 glucose transporter isoforms were 
prepared using synthetic C-terminal peptides. EELFHPLGADSQV and 
STELEYLGPDEND, respectively, as described by Davies et al. (1987). The anti- 
GLUT1 antibody was affinity purified using alkali-stripped erythrocyte membranes
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(Schroer et al., 1986). Human erythrocyte membranes were stripped of peripheral 
proteins by alkaline treatment. Antiserum (4 ml) was mixed with the membranes (32 
ml at 2 mg/ml protein) in 10 mM NaCl (pH 7.4). After incubation for 1 hour, the 
membranes were pelleted at 48000 gmax for 10 min. The membranes were 
resuspended by homogenization in 40 ml of 10 mM sodium phosphate/800 mM NaCl 
(pH 7.4) and pelleted again. After a second wash in the same buffer, the membranes 
were resuspended in 32 ml of 200 mM glycine/82 mM HC1 (pH 2.4) in order to 
release the bound antibodies. The membranes were pelleted, and the supernatant was 
quickly neutralized with 2 M Tris. The yield of affinity-purified antibodies was about
3.5 mg per ml of serum. These antibodies then were aliquoted and stored at -80°C.
The anti-GLUT4 antibody was affinity purified using a peptide column in a 
manner similar to that described by Oka et al. 1988. 2 ml of Reacti-gel (6 x) (1,1- 
carbonyldiimidazole activated 6 % cross-linked beaded agarose, Pierce) was filtered 
through Whatman 1 filter paper on a Buchner funnel under gentle suction and washed 
thoroughly with double-distilled water at 0-4°C to remove any acetone. 5 mg of 
peptide (CSTELEYLGPDEND) was coupled to Reactigel-6 x by rotation at 0-4 °C for 
48 hours with 2 ml of gel matrix in 0.1 M sodium borate buffer, pH 8.5. (stirring 
was avoided as this would damage the beads).
The mixture was then filtered and the beads were added to 2 ml of 1.0 M 
ethanolamine in sodium borate buffer, pH 8.5 and mixed for 3 hours at room 
temperature. The beads were then added to the column ( 8  mm diameter x 50 mm 
length) and washed with 1 M sodium chloride, then double-distilled water and then 
PBS pH 7.2. 5 ml of antiserum was circulated three times through the column. The 
column was then successively washed in PBS, pH 7.2 and 2 M sodium chloride in 5 
mM phosphate buffer pH 7.2. The antibody was eluted with 3.5 M sodium 
thiocyanate in 10 mM phosphate buffer, pH 6 . 6  and immediately dialyzed against 
phosphate-buffered saline for 18 hours. Finally, the sample was concentrated with
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polyethylene glycol 4000 (PEG) then aliquoted and stored at -80°C. An ELISA was 
used to test the presence of specific antipeptide antibodies for both GLUT1 and 
GLUT4 at every stage of the purification.
2.7 ENZYME LINKED IMMUNOSORBANT ASSAY (ELISA)
An ELISA was used to confirm the presence of anti-GLUTl and anti-GLUT4 
peptide antibodies in serum samples from immunized rabbits.
96 well ELISA plates (Titertek-Flow) were used. For assaying anti-GLUTl 
antibodies, wells were coated with erythrocyte protein depleted membranes (1  /xg in 
100 /xl of 50 mM sodium hydrogen carbonate buffer, pH 9.6 per well) overnight at 
4°C. For assaying anti-GLUT4 antibodies, wells were coated in GLUT4 peptide (20 
ng in 100 /xl of 50 mM sodium hydrogen carbonate buffer pH 9.6 per well) overnight 
at 4°C.
Unoccupied protein binding sites were blocked by washing three times with 
100 /xl of blocking buffer (1% casein, 0.05% tween 20 [polyoxyethylene-sorbitan 
monolaurate, Sigma ] in PBS pH 7.2). Each incubation was for 10 minutes at room 
temperature. Antiserum was diluted 1:100 in blocking buffer. 100 /xl of antiserum 
was added to each incubation well for 2 hours at 37°C. Unbound antisera was 
removed by washing three times with 1 0 0  /xl of blocking buffer for 1 0  min each time.
100 /xl of a 1:2000 dilution of Goat anti-rabbit peroxidase conjugate (Sigma) 
in blocking buffer was incubated in the wells for 2 hours at 37°C. All horse radish 
peroxidase conjugated antibodies (Sigma) were diluted 1:2 with glycerol on receipt, 
to allow prolonged storage at -20°C without freezing. Excess conjugate was removed 
by three times 10 min washes with a substrate containing 100 /xl PBS, 0.05% Tween 
20, pH 7.2 and then 1% 35'55 tetramethyl benzine (TMB) in DMSO which was
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diluted 1:100 in lOOnM acetate citrate buffer (pH 6.0). Hydrogen peroxide was 
added at > 3  /xl/20 ml. 100 /xl of this freshly prepared substrate was added to each 
well. After 15-20 min a bright blue colour developed. 100 /xl of 2 M H2 SO4  were 
added and the resulting bright yellow colour was read on a Titertex multiscan plate 
reader, using a dual beam. Substrate absorbance was measured at 450 nm. A reading 
was made at 695 nm and was used to correct for any optical differences in the 
polystyrene wells. Absorbance values were corrected for the non-specific binding of 
conjugates to the plastic wells, by including a control to which no antiserum was 
added.
2.8 MEASUREMENT OF 2-DEOXYGLUCOSE UPTAKE IN 3T3-L1 CELLS
2.8.1 Measurement of insulin stimulation
2-deoxy-D-glucose was used to measure glucose transport activity. The cold 
2-deoxy-D-glucose was prepared in 2 mM stock and kept at -20°C. The final 
concentration for each assay was 50 /xM. The 2-deoxy-(2,6 -^H)-D-glucose activity 
was 0.3 /xCi/sample [25 /xl of cold 2-deoxy-D-glucose (2 mM stock) plus 0.3 /xl( 1 
/xCi=l /xl) of 2-deoxy-(2,6-^H)-D- glucose plus 24.7 /xl KRH buffer]. The 
monolayer fibroblasts or fully differentiated 3T3-L1 cells were washed twice with 
warm PBS, seeded in serum free DMEM medium for 2 hours and then washed three 
times with 2 ml KRH buffer pH 7.4 (or pH 8.0, pH 6.5, for detail see figure 
legends) at 37°C or 27°C (for detail see figure legends). Incubation was with or 
without insulin (usually 100 nM) for 30 minutes or the indicated time in 1 ml of KRH 
buffer at 37°C or 27°C. 50 /xl of labelled 2-deoxy-D-glucose was added in the 1 ml 
buffer for 5 minutes and then the cells were rapidly washed four times in 2 ml of 
KRH buffer at room temperature or in some experiments at 4°C. Monolayers were 
then solubilized with 1 ml of 0.1 M NaOH. In some experiments a small aliquot was 
removed for a protein assay. The radioactivity was counted in an LKB counter. The
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results were expressed in terms of pmoles/min/35 mm dish or pmoles/min/10^ cells.
2.8.2 Measurement of reversal of insulin stimulation
Cell monolayers were stimulated with 100 nM insulin at 37°C for 30 min. 
The insulin stimulation was then reversed by washing cell monolayers twice with a 
MES buffer (136 mM NaCl, 4.7 mM KC1, 1.25 mM MgS04, 1.25 mM CaC12, 10 
mM MES pH 6.0) and then maintaining them in this buffer at 37°C. At the times 
indicated in the figure legends the dishes were washed twice in KRH at 18°C and 
then either used for 2-deoxy-D-glucose uptake determinations (as above) or in cell- 
surface photolabelling experiments.
2.9 MEASUREMENT OF INSULIN BINDING
3T3-L1 adipocytes in 35 mm dishes were incubated in serum-free DMEM for 
2 hours, washed three times in KRH buffer and incubated at 20°C in 1 ml of KRH 
buffer containing 30 fmol of mono-A14-^I-insulin, 2% serum albumin, bacitracin 
(10 mg/ml), 5 jzM of unlabelled insulin were added to 2 control dishes. 0.025, 0.05, 
0.1, 1 and 100 nM unlabelled insulin were added to the other dishes. The dishes were 
shaken (65 oscillations/min) for 3 hours. After washing three times in KRH buffer, 1 
ml of ice-cold 1 0 % trichloracetic acid was added and the insoluble protein was 
precipitated and counted for radioactivity. Specific ^I-insulin  binding was 
calculated as the difference between the samples with 5 /zM unlabelled insulin added 
and the other different concentrations of insulin.
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2.10 PHOTOLABELLING WITH ATB-BMPA
2.10.1 Preparation of ATB~[2-3 H]-BMPA
The ATB-[2-3 H]-BMPA was prepared from (2-3 H) BMPA and l-azi-2.2.2- 
trifluoroethyl-benzoic acid by Dr.G.D.Holman as previously described (Clark and 
Holman, 1990).
ATB-(2-^H) BMPA had a specific activity of 10 Ci/mmol and was stored at - 
20°C in PBS in the dark at a concentration of 0.5 mM (5 mCi/ml).
2.10.2 Cell surface photolabelling
Plates of the 3T3-L1 cells (35 mm) were washed in KRH buffer pH 7.4 (some 
experiments used pH 8.0 or pH 6.5 buffer, see Figure legends) and incubated in 1 ml 
of this buffer at 37 °C in the presence or absence of insulin (100 nM) for 30 minutes. 
Under these conditions the full stimulation of hexose transport occurs. Following this 
stimulation, the cells were washed quickly with KRH buffer at 18°C and then 
incubated with 250 /xl of KRH buffer contain 100 fiCi of(2- ^H) ATB-BMPA (about 
160 iiM ) and 100 nM of insulin for 3 minutes at 18°C. The dishes were then 
irradiated at 18°C for 1 min in the presence of 100 /xCi of ATB-[2-^H]-BMPA on a 
wire shelf placed 5 cm from the bottom in a Rayonet RPR-100 reactor with RPR- 
3000A lamps turned on its side (most experiments used 300 nm lights. In the studies 
of comparison of GLUT1 and GLUT4 subcellular trafficking in basal and insulin- 
stimulated 3T3-L1 cells the irradiaton was used half 300 nm and half 350 nm lights. 
The irradiated cells were washed four times in KRH buffer.
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2.10.3 Total cellular pool photolabelling
To photolabel the total cellular transport pool, cells were permeabilized by 
treatment with 0.025 % ( w t/vol) digitonin for 8  minutes at 18°C in the presence of 
100 /xCi of ATB-(2-^H )BMPA. The digitonin used ( Sigma D1407 and suitable for 
use in aqueous solution ) was 50% pure and an allowance for this was made in 
preparing the digitonin solution. The digitonin was dissolved in KRH buffer. The 
other procedures were the same as cell surface labelling.
2.10.4 Immunoprecipitation of ATB-BMPA labelled proteins
Photolabelled proteins, either from solubilized cells or from crude plasma 
membranes, or crude light-microsome fractions (see 2 . 1 1 ), were immunoprecipitated 
with rabbit antisera raised against GLUT1 or GLUT4 antibodies. Preimmune rabbit 
serum was used in some experiments for a control.
The pellets of washed photolabelled cells, crude plasma membrane or light- 
microsome fractions were solubilized for 20 min on ice in 1.5 ml of 5 mM sodium 
phosphate buffer (pH 7.2) containing 2% nonaethylene glycol dodecyl ether (C1 2 E9 ) 
detergent (Boehringer Mannheim) and the proteinase inhibitors pepstain A, leupeptin, 
antipain and aprotinin each at 1 jtg/ml. Following centrifugation at 20,000 gmax f°r 
2 0  min the supernatant was carefully separated from unsolubilized pellet and the 
insoluble fat-cake and the supernatant were subjected to immunoprecipitation to 
determine the amounts of photolabelled GLUT1 and GLUT4 transporter.
For each immunoprecipitation, 7 mg of protein A-Sepharose (Sigma) were 
coupled with 100 /* 1 of anti-GLUTl and 5 mg of protein A-Sepharose were coupled 
with 50 pi of anti-GLUT4 antiserum. The solubilized material from the supernatants 
was incubated with the protein A-sepharose antibody-complex (GLUT4) for IV2
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hours by rotation at 4°C. The protein A-sepharose immunoprecipitates were pelleted 
by low speed centrifugation. The supernatant from this low speed centrifugation was 
then incubated with the protein A-sepharose antibody-complex (GLUT1) for one IV2 
hours by rotation at 4°C (in some experiments, the GLUT1 was immunoprcipitation 
first).
The protein A-sepharose immunoprecipitates were washed three times with 
1.0% and once in 0.1% C1 2 E9  detergent buffer (5 mM Sodium phosphate buffer pH
7.2 with proteinase inhibitors pepstain A, leupeptin, antipain and aprotinin each at 1 
/xg/ml). In studies of the comparison of GLUT1 and GLUT4 subcellular trafficking in 
basal and insulin-stimulated 3T3-L1 adipocytes (see results 3.6), the 
immunoprecipitates from tracer-tagged GLUT1 and GLUT4 in the basal state were 
washed five times with 1 .0 % and once in 0 . 1 % C1 2 E9  detergent buffer and in 
insulin-stimulated states were washed four times with 1.0% and once in 0.1% C1 2 E9  
detergent buffer.
The labelled glucose transporters were released from the antibody complexes 
with 10% SDS, 6  M Urea, 10% mercaptoethanol electrophoresis sample buffer and 
subjected to electrophoresis.
2.11 CELL FRACTIONATION
2.11.1 Preparation of crude plasma membrane
The procedures used for the preparation of the fraction by homogenization 
with TES buffer were described by McKeel et a /.,(1970). For each condition two 35 
mm dishes of fully insulin-stimulated or basal state 3T3-L1 adipocytes were 
photolabelled with 100 /xCi each of ATB-[2-^H]-BMPA. In the studies of comparison 
of GLUT1 and GLUT4 subcellular trafficking 500 /*Ci were used in the basal state,
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and in the insulin stimulated state 250 /*Ci was used. The labelling was carried out 
with the lids on the 35 mm dishes so that radiation damage of the cells was 
minimized. Some experiments used half 300 nm and half 350 nm lights and with 2 
mm glass plates to protect the cells. Following four washes of the dishes in KRH 
buffer to remove excess label, the cells were incubated at 37°C for the indicated 
times. The cells from each dish were scraped into 0.5 ml for each dish of TES buffer 
(255 mM sucrose, 10 mM Tris hydrochloride and 0.5 mM EDTA, pH 7.2). The 
pooled material from the two dishes was then homogenised at 900 rpm in a 2  ml 
tight-fitting teflon homogeniser (clearance *0 .15  mm) with 10-15 complete strokes. 
The homogenate was then centrifuged at 20,000 gmax f°r 20 min (in studies of 
comparison of GLUT1 and GLUT4 subcellular trafficking in basal and insulin- 
stimulated 3T3-L1 cells, the samples was centrifuged at 12,500 gmax f°r 20 min). 
The pellet, containing the crude plasma membrane fraction, was dissolved in 0.5 ml 
of 6 % C1 2 E9  detergent buffer and diluted with 1 ml 5 mM sodium phosphate 
buffer. The 20,000 gmax supernatant from above, containing the crude light 
microsome fraction, was mixed with 0.5 ml of 6 % C4 2 E9  detergent buffer. Both 
detergent solubilized samples were kept at 0-4 °C for 30 min and then re-centrifuged 
at 20,000 gmax f°r 20 min. The supernatants were then subjected to 
immunoprecipitation with anti-GLUTl and anti-GLUT4 antibodies. In some 
experiments cells were homogenised in a KC1 buffer (150 mM KC1, 2 mM MgC12, 
20 mM Hepes, pH 7.4) and 16,000 gmax plasma membrane and supernatant fractions 
were isolated as described by Brown et ah , (1988). The results obtained were the 
same as those obtained using the TES buffer.
2.11.2 Preparation of purified plasma membrane
To prepare purified plasma membrane of 3T3-L1 adipocytes , four 35 mm 
dishes of cells were washed and incubated in different pHs (pH 7.4, pH 8.0 and pH 
6.5) KRH buffer and treated with zero, 0.025, 0.05, 0.1, 1 and 100 nM insulin at
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37°C for 30 min. The cells from each dish were scraped into 0.5 ml for each dish of 
TES buffer (255 mM sucrose, 10 mM Tris hydrochloride 0.5 mM EDTA, pH 7.2). 
The pooled material from the four dishes were then homogenised at 900 rpm in a 2 
ml tight-fitting teflon homogeniser (clearance *0 .15  mm) with 10 complete strokes. 
The homogenate was then centrifuged at 15,000 rpm for 20 min. The pellet, 
containing the crude plasma membrane fraction, was re-homoginized in 300 jil of 
TES buffer and then centrifuged at 15,000 rpm for 20 min. The pellet was re- 
homoginized in 150 fil of TES buffer and then layered on top of the sucrose cushion 
(0.6 ml, containing 1.12 M sucrose, 20 mM TRIS, 1 mM EDTA, pH 7.2) and then 
centrifuged at 35,000 rpm for 20 min. The supernatant was gently taken off, made up 
to 3ml volume with TES buffer and then centrifuged in 37,000 rpm for 9 min. The 
pellet was re-homoginized in 300 fil of TES buffer, made up to 3ml with TES buffer 
and centrifuged at 37,000 rpm for 9 min. The 100 fil of TES buffer was added to the 
pellet (containing the purified plasma membrane) and protein was measured by the 
BCA method.
2.12 SODIUM DODECYL SULPIIATE-POLYACRYLAMIDE GEL 
ELECTROPHORESIS (SDS-PAGE)
Proteins either from membrane preparations or immunoprecipitates were 
analysed by SDS-PAGE using the protean II gel system (Bio-Rad).
SDS-PAGE was carried out as described by Laemmli (1970). The gel were 
run in the Laemmli discontinuous buffer system. Gels were prepared from stock 
solutions. 10% acrylamide resolving gels (Tris 1.5 M, SDS 0.4%, pH 8 . 8  ) were 
used, with stacking gels containing 3.7% acrylamide ( Tris 0.5 M, SDS 0.4%, pH
6 . 8  ). The gel was polymerised chemically by the addition of 0.6 fill ml N, N, 
N'.N',tetramethylethylene-diamine (TEMED) and 6  /zl/ml of a 10% solution of 
ammonium persulphate. The poured gel was overlaid with a layer of water-saturated
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butanol and left to polymerize ( »  1 hour). Following removal of the butanol, the 
resolving gel was overlaid with a stacking gel and allowed to polymerize for about 
half hour.
Electrophoresis was generally carried out overnight at 25 mA for a 3 mm gel 
or at 12.5 mA for a 1.5 mm gel in buffer containing 25 mM TRIS, 192 mM glycine 
and 0.1% SDS (pH 8.3).
The protein samples were solubilized at room temperature for 20 minutes in 6  
M urea sample buffer (10% SDS, 6  M urea, 5% 5-bromophenyl-l% blue ) 180 pi 
sample buffer were added to each sample and subjected to electrophoresis using 16 
cm x 3 mm gels with 2.5 cm wide sample wells in the stacking gel.
The gels were stained with 0.2% Coomassie Blue in destain and then 
destained in 10% acetic acid, 30% methanol, 60% distilled water for 2 hours and 
then sliced. The slices ( in scintillation vials ) where dried at 80°C for 2-3 hours and 
were then dissolved in 0.5 ml of alkaline hydrogen peroxide at 80°C for a further 2 
hours. Scintillant was added and the radioactivity counted. The positions of the 
photolabelled peaks were compared with the positions of molecular weight markers 
(Sigma) in adjacent lanes. Molecular weight marker proteins (Sigma): Myosin 205 
kDa, B-galactosidase 116 kDa, Phosphorylase 97 kDa, Bovine serum albumin 6 6  
kDa, Ovalbumin 45 kDa and Carbonic anhydrase 29 kDa. The variations of labelled 
peak positions relative to the slice numbers, which are shown in the figures, occurs 
because of variations in the total migration distance allowed. The levels of 
radioactivity associated with each peak were obtained by summing the radioactivity in 
all the slices under the peak and subtracting a background radioactivity based on the 
average radioactivity of the slices on either side of the peak.
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2.13 WESTERN BLOTTING
2.13.1 Electrophoretic transfer of proteins to nitrocellulose
For analysis of proteins by Western blotting, samples were subjected to 
electrophoresis on 1.5 mm thick gels with 10-50 /xg of protein per lane and 
transferred to nitrocellulose paper (Gelman Sciences pore size 0.4 /xm) using semi­
dry transfer methods.
The 1.5 mm thick SDS-polyacrylamide stacking gel was removed and the 
resolving gel was put in continuous transfer buffer (39 mM glycine, 48 mM Tris, 
0.0375% w/v SDS, 20% methanol, pH 8 .8 ). Proteins were transferred using a 
Multiphor II NovaBlot electrophoretic transfer method which involved soaking sheets 
of filter paper, nitrocellulose sheets and the gel in the continuous transfer buffer and 
then layering them on the anode electrode (presoaked in distilled water).
1 transfer unit consisted of 9 sheets of filter paper, the nitrocellulose 
(Biotrace, Gelman Sciences), the resolving gel and then an additional 9 sheets of 
filter paper. The cathode electrode (presoaked in distilled water) was then placed on 
the top and a current applied (0 .8  x trans unit area, mA ) for 1 hour and 45 minutes.
Care was taken to cut all the sheets to the same size, to soak the sheets evenly 
and to remove all the trapped air bubbles when layering the sheets together.
2.13.2 Staining nitrocellulose filters for total protein
When the transfer was finished, the nitrocellulose was washed in distilled 
water and the protein was temporarily stained in Ponceau S ( 0.1 Ponceau S in 3% 
trichloroacetic acid ). If the protein had transferred well the band could be seen very
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clearly. Then, the sheets were cut to the required size. The nitrocellulose was washed 
twice in blocking buffer containing 3% bovine serum albumin (BSA), 0.2% Tween 
20, in TBS buffer (10 mM Tris, 0.9% sodium chloride, pH 7.4) to remove the 
Ponceau S and then was incubated in blocking buffer overnight at 0-4°C.
Pre-stained molecular weight marker proteins with weights of about 116 and 
29 kDa were included on the polyacrylamide gel. When the temporary stain was 
removed, these could be seen as blue bands on the nitrocellulose paper. The position 
of transferred protein can thus also be identified by pre-stained molecular weight 
marker proteins.
2.13.3 Immunoblotting of nitrocellulose-bound protein
This method was based on the protocol used by Dr. S. Cushman and co­
workers (personal communication). Nitrocellulose filters were blocked for 1 hour 
with TBS containing 3% (w/v) BSA in shaker. The nitrocellulose filters were 
incubated with antisera (1:200 dilution in 1% BSA, 0.2% Tween 20, TBS buffer) for 
2 hours at room temperature in shaker, then washed for 5 minutes three times and 
once for 15 minutes with 50 ml of this buffer.
^ 1  -labelled Protein A (Amersham) was then added at 0.1 ftCi/ml in 
TBS/Tween for 2 hours at room temperature in a shaker. Then the nitrocellulose was 
washed at least six times. Every wash was 5 minutes in 50 ml TBS/Tween. The 
nitrocellulose was air-dried and wrapped in cling-film and then exposed to x-ray film 
(from Amersham International) for 24-72 hours at -70° C. The glucose transporter 
band was then cut out of the nitrocellulose using the prestained standards as a 
reference as these always gave a band with ^I-Protein A and counted in a Gamma 
counter ( see "Results" part in  ). A background count was obtained from 
nitrocellulose which was the same size and was cut from above and below the glucose
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transporter band. This was subtracted to get the glucose transporter-specific counts.
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3.0 RESULTS 
PART I BACKGROUND STUDIES
3.1 MORPHOLOGY OF MURINE 3T3-L1 CELLS
Unlike most other cell lines the mammalian fibroblast line 3T3 stop growing 
when they reach a confluent monolayer and remain viable in a resting state for long 
periods (Todaro and Green, 1963).
The murine 3T3 fibroblasts convert to adipose cells under defined culture 
conditions. This conversion is a cellular differentiation which occurs after the cells 
stop growing, at which time there is an increased incorporation of fatty acid 
precursors into triglycerides (Russell and Ho, 1976). The mature adipocytes do not 
divide (Russell and Ho, 1976).
3.1.1 3T3-L1 fibroblasts
Fig.7a shows the picture of pre-confluent 3T3-L1 fibroblasts. The cells were 
seeded at 0.1 x 106 per 175 cm2  flask. Most cells are elongated in shape and at this 
stage the cells are almost unresponsive to insulin. After about one week from 
seeding, the cells in the flask became subconfluent and were reseeded at 0.03-0.05 x 
106  cells per 35 mm dishes. In about 5 days the cells became fully confluent and 
reached a monolayer. More than 90% of the cells were round at this stage and the 
cells remained viable in a resting state for long periods ( Fig.7b). If cells stay as a 
confluent monolayer for a long time (more than about 3 weeks), some fibroblasts will 
start to differentiate to adipocytes even without treating the cells with IBMX, insulin 
and dexamethasone.
Fig.7a Light micrographs of preconfluent 3T3-L1 Fibroblasts
Most cells are isolated and elongated in shape. Magnification xlOOO.
Fig.7b Light micrographs of fully conflunt Fibroblasts.
The majority of cells are rounded or triangular in shape. The cells are firmly 
attached to each other. Magnification x3000.
74
3.1.2 3T3-L1 adipocytes
The fibroblasts are fully confluent after about 2-4 days. In most studies cells 
were left for 10 days before differentiation. The IBMX, insulin and dexamethasone 
were added for 48 hours and insulin alone was then added for a further 48 hours. At 
this stage a dramatic change occurred (Fig. 8 a and 8 b). Numerous clusters of adipose 
cells develop. Cells begin to accumulate multiple fat droplets and the cells come to 
resemble brown adipose cells; later, the droplets fuse to make a single large central 
droplet surrounded by a thin rim of cytoplasm and an eccentric nucleus, giving the 
cells a typical signet ring appearance resembling that of white adipose cells. (Fig.9).
3.2 INSULIN STIMULATION OF GLUCOSE TRANSPORT AND ATB-BMPA 
LABELLING THE CELL SURFACE GLUT1 AND GLU4
3.2.1. Determination of anti-GLUTl and GLUT4 antibody levels by ELISA
The rabbit antiserum to the purified human erythrocyte glucose transporter has 
been described by Lienhard et al. (1982). This serum has previously been shown to 
contain antibodies against the erythrocyte transporter by two criteria (Lienhard et al. , 
1984). First, these antibodies bind to a polypeptide of average Mr 55000 on 
immunoblots of erythrocyte proteins. Second, they immunoprecipitate the transporter 
polypeptide from a detergent-solubilized mixture of erythrocyte membrane proteins, 
as determined by assay for the removal of a specific transporter function (D-glucose- 
inhibitable cytochalasin B binding).
To determine if anti-GLUTl and anti-GLUT4 antibody were present in 
antiserum, an enzyme linked immunosorbent assay (ELISA) was carried out as 
described in Materials and Methods.
7 5
Fig. 8 a Light micrographs of day 2 differentiated 3T3-L1 cells.
Some fat droplets developed. Magnification x3000.
Fig. 8 b Light micrographs of day 4 differentiated 3T3-L1 cells.
Numerous clusters of adipose cells developed. Magnification x3000.
7 6
Fig. 9 Light micrographs of fully differentiated (day 10) 3T3-L1 
adipocytes.
Most fat droplets fuse to become a single large droplet. Magnification x3000.
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Rabbit serum samples (rabbits were immunized with the carboxy-terminal 
peptide) were assayed using an ELISA. Antiserum from rabbit 17 (as record 
number), obtained 9 weeks after immunization, was assayed in an ELISA using 
erythocyte protein depleted membranes as an antigen and as shown in Fig. 10. At a 
1:100 dilution the anti-peptide serum showed about a 75% increase in binding over 
that detected in the preimmune serum.
A comparison of the binding of serum from rabbit 16 taken at week 9 is also 
shown at Fig. 10. At a 1:100 dilution the anti-peptide serum showed about a 60% 
increase in binding over that detected in the preimmune serum.
The anti-serum from rabbit 17 taken at week 9 was chosen for experiments 
because this rabbit produced good anti-GLUTl antibody.
Fig. 11. shows antiserum from rabbit 13 which was taken at week 9 after 
immunization and was assayed in an ELISA using a synthetic C-terminal peptide as 
an antigen for GLUT4. At a 1:100 dilution the anti-peptide serum showed an about 
90% increase in binding over that detected in the preimmune serum. This indicated 
that rabbit 13 after immunization for 9 weeks produced very good anti-GLUT4 
antibody.
3.2.2. Insulin dose-response.
To obtain the maximal transport rate after 3T3-L1 adipocytes were exposed to 
insulin (i.e. the ability of the 3T3-L1 adipocytes to respond to a maximal dose of 
insulin), the uptake of 2-deoxy-D-glucose was carried out at 37°C using different 
concentrations of insulin. Fig. 12 shows that after 3T3-L1 adipocytes were incubated 
with different concentration of insulin for 30 minutes at 37°C, 50 /xM 2-deoxy-D- 
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Fig. 10 Testing the anti-GLUTl antiserum with ELISA.
ELISA 96 well plates were coated with erythrocyte protein depleted 
membrane at 1 /ig/well. Unoccupied protein binding sites were blocked. The plates 
were incubated with anti-GLUTl antiserum (1:100 dilution) from week 9 
immunized rabbit 16 (A), rabbit 17 ( • )  or preimmune serum (▼) for two hours in
blocking buffer and were incubated with the goat anti-rabbit peroxidase conjugate 
(1:2000 dilution) for another two hours in blocking buffer. The excess conjugate 
was washed and the colour was developed (see Materials and Method). Substrate 












-lo g  10 dilution
Fig. 11 Testing the anti-GLUT4 antiserum with ELISA.
ELISA 96 well plates were coated with anti-C-terminal peptide 20 ng/well. 
Unoccupied protein binding sites were blocked. The plates were incubated with 
anti-GLUT4 antiserum (1:100 dilution) from week 9 immunized rabbit ( • )  or
preimmune serum (A) for two hours in blocking buffer and were incubated with the 
goat anti-rabbit peroxidase conjugate (1:2000 dilution) for another two hours in 
blocking buffer. The excess conjugate was washed and the colour was developed 

















Fig. 12 Insulin stimulation of 2-deoxy-D-glucose uptake in 3T3-L1 
adipocytes.
3T3-L1 adipocytes in 35 mm-diameter dishes were treated with insulin at 
37°C at the indicated concentration for 30 min. 2-deoxy [2,6-^H]-D-glucose uptake 
(50 fiM) was measured over 5 min at 37°C. After washing four times with KRH 
buffer at 4°C, the cells were dissolved in 0.1 M MaOH and the radioactivity was 
counted.
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dose response curve shows that maximal stimulation at 37°C was seen in cells 
incubated with 100 nM insulin and no effect of hgher insulin concentration was 
noted. 2-deoxy-D-glucose uptake was half-maximally stimulated by insulin at 
approximately 1.9 nM. In this thesis, the studies of acute insulin treatment were all 
performed at this concentration (100 nM).
The rate of uptake 2-deoxy-D-glucose was calculated as below:
Concentration of sugar (jjlM)
-------------------------------------- x 1000 x cpm at 5 mil =  Pmol/5min
Total radioactivity (cpm)
Then above values divided by 5 min will gave the rate of pmol/min.
For example: If the counts of a sample are 892 cpm, and the total
radioactivity is 144560, the rate will be 61.7 pmol/min.
50 fiM. 1000
------------------- x   x 892 (cpm) =  61.7 pmol/min
144560 (cpm) 5
3.2.3 Basal and insulin stimulated 2-deoxy-D-glucose transport activity
The 2-deoxy-D-glucose has been used in the study of glucose transport in 
adipocytes. This glucose analogue is supposed to be transported and subsequently 
phosphorylated by hexokinase, but is not further metabolised (Wick et al., 1951), 
Hence, the total rate of labelled 2-deoxy-D-glucose glucose uptake can be taken as a 
measure of the rate of hexose transport.
The 2-deoxy-D-glucose-[l-3H]D-glucose uptake rate in control (basal state)
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and in the acute insulin stimulated state is shown in Fig. 13. The classical inhibitor of 
facilitated glucose transport in animal cells, cytochalasin B, was studied. This 
compound at 30 /xM inhibited both basal and insulh-stimulated 2-deoxy-D-glucose 
uptake. Basal,insulin stimulated cells and cytochaasin B treated cells were all 
incubated at 37°C for 30 min. Fig. 13 shows that the uptake rate of 2-deoxy-D- 
glucose in the basal state was 31.85 ±  2.57 pmol/nin/35 mm dish, in the insulin 
stimulated cells it was 502.87 ±  19.42 pmol/itin/35 mm dish, and in the 
cytochalasin B treated cells it was 6.85 ±  0.22 pmol/min/35 mm dish. After 
correcting for the rate of uptake in the presence of cytochalasin B, the acute insulin 
treatment was calculated to increase transport by 2 0  fold compared with the basal 
state.
After stimulation with a 100 nM insulin for 30 min at 37°C, the transport 
activity in 3T3-L1 adipocytes measured by 2-deoxy-D-glucose (where the increase 
was about 2 0  fold compared with the basal state), was very similar to the transport 
activity in rat adipocytes measured by 3-O-methyl-D-glucose. This indicates that the 
3T3-L1 adipocytes have a good response to insulin stimulation.
3.2.4 Cell surface labelling of GLUT1 and GLUT4 by ATB-BMPA 3T3-L1 
adipocytes.
Holman et al. (1990) have used a membrane impermanent photoaffinity label 
ATB-BMPA to identify the cell surface glucose transporters in isolated rat adipose 
cells. A primary advantage is the rapidity of its activation (Holman et al. , 1988). The 
maximum incorporation of label can be achieved within 45 sec. During 90 sec of uv 
irradiation, the cells did not appear to lyse and the insulin-stimulated glucose 
transport activity was found to be unimpaired (Holman et al., 1990). The 
photolabelled glucose transporters run as a peak at about 50 kDa and the peak is 
























Fig. 13 Uptake of 2-deoxy-D-glucose in 3T3-L1 adipocytes.
(All experiment in this thesis used 35 mm-diameter dishes). 3T3-L1 
adipocytes in 35 mm-diameter dishes were incubated with (Insulin) or without 
(Basal) 100 nM insulin, or with 30 of cytochalasin B (Cyt B) for 30 min at 
37°C. 2-deoxy [2,6-^H]-D-glucose uptake (50 /lcM) was measured over 5 min at 
37°C. After washing four times with KRH buffer at 4°C, the cells were dissolved 
in 0.1 M NaOH and the radioactivity was counted.
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region of the SDS gel is unrelated to the presence of glucose transporters because it is 
not immunoprecipitated by either anti-GLUTl or anti-GLUT4 antibodies (Holman et 
al., 1990).
Using the membrane impermanent photolabel ATB-BMPA, the cell surface 
glucose transporter isoforms GLUT1 and GLUT4 in the basal and acute insulin 
stimulated state were labelled in the 3T3-L1 adipocytes. Fig. 14 shows the GLUT1 
cell surface labelling result from basal (control) and 100 nM insulin stimulated 3T3- 
L1 adipocytes. In the glucose transporter region of the gel there is a slight peak above 
the normal gel background for cells labelled in the basal state. The calculated dpm for 
basal is 332 and for the insulin stimulated cells it is 2204. Acute insulin stimulation 
increased labelling by about 6  fold. Over seven individual experiments the labelling 
was increased 5 fold compared to the basal state. Fig. 15 shows the GLUT4 cell 
surface labelling results from basal and acute insulin stimulated 3T3-L1 adipocytes. 
The calculated dpm for basal state is 143 and in the insulin stimulated state it is 2083. 
Insulin increased the labelling about 14 fold. Over seven experiments the fold 
increase is about 11 fold. In basal state, the GLUT4 cell surface labelling is about 
one-third of the GLUT1. These results are consistent with the results reported by 


























Fig. 14 ATB-BMPA cell-surface labelling GLUT1 in 3T3-L1 adipocytes.
3T3-L1 adipocytes were incubated with (A) or without ( • )  100 nM insulin at
37°C and then insulin was removed. The cells were labelled at 18°C with 100 f i d  
of ATB-BMPA in 250 fil of KRH buffer. After labelling, the cells were washed 
four times in KRH buffer and then directly solubilized in C4 2 E9 detergent buffer. 
GLUT1 was then immunoprecipitated with anti-(C-terminal peptide) antibodies. 
The protein was then subjected to electrophoresis and the radioactivity was 
estimated by cutting out and counting the gel slices. The radioactivity in the 
transporter peaks was corrected for background radioactivity which was based on 
the average radioactivity of the slices on either side of the peak ( the following 
























Fig.15 ATB-BMPA cell-surface labelling GLUT4 in 3T3-L1 adipocytes. 
3T3-L1 adipocytes were incubated with (A) or without ( • )  100 nM insulin at
37°C and then insulin was removed. The cells were labelled at 18°C with 100 /xCi 
of ATB-BMPA in 250 fi\ of KRH buffer. After labelling the cells were washed four 
times in KRH buffer and then directly solubilized in C 12E9 detergent buffer. 
GLUT4 was then immunoprecipitated with anti-(C-terminal peptide) antibodies. 
The protein was then subjected to electrophoresis and the radioactivity was 
estimated by cutting out and counting the gel slices.
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PART n  DEVELOPMENT OF AN INTRACELLULAR POOL OF GLUCOSE 
TRANSPORTERS IN 3T3-L1 CELLS
This part of the thesis describes experiments designed to further characterize 
the development of the insulin-sensitive glucose transport system in 3T3-L1 cells 
upon differentiation. The two glucose transporter isoforms GLUT1 and GLUT4 have 
been studied at different stages of this development.
3.3 MEASUREMENT TRANSPORT ACTIVITY AND ATB-BMPA 
PHOTOLABELLING IN 3T3-L1 FIBROBLASTS
3.3.1 Measurement of 2-deoxy-D-glucose transport activity in 3T3-L1 fibroblasts
To examine the rate of 2-deoxy-D-glucose transport in fibroblasts, the 
transport activity from initial seeding of dishes to the development of a confluent cell 
monolayer (which occurs at about Day 5 after seeding) has been studied (Fig. 16). 
One day after initial seeding of the dishes the transport rate was 0.13 nmoles/10  ^
cells/min (with 0.026 x 106 cells/ 35 mm dish). This gradually fell over 7 days to 
0.025 nmoles/106 cells/min (with 0.3 x 106 cells/ 35 mm dish) and stayed at this low 
level for at least a further 6  days. In preconfluent fibroblasts (one day after initial 
seeding) the 2-deoxy-D-glucose transport activity was about 5 times higher than in 
confluent fibroblasts. This result is similar to that observed by Ziehm et al. (1993). 
They have measured 2-deoxy-D-glucose transport activity at 4 days after plating and 
3 days before confluence and they found the glucose transport rates in preconfluent 
cells were approximately 5-fold higher than those in the confluent cells.
Insulin failed to stimulate glucose transport in preconfluent cells and from 
about 7 days after seeding the 2-deoxy-D-glucose transport rate was increased by 





















Fig. 16 2-deoxy-D-glucose transport activity in 3T3-L1 fibroblasts.
3T3-L1 fibroblasts were seeded at a density of 0.03 x 10^ cells per 35 mm 
dish and maintained in culture in DMEM with 10% newbom-calf serum for up to 
13 days. On the indicated days the cells were incubated in the presence of serum- 
free medium for 2 hours and then maintained at 37°C for 30 min in either the 
absence (A) or presence of 100 nM insulin (■) in 1 ml KRH buffer. The transport
of 50 /zM 2-deoxy-[2,6-^H]-D-glucose was then measured and cell number 
determined. Results are mean and S.E.M . from 4 independent determinations.
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the results of Ziehm et al. (1993), who found insulin did not stimulate glucose 
transport in preconfluent cells, but gave rise to an approximately 2 -fold stimulation of 
the glucose transport rate in confluent cells (from 10 experiments). However, even in 
the presence of insulin the transport rate (0.06 nmoles/1 0 6  cells/min) was 
approximately half the rate which was observed in preconfluent fibroblasts.
3.3.2. ATB-BMPA labelling of cell-surface and total-cellular pools of GLUT1 in 
3T3-L1 fibroblasts
In order to determine the subcellular distribution of transporters, the cell- 
surface availability of transporters has been measured using the impermeant 
photolabel ATB-BMPA and this labelling has been compared with that obtained in 
digitonin-permeabilized cells. When fibroblasts are treated with digitonin the cells 
detach very easily, so great care should be taken during the washing procedure. The 
subcellular distribution of GLUT1 in confluent cells was shown in Fig. 17. No 
GLUT4 was detected in the fibroblasts. There was an *  4-fold increase in labelling in 
permeabilized cells compared with untreated cells. Insulin only increased the cell- 
surface labelling by *  2-fold and did not increase the total pool of cellular GLUT1. 
The data from 3 experiments are shown in Fig. 18. The ATB-BMPA photolabelling 
experiment was also carried out on preconfluent cells. These results are also shown in 
Fig. 18. From this result it is clearly shown that in preconfluent cells there is no 
significant increase in labelling in the presence of digitonin indicating that most of the 
cells transporters were at the cell surface.
Together with the transport data in Fig. 16 and Fig. 18, the labelling data 
show that in preconfluent 3T3-L1 fibroblasts the high transport rate is associated with 
the presence of most of the transporters at the cell-surface. As the cells reach 
confluence, transporters are sequestered from the cell surface and an intracellular 





























Fig. 17 ATB-BMPA labelling of cell-surface and total-cellular pools of 
GLUT1 in confluent 3T3-L1 fibroblasts.
Cells were maintained in culture for 11 days in DMEM with 10 % newbom- 
calf serum and then incubated in serum-free medium for 2 hours. Cells were then 
maintained at 37°C for 30 min either in the absence (O) or in the presence (A) of
100 nM insulin in 1 ml of KRH buffer. Cells were then labelled with 100 /xCi of 
A T B - [ 2 - 3 h ] - B M P A  in 250 /d KRH buffer at 18°C either without (open symbols) 
or with (closed symbols) of 0.025 % digitonin. Labelled cells were immediately 
solubilized in C 12E9 detergent buffer and the labelled proteins were subjected to 
immunoprecipitation with GLUT1 C-terminal-peptide antibody and then analyzed 
by electrophoresis.
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Fig. 18 Comparison of GLUT1 cellular distribution in preconfluent and 
confluent 3T3-L1 fibroblasts.
a) 3T3-L1 fibroblasts were harvested and plated into two 35 mm dishes to 
give a total of 0.28 x 10^ subconfluent cells after 1 day in culture. Cells in each 
dish were incubated in serum-free medium for 2  hours and then labelled with 1 0 0  
/zCi of A T B - [ 2 - 3 h ] - B M P A  in 250 /xl of K R H  buffer at 18°C either in the absence, 
B(sur), or presence B(tot) of 0.025 % digitonin. Labelled cells from the 2 dishes 
were then immediately solubilized in detergent buffer and labelled proteins 
were subjected to immunoprecipitation with GLUT1 C-terminal-peptide antiserum 
followed by electrophoresis. Results are the mean and S.E.M. from 4 experiments.
b) 3T3-L1 fibroblasts were maintained in culture for 11 days and at 
confluence reached a density of 0.28 x 10^ cells / 35mm dish. The cells were 
incubated for 2 hours in serum-free medium and then maintained at 37°C for 30 
min either without (B) or with (I) 100 nM insulin in 1 ml KRH buffer. Cells were 
then labelled with 100 ^Ci o f ATB-[2-3 H]-BMPA in 250 /d of KRH buffer at 18°C 
either in the absence (sur) or presence (tot) of 0.025 % digitonin and GLUT1 
immunoprecipitated as described in the Fig. 17 legend. Results are the mean and 
S.E.M. of 3 experiments.
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the transport activity which can then be partially restored by acute-insulin treatment 
which redistributes approximately half of the available transporters to the cell surface. 
A similar result was achieved by Ziehm et al. (1993) who used a western blotting 
technique to show that in preconfluent fibroblasts GLUT1 was almost exclusively 
located in plasma membranes. In confluent fibroblasts, the abundance of GLUT1 in 
the plasma membranes was moderately decreased, and the relative amount of GLUT1 
in the low-density microsomes appeared higher than in the preconfluent cells. No 
GLUT4 was detected in fibroblasts.
3.4 ATB-BMPA LABELLING OF CELI^SURFACE AND TOTAL- 
CELLULAR POOLS OF GLUT1 AND GLUT4 IN 3T3-L1 ADIPOCYTES
The technique for comparing cell-surface and total-cellular transporters has 
also been used to examine the distribution of GLUT1 and GLUT4 in differentiated 
3T3-L1 adipocytes. Fig. 19 and Fig. 20 shows an SDS polyacrylamide gel of ATB- 
BMPA labelled and immunoprecipitated GLUT1 and GLUT4. As shown in previous 
studies in this thesis {and also by Calderhead et al. (1990); Kozka et al. (1991)}, 
there was very little GLUT4 at the cell-surface in the basal state. Upon insulin 
stimulation the GLUT4 labelling increased by « 12-fold in this experiment, while the 
GLUT1 increased about 5 fold. However, as is the case with GLUT1 in confluent 
fibroblasts only about half of the total available transporters were returned to the cell 
surface upon insulin treatment. In the digitonin-permeabilized cells there was only a 
slight difference between the amount of GLUT1 and GLUT4 labelled in the basal 
compared with the insulin-treated condition. The small difference observed in this 
experiment and others (see Fig. 21) ( from 7 experiments ) was possibly due to a 
difference in efficiency of labelling of the intracellular pool compared with the cell- 
surface GLUT1 and GLUT4. This small difference was not observed in all 
experiments and over 7 experiments the mean was only slightly lower than that 




















Fig. 19 ATB-BMPA labelling of cell-surface and total cellular pools of 
GLUT1 in 3T3-L1 adipocytes.
Fully differentiated 3T3-L1 adipocytes in 35 mm dishes were incubated in 
serum-free medium for 2 hours and were then maintained at 37°C for 30 min either 
in the absence (O) or presence (A) of 100 nM insulin in 1 ml KRH buffer. Cells
were then labelled with 100 jiCi of ATB-[2-^H]-BMPA in 250 /xl of KRH buffer at 
18° either without (closed symbols) or with (open symbols) 0.025 % digitonin. 
Cells were then washed twice in KRH buffer and then solubilized in C 12E9 
detergent buffer and the labelled proteins were subjected to immunoprecipitation 























Fig.20 ATB-BMPA labelling of cell-surface and total cellular pools of
GLUT4 in 3T3-L1 adipocytes.
Fully differentiated 3T3-L1 adipocytes in 35 mm dishes were incubated in 
serum-free medium for 2 hours and were then maintained at 37°C for 30 min either 
in the absence (O) or presence (A) of 100 nM insulin in 1 ml KRH buffer. Cells
were then labelled with 100 /*Ci of ATB-[2-^H]-BMPA in 250 /il of KRH buffer at 
18° either without (open symbols) or with (closed symbols) 0.025 % digitonin. 
Cells were then washed twice in KRH buffer and then solubilized in C ^ E g  
detergent buffer and the labelled proteins were subjected to immunoprecipitation 
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Fig.21 GLUT1 and GLUT4 cellular distribution in 3T3-L1 adipocytes.
Cells were fully differentiated in 35 mm dishes and then subjected to the 
labelling procedure described in the Fig. 19 and 20. The total dpm under the gel 
peaks were calculated for GLUT1 (Fig. 19) and GLUT4 (Fig.20) either without or 
with 0.025 % digitonin to obtain cell-surface (sur) or total-cellular (tot) levels of 
labelling for basal cells (B) or cells treated with 100 nM insulin (I). The results are 
the mean and S.E.M . from 7 experiments.
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larger for the labelling of the total-cellular pool of both GLUT1 and GLUT4 in the 
basal cells. The greater variability of labelling the intracellular pool (which 
constitutes a greater proportion of the total in the basal state) was probably a 
consequence of variations between cell-batches in the susceptibility to digitonin 
permeabilization or the efficiency with which the uv. light could penetrate to 
intracellular sites of transporter localization. Fig. 21 also shows that in the insulin- 
stimulated state approximately half of the total of both GLUT1 and GLUT4 was 
recruited to the plasma membrane. However, as previously shown by Calderhead et 
al. (1990) and also from other studies in this thesis, the GLUT4 has a greater 
tendency to be internalized in the absence of insulin and the cell-surface labelling of 
GLUT4 is about a third of the GLUT1 level in this basal state.
3.5 MEASUREMENTS OF THE CHANGES OF GLUCOSE TRANSPORT 
ACTIVITY AND THE CHANGES OF GLUT1 AND GLUT4 THROUGHOUT 
THE CELL DIFFERENTIATION
The time-course for changes in the glucose transport activity and subcellular 
transporter distribution during the transition from confluent fibroblasts to fully 
differentiated adipocytes have been examined. The experiment was started when the 
fibroblasts was fully confluent (as day 0). The experiment was then carried out on 
every other day. Fig. 22 shows that the basal level of 2-deoxy-D-glucose transport 
remained low throughout the differentiation period. The transport rate in basal cells 
was * 8  pmoles/ dish/ min in confluent fibroblasts (with 0.3 x 106 cells/ dish) and 
increased to * 2 5  pmoles/ dish/ min in fully differentiated cells, where the cell 
number had also increased to 0.6 x 106 cells/ dish. During the differentiation the 
amount of protein per 35 mm dish increased enormously from 8 8  jig! dish to 1.1 mg/ 
dish. The insulin-stimulated rate of transport was approximately double the basal rate 
for about 4 days after the initiation of differentiation. By 6  days there was a very 




















Fig.22 Time course for differentiation of highly insulin-responsive glucose 
transport in 3T3-L1 cells.
Confluent 3T3-L1 fibroblasts in 35 mm dishes were treated with 
dexamethasone, IBMX and insulin in DMEM with 10% foetal-bovine serum to 
initiate differentiation. On the indicated days cells were incubated in serum-free 
medium for 2 hours and then maintained at 37 °C for 30 min in the absence (A) or 
presence (■) of 100 nM insulin in 1 ml of KRH buffer. This was followed by
determination of the rate of uptake of 50 2-deoxy-[2,6-^H]-D-glucose. Results 
are the mean of 2 experiments.
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rate which was «  2 0 -times the basal rate.
Fig.23. shows the distribution of GLUT1 throughout this differentiation 
period. During the first 4 days the cells behaved in a manner similar to that observed 
in confluent fibroblasts. The basal level of labelling was approximately 2.5-fold 
lower than the insulin-stimulated level. The total-cellular levels were approximately 
double the level found at the cell-surface in the insulin-stimulated state. Between 6  
and 11 days there was a marked rise in the total-cellular GLUT1. The cell-surface 
GLUT1 in the basal cells rose slightly throughout this period and this may have been 
a consequence of the increased cellular level of this transporter. The GLUT4 was 
produced in parallel with the rise in GLUT1 (Fig. 24). Thus there was little 
detectable GLUT4 over the first 2 days of differentiation and then this rose steeply 
between days 6  and 1 1 .
In contrast with the rise in the basal level of labelled GLUT1, labelling 
showed that the GLUT4 that was newly synthesized was very effectively sequestered 
inside the cell. The basal GLUT4 labelling remained consistently low from days 4-11 
after the initiation of differentiation while the total cellular GLUT4 rose by >  10- 




















Fig.23 Time course for the increase in cell-surface and total cellular pools 
of GLUT1 in 3T3-L1 cells.
3T3-L1 fibroblasts in 35 mm dishes were treated with dexamethasone, IBMX 
and insulin in DMEM with 10% foetal-bovine serum to initiate differentiation. On 
the indicated days cells were incubated in serum-free medium for 2 hours and were 
then maintained at 37 °C for 30 min either in the absence (□) or presence (A) of 100 
nM insulin in 1 ml KRH buffer. GLUT1 distribution was determined by labelling 
with 100 / i d  ofA TB -[2-3H]-BMPA in 250 of KRH buffer at 18°C to obtain 
either cell-surface levels (closed symbols) or total-cellular levels in cells 
permeabilized with 0.025 % digitonin ( open symbols). Cells were washed twice in 
KRH buffer and then solubilized in C 12E9 detergent buffer except Day-0 cells 
which were immediately solubilized in detergent buffer. The isoforms were then 
immunoprecipitated with anti-C-terminal-peptide antibodies and analyzed by 




















Fig.24 Time course for the increase in cell-surface and total cellular pools 
of GLUT4 in 3T3-L1 cells.
3T3-L1 fibroblasts in 35 mm dishes were treated with dexamethasone, IBMX 
and insulin in DMEM with 10% foetal-bovine serum to initiate differentiation. On 
the indicated days cells were incubated in serum-free medium for 2 h. and were 
then maintained at 37°C for 30 min either in the absence (□) or presence (A) of 100 
nM insulin in 1 ml KRH buffer. GLUT1 distribution was determined by labelling 
with 100 /tCi of ATB-[2-3H]-BMPA in 250 *0 of KRH buffer at 18°C to obtain 
either cell-surface levels (closed symbols) or total-cellular levels in cells 
permeabilized with 0.025 % digitonin (open symbols). Cells were washed twice in 
KRH buffer and then solubilized in C 12E9 detergent buffer except Day-0 cells 
which were immediately solubilized in detergent buffer. The isoforms were then 
immunoprecipitated with anti-C-terminal-peptide antibodies and analyzed by 
electrophoresis to obtain the total dpm under the gel peaks. Results are the mean 
from 2 experiments.
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PART i n  TRAFFICKING OF GLUT1 AND GLUT4 IN 3T3-L1 ADIPOCYTES
3.6 INSULIN STIMULATION OF GLUCOSE TRANSPORT AND THE 
AVAILABILITY OF CELL-SURFACE TRANSPORTERS
3.6.1 Insulin stimulation of glucose transport and the availability of cell-surface 
transporters at 37°C.
Kamielli et al. (1981a) have studied the time course of insulin's action on 
glucose transport activity in intact cells, measured using 3-O-methylglucose. The 
maximal response to insulin is achieved within 1 2  min, with a half-time of 
approximately 4.0 min. A similar result was obtained in intact rat adipocytes by 
Clark et al. (1991) who found the maximal response to insulin (10 nM) is obtained 
with 9.2 min with half time of about 3.0 min. To study the insulin's action on 3T3- 
L1 adipocytes, the time course of 2-deoxy-D-glucose transport activity was measured 
and cell surface glucose transporters were labelled by ATB-BMPA at 37°C.
Fig.25. shows the time course of insulin stimulated glucose transport at 37°C. 
The monolayers of fully differentiated 3T3-L1 adipocytes were incubated with insulin 
at 0, 3, 5, 7, 10, 20, 30 min. When the cells were exposed to insulin for 3.8 min, 
half maximal rate was achieved. In about 12 min of stimulation, the 2-deoxy-D- 
glucose uptake rate reached a maximum level and maintained this level until 30 min.
Using the cell-impermeant photoaffinity label ATB-BMPA, the time course of 
insulin-stimulated appearance of cell surface glucose transporters was examined at 
37°C. Fig.26 shows the result from GLUT1, Fig.27 shows the result from GLUT4. 
The basal level for GLUT1 was 321 dpm, GLUT4 was 108 dpm. The counts of 
maximum insulin stimulation (30 min) of GLUT1 was 1296 dpm, for GLUT4 it was 
1742 dpm. Insulin-stimulated appearance of the cell surface glucose transporter
102
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Fig.25 Insulin stimulation of 2-deoxy-D-glucose transport in 3T3-L1 
adipocytes at 37°C.
(a) 3T3-L1 adipocytes stimulated with 100 nM-insulin at 37°C and then at 
zero, 3 min, 5 min, 7 min, 10 min, 20 min, 30 min, the 2-deoxy [2,6-^H]-D- 
glucose uptake (50 ^M) was measured over 5 min at 37°C. The cells were washed 
four times with KRH buffer at 4°C and then dissolved in 0.1 M NaOH and the 
radioactivity was counted. The results are from 2 experiments.
(b) Semi-log plots of -ln(l-f) against time, f  is the fraction of the maximum 
stimulation. The \>h values were calculated according to the equation: \>h =(ln2- 
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Fig.26 Insulin stimulation of the cell-surface appearance of GLUT1 in 
3T3-L1 adipocytes at 37° C.
(a) 3T3-L1 adipocytes were stimulated with 100 nM insulin at 37°C and then 
at zero time (A), 2.5 min (A), 5 min (v), 7 min (□), 12 min (O) and 30 min (■)
the insulin was removed by washing twice in KRH buffer at 18°C. The cells were 
then labelled at 18°C with 100 /xCi of ATB-BMPA in 250 /xl o f KRH buffer. After 
labelling the cells were washed four times in KRH buffer and then directly 
solubilized in C \2^g detergent buffer. GLUT1 was then immunoprecipitated with 
anti-(C-terminal peptide) antibodies. The protein was then subjected to 
electrophoresis and the radioactivity was estimated by cutting out and counting the 
gel slices.
(b) Semi-log plots o f -ln(l-f) against time, f  is the fraction o f the maximum 
stimulation. The \>h values were calculated according to the equation: ilh  =(ln2- 
a)/b where a is the intercept on the -ln(l-f) axis and b is the slope. The \}/i = 3 . 2  



























Fig.27 Insulin stimulation of the cell-surface appearance of GLUT4 in 
3T3-L1 adipocytes at 37°C.
(a) 3T3-L1 adipocytes were stimulated with 100 nM insulin at 37°C and then 
at zero time (A), 2.5 min (A), 5 min (v), 7 min (□), 12 min (O) and 30 min (■)
the insulin was removed by washing twice in KRH buffer at 18°C. The cells were 
then labelled at 18°C with 100 /xCi of ATB-BMPA in 250 jd of KRH buffer. After 
labelling the cells were washed four times in KRH buffer and then directly 
solubilized in C1 2 E9  detergent buffer. GLUT4 was then immunoprecipitated with 
anti-(C-terminal peptide) antibodies. The protein was then subjected to 
electrophoresis and the radioactivity was estimated by cutting out and counting the 
gel slices.
(b) Semi-log plots o f -ln(l-f) against time, f  is the fraction of the maximum 
stimulation. The tlA values were calculated according to the equation: txh  =(ln2- 
a)/b where a is the intercept on the -ln(l-f) axis and b is the slope. The \}h — 2.4  
min. The results from 2 experiments.
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GLUT1 measured by impermeant photoaffinity label ATB-BMPA was increased 
about 4 fold compared to the basal state and GLUT4 was increased about 16 fold. 
After the cells were stimulated with insulin for 3.2 min, the counts for GLUT1 were 
732 dpm, and after the cells were stimulated with insulin 2.4 min, the counts for 
GLUT4 were 1056 cpm. The half time of appearance of GLUT1 at the cell surface 
was 3.2 min and GLUT4 was 2.4 min.
The rate of stimulation was determined from semi-log plots of -Ln(l-f) against 
time, where f  is the fraction of the maximum stimulation.
Normally the slope of such a plot gives the activation rate constant, but 
because a lag phase occurred before the transport activation, the P/2  values for the 
transport activation were calculated according to the equation:
P/2  =  (Ln2-a) / b (Eq. 1)
where a is the intercept on the -Ln(l-f) axis and b is the slope.
3.6.2 Insulin stimulation of glucose transport and the availability of cell-surface 
transporters at 27°C
The insulin stimulation of the cell-surface availability of glucose transporters 
at 37°C was found to be very rapid (P/2  * 2  min). This was considered to be too 
rapid for comparison with the stimulation of 2-deoxy-D-glucose transport activity at 
this temperature (P/2  »  3min). In rat adipocytes it was possible to measure the time 
course for stimulation at 37°C because the stimulation of these cells could be blocked 
at short time points by the addition of KCN. However, that the stimulation of 
transport in 3T3-L1 cells was not blocked by KCN. Instead, the approach of Gibbs et 
al. (1988) was used. These investigators studied the time-course for insulin
1 0 6
stimulation at 27°C. In Fig.28 3T3-L1 adipocytes were incubated with insulin for 0, 
2.5, 5, 7.5, 10. 20, 30 min at 27°C. The 2-deoxy-D-glucose transport activity was 
measured in 1-5 min at 18°C. The counts for basal state was 42.52 +  3.16 
pmol/min/35 mm dish, the maximal insulin stimulation counts was 201.44 ±  36.95 
pmol/min/35 mm dish, the half maximum time was 8 . 6  ±  0.5 min and the fully 
activated cells exhibited an 5-8 fold increase in uptake rate. This correlates well with 
the results that Gibbs obtained, they found the half time for stimulation at 27°C was
9.5 min and the activated cells give an 8.3 fold increase in transport rate.
No further insulin stimulation occurs once insulin is removed and the dishes 
were washed at 18°C. Fig.29 shows the 3T3-L1 dishes which were first stimulated 
with 100 nM insulin for 5 min and the insulin was then removed and replaced 1 ml 
KRH buffer at 18°C for 1, 3, 5, 7, 15 min. Then uptake of 2-deoxy-D-glucose was 
measured for 1 min at 18°C. The dishes were washed four times with KRH buffer at 
18°C. The data shows no further insulin stimulation occurs once insulin is removed 
and the cells were incubated at 18°C for further 15 min. This indicates that the 
transport stimulation can be blocked by an 18°C buffer.
At 27°C the increase in cell-surface GLUT1 and GLUT4 occurred in parallel. 
Fig.30 and Fig.31 show that a large increase above basal levels (*45%  of 
maximum) in cell-surface labelling of these two isoforms occurred with only 5 min of 
stimulation by 100 nM insulin. The cell-surface levels of both isoforms then rose 
progressively and reached a maximum level of stimulation in * 1 2  min. The cell- 
surface GLUT1 increases with a ixh  of 5.7 ± 1 . 5  min (from two experiments) which 
was similar to the rate of increase in cell-surface GLUT4 (tV4 =5.4 ±  0.7 min; from 
two experiments). In Fig.32 the time-course for this stimulation of the cell-surface 
availability of transporters is shown to slightly precede the time-course for insulin 
stimulation of 2-deoxy-D-glucose transport activity (V/i = 8 . 6  ±  1.5 min ; from three 
experiments). The observed lag between transporter appearance at the cell surface
1 0 7
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Fig.28 Insulin stimulation of 2-deoxy-D-glucose transport in 3T3-L1 
adipocytes at 27°C.
(a) 3T3-L1 adipocytes were stimulated with 100 nM insulin at 27°C and then 
at zero time, 2.5 min, 5 min, 7.5 min, 12 min, 30 min; the 2-deoxy [2,6-^H]-D- 
glucose uptake was measured over 1-5 min at 18°C. The cells were washed four 
times with KRH buffer and dissolved in 0.1 M NaOH and the radioactivity was 
counted.
(b) Semi-log plots of -ln(l-f) against time, f  is the fraction of the maximum 
stimulation. The tVi =  8.6 ± 1 . 5  min. The results are from 3 experiments. The txh  
values were calculated according to the equation: 0/2 = (ln2-a)/b where a is the 























Fig.29 The effect of 18°C to stop further insulin stimulation at 2-deoxy- 
D-glucose transport in 3T3-L1 adipocytes.
3T3-L1 adipocytes were stimulated with 100 nM insulin at 27°C for 5 min 
and then insulin was removed. The cells were washed four times with KRH buffer 
at 18°C and the cells were kept in KRH buffer at 18°C for 1-10 min. Then 2-deoxy 
[2,6-^H]-D-glucose (50 /*M) was measured over 1 min at 18°C.
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Fig.30 Insulin stimulation of the cell-surface appearance of GLUT1 in 
3T3-L1 adipocytes at 27°C.
(a) 3T3-L1 adipocytes were stimulated with 100 nM insulin at 27°C and then at zero 
time (A), 2.5 min (A), 5 min (v), 7 min (□ ), 12 min (O) and 30 min (■). The insulin was
removed by washing twice in KRH buffer at 18°C. The cells were then labelled at 18°C 
with 100 /xCi of ATB-BMPA in 250 /xl of KRH buffer. Following labelling the cells were 
washed four times in KRH buffer and then directly solubilized in C 12E9 detergent buffer. 
The GLUT1 was then immunoprecipitated with anti-C-terminal peptide antibodies. The 
protein was then subjected to electrophoresis and the radioactivity was estimated by cutting 
and counting gel slices.
(b) Semi-log plots of -ln(l-f) against time, f  is the fraction of the maximum 
stimulation. The V/2  = 5.7 ±  1.5 min. The results are from 2 experiments. The V/2  values 
were calculated according to the equation: V/2  = (ln2-a)/b where a is the intercept on the - 
ln(l-f) axis and b is the slope.
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Fig.31 Insulin stimulation of the cell-surface appearance of GLUT4 in 
3T3-L1 adipocytes at 27°C.
(a) 3T3-L1 adipocytes were stimulated with 100 nM insulin at 27°C and then at zero 
time (A), 2.5 min (A), 5 min (v), 7 min (□ ), 12 min (O) and 30 min (■) the insulin was
removed by washing twice in KRH buffer at 18°C. The cells were then labelled at 18°C 
with 100 /xCi of ATB-BMPA in 250 /d of KRH buffer. Following labelling the cells were 
washed four times in KRH buffer and then directly solubilized in C 12E9 detergent buffer. 
The GLUT4 was then immunoprecipitated with anti-C-terminal peptide antibodies. The 
protein was then subjected to electrophoresis and the radioactivity was estimated by cutting 
and counting gel slices.
(b) Semi-log plots of -ln(l-f) against time, f  is the fraction of the maximum 
stimulation. The Vh = 5.4 ±  0.7 min. The results are from 2 experiments. The FA values 
were calculated according to the equation: V/2  =(ln2-a)/b where a is the intercept on the - 
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Fig.32 Time course for insulin stimulation of cell-surface availability of 
glucose transporters and for stimulation of 2-deoxy-D-glucose 
transport
Compares the time-course for insulin stimulation of cell-surface availability of 
glucose transporters GLUT1 (Fig.30) ( • ) ,  GLUT4 (Fig.31) (A) and for stimulation
of 2-deoxy-D-glucose transport (Fig.28) (□) at 27°C. The levels o f transporter 
labelling and transport activity at the indicated times were calculated as a fraction of 
the maximum determined from the samples which were stimulated with insulin for 
30 min. Results shown are from 3 experiments and the average half-time for 
stimulation was calculated according to the equation: \>h — (ln2 -a)/b.
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and the full stimulation of transport was also reported by Gibbs et al. 1988, Kamielli 
et al. , Clark et al. 1991, Satoh et al. 1991.
3.7 REVERSAL OF INSULIN ACTION ON GLUCOSE TRANSPORT AND 
LOSS OF CELL-SURFACE GLUCOSE TRANSPORTERS
The reversal of insulin stimulation might result in glucose transport 
phosphorylation and this modification could serve as the signal for glucose transport 
internalization. The binding of insulin to its receptor is known to be weaker at lower 
pH (Posner et al., 1978), and it was found that the insulin-stimulation of transport 
was reversed by washing and incubating cells in buffer at pH 6.0 (Gibbs et al., 
1986). The time-course for the reduction of 2-deoxy-D-glucose transport activity has 
been examined (Fig. 33). The cells were fully stimulated by treatment with 100 nM 
insulin for 30 min at 37°C and then the insulin was removed by washing and 
incubation was carried out with MES buffer (KRM buffer) at pH 6.0 for the indicated 
times. The 2-deoxy-D-glucose uptake was carried out at 37°C for 5 min. The fully 
insulin stimulated rates were 441.27 ±  54.3 pmol/min/35 mm dish, after removal of 
insulin with MES buffer (KRM buffer) for 30 min the rate reached was 79 ±  1.9 
pmol/min/35 mm dish and these low levels were maintained until 60 min. The half 
time of loss of cell-surface glucose transport activity was calculated as 6.5 ±  0.4 
min. This procedure was developed by Gibbs et al. (1986) who showed that this low 
pH buffer resulted in insulin dissociation and a consequent reduction in transport 
activity. In Fig. 34 and Fig. 35, the cells were treated in the same way as above. 
Cells were insulin stimulated for 30 min and then insulin was removed with MES 
buffer (KRM buffer) at the indicated time. The cells were exposed to 100 ^Ci of 
ATB-BMPA for 3 min at 18°C and then irradiated for 1 min in the uv lamp . The 
cells were solubilized with detergent buffer and the immunoprecipitation was carried 
out to determine the loss of from the cell surface of GLUT1 and GLUT4. The 























Fig.33 Time course of 2-deoxy-D-glucose transport activity for the 
reversal of insulin stimulation.
(a) 3T3-L1 adipocytes were stimulated with 100 nM insulin for 30 min at 
37 °C and then insulin was removed by washing twice with MES buffer and by 
maintaining the cells in this buffer for the indicated times. The cells were washed in 
KRH buffer at 18°C and then 2-deoxy [2,6-^H]-D- glucose (50 /*M) uptake was 
measured over 2.5 min. The cells were washed four times with KRH buffer and 
dissolved in 0.1 M NaOH and the radioactivity was counted.
(b) Semi-log plots of -ln(f) against time, f  is the fraction of the maximum 
stimulation. The \>h for reversal insulin stimulation at glucose transport was 6.5 ±  
0.4 min. The results were from 3 experiments. The tVi values were calculated 
according to the equation: tVz = (ln2-a)/b where a is the intercept on the -ln(f) axis 

























Fig.34 Time course of ATB-BMPA labelled cell-surface GLUT1 for the 
reversal of insulin stimulation in 3T3-L1 adipocytes.
(a) 3T3-L1 adipocytes were stimulated with insulin for 30 min at 37°C and 
then insulin was removed by washing twice with MES buffer and by maintaining 
this buffer for zero time (A), 7 min (A), 12 min (v), 20 min (□), 30 min (O ) and 
60 min (■). The cells were washed twice in KRH buffer at 18°C and then 
photolabelled with 100 nCi of ATB-BMPA. Following labelling the cells were 
washed four times with KRH buffer and then directly solubilized in C 12E9 
detergent buffer. The levels of the GLUT1 transporters were determined by 
immunoprecipitation and electrophoresis.
(b) Semi-log plots of -ln(f) against time, f  is the fraction o f the maximum 
stimulation. The 0/2 =  9.2 ± 0 . 8  min. The results were from 2 experiments. The 
V/2  values were calculated according to the equation: \}/i =(ln2-a)/b where a is the 



















Fig.35 Time course of ATB-BMPA labelled cell-surface GLUT4 for the 
reversal of insulin stimulation in 3T3-L1 adipocytes.
(a) 3T3-L1 adipocytes were stimulated with insulin for 30 min at 37°C and 
then insulin was removed by washing twice with MES buffer and by maintaining 
this buffer for zero time (A), 7 min (A), 12 min (v), 20 min (□), 30 min (O ) and 
60 min (■). The cells were washed twice in KRH buffer at 18°C and the 
photolabelled with 100 fiCi of ATB-BMPA. Following labelling the cells were 
washed four times in KRH buffer and then directly solubilized in C 12E9 detergent 
buffer. The levels of the GLUT4 transporters were determined by 
immunoprecipitation and electrophoresis.
(b) Semi-log plots of -ln(f) against time, f  is the fraction of the maximum 
stimulation. The tVi =  6.8 ±  1.7 min. The results were from 2 experiments. The 
tlA values were calculated according to the equation: tVi =(ln2-a)/b where a is the 
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Fig.36 Time course for the reversal of insulin stimulation.
The time course for the reversal of insulin stimulation on labelling the levels 
of the GLUT1 (Fig.34) ( • )  and GLUT4 (Fig.35) (□) transporters and 2-deoxy-D-
glucose transport activity (Fig.33) (A) were compared in 3T3-L1 adipocytes. The 
levels of transporter labelling and transport activity at the indicated times were 
calculated as a fraction of the maximum determined. The results shown are the 
mean of two photolabelling experiments and three experiments to determine 
transport activity.
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GLUT4 it was 6 . 8  ±  1.7 min (both results were from two experiments). This 
correlates well with the decrease in 2-deoxy-D-glucose-transport activity of 6.5 ±  
0.4 min (three experiments). The comparison of glucose transport activity and the 
cell surface labelling of GLUT1 and GLUT4 is shown in Fig. 36. The decrease in 
cell-surface GLUT4 was slightly more extensive than for GLUT1, possibly reflecting 
the greater tendency of GLUT1 to be re-exocytosed in the absence of insulin.
3.8 EFFECT OF PHENYLARSINE OXIDE  ON GLUT1 AND GLUT4 
TRAFFICKING
3.8.1 The effect of low concentration PAO on basal glucose transport
A number of effects of phenylarsine oxide on the glucose transport activity in 
basal 3T3-L1 cells have been noted. Frost and Lane (1985) reported that PAO 
reduced the insulin stimulation of transport activity but had no effect on the transport 
activity of basal cells. However, Gould et al. (1988) reported that at low 
concentrations of PAO (of <  20 /xM) a stimulation of the basal rate of transport 
occurred. Surprisingly, at concentrations of PAO where a transport stimulation was 
noted they found a decrease in cell-surface transporters (as detected by cell-surface 
labelling with sodium borotritide of galactose oxidase treated cells) and a rise in 
plasma-membrane associated GLUT1 as detected by western blotting. Therefore the 
transport activity after treatment with 1-20 /xM PAO in the basal state was examined. 
The Fig. 37 shows the transport rate after 1-20 /xM PAO treatment. A maximum rate 
was achieved at 10 /xM and this gave a ~  1.5-fold increase in 2-deoxy-D-glucose 
transport activity. To determine the changes on cell surface glucose transporter after 
10 jxM PAO treatment, the cells were labelled with 100 /xCi ATB-BMPA. As shown 
in Fig. 38 and Fig. 39. 10 /xM PAO gave no detectable rise in either the 
concentration of GLUT1 or GLUT4. It is clear from this result, however, that any 
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Fig.37 Effect of different concentration of PAO on 2-deoxy-D-glucose 
transport activity.
3T3-L1 adipocytes were incubated with 5 /cM, 10 fiM and 20 /*M of PAO, or 
without PAO for 30 min at 37°C. The 2-deoxy [2,6-^H]-D-glucose (50 fiM) uptake 

















Fig.38 Effect of PAO and insulin on the cell-surface photolabelling of 
GLUT1.
3T3-L1 adipocytes cells were maintained either with no additions (O ) , with 
100 nM insulin ( • )  , or with 10 ^iM phenylarsine oxide (A) for 30 min at 37°C. 
The cells were then labelled with 150 /xCi of ATB-BMPA. Following labelling the 
cells were washed four times in KRH buffer and then directly solubilized in C4 2 E9 
detergent buffer. The GLUT1 was immunoprecipitated with anti-C-terminal peptide 
antibodies. The protein was then subjected to electrophoresis and the radioactivity 
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Fig.39 Effect of PAO and insulin on the cell-surface photolabelling of 
GLUT4.
3T3-L1 adipocytes cells were maintained either with no additions (O ) , with 
100 nM insulin ( • ) ,  or with 10 /xM phenylarsine oxide (A) for 30 min at 37°C. 
The cells were then labelled with 150 /xCi of ATB-BMPA. Following labelling the 
cells were washed four times in KRH buffer and then directly solubilized in C 12E9 
detergent buffer. The GLUT4 was immunoprecipitated with anti-C-terminal peptide 
antibodies. The protein was then subjected to electrophoresis and the radioactivity 
was estimated by cutting and counting gel slices.
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stimulating effect of insulin.
3.8.2 The effect of 20 /xM PAO on glucose transport activity
Frost and Lane have reported in 1985 that maximal inhibition of insulin- 
activated sugar uptake was achieved at 20 jxM PAO, so this concentration was used in 
this studies. Fully insulin-stimulated 3T3-L1 cells (30 min) were treated with 20 /xM 
phenylarsine oxide for 7.5, 12.5, 22.5, 32.5, and 57.5 min at 37°C and then the 2- 
deoxy-D-glucose uptake was measured for 2.5 min at 37°C. When PAO was added 
to fully insulin stimulated cells, the transport activity declined slowly toward the 
basal rate (tVi = 9 . 8  min. The result is shown in Fig.40). This correlates well with 
the results of Frost and Lane in which they found the half maximal time is 10 min. 
This result suggest that phenylarsine oxide blocks the movement of transporters from 
one compartment to another, specifically from the intracellular location to the plasma 
membrane. However, in the "activated" state when most of the glucose transporters 
are already at the plasma membrane as monitored by transport rate in Fig. 40, 
phenylarsine oxide dose not block the re-entry of the transporter back to its internal 
"inactive" site. This is in contrast to the effects of other thiol-reactive reagents which 
block not only activation but also reversion to the basal state (Czech, 1976).
3.8.3 The effect of PAO on the availability of GLUT1 and GLUT4 in insulin 
stimulated 3T3-L1 adipocytes
The time course of changes in the uptake of 2-deoxy-D-glucose from 20 jxM 
PAO treated 3T3-L1 cells after full insulin stimulation have show that the maximum 
effect of inhibitor occurs before 60 min. Therefore, treatment of fully insulin- 
stimulated 3T3-L1 cells with 20 /xM PAO was for 60 min followed by labelling with 
ATB-BMPA (100 /xCi). This markedly reduced the cell-surface level of the GLUT4 
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Fig.40 Time course for the PAO-induced loss of 2-deoxy-D-glucose 
transport activity in 3T3-L1 adipocytes.
(a) 3T3-L1 adipocytes were stimulated with 100 nM insulin for 30 min at 
3 7 °C. At zero time insulin was removed and 20 jiM PAO was added for 7.25 min, 
12.5 min, 22.5 min, 32.5 min and 57.5 min and at indicated time the 2-deoxy-[2,6- 
^H] glucose (50 fiM) was measured for 2.5 min. The cells were dissolved in 0.1 M 
NaOH and the radioactivity was counted.
(b) Semi-log plots of -ln(f) against time, f  is the fraction of the maximum 
stimulation. The txh  — 9.8 ±  1.6 min. The results from 3 experiments. The tl/i 
values were calculated according to the equation: txh  =(ln2 -a)/b where a is the 
intercept on the -ln(f) axis and b is the slope.
123
Fig. 41). To further examine the kinetics of trafficking in insulin stimulated 3T3-L1 
adipocytes which were treated with PAO, the time-course for the PAO induced loss 
of cell-surface transporters was determined by labelling with 100 /iCi ATB-BMPA. 
Again, the cells were first stimulated with insulin for 30 min at 37°C and then 20 /xM 
PAO was added at the indicated times. The cells were then labelled and subjected to 
immunoprecipitation. The ATB-BMPA labelled cell surface GLUT1 is shown in Fig. 
42 and GLUT4 is shown in Fig. 43. The time course for the PAO induced loss of the 
cell-surface transporters was also compared with the reduction in 2-deoxy-D-glucose 
transport activity in Fig. 44. The loss of transport activity and GLUT4 occurred with 
half-times of 9.8 ±  1.6 and 7.8 ±  0.8 min respectively (from two experiments) 
which were similar to the half-time for the reduction of transport activity that 
occurred when insulin was removed by the low pH washing procedure (Fig.33). In 
contrast to this, the level of cell-surface GLUT1 remained high during the PAO 
treatment. During the PAO treatment the half-time for the reduction in cell-surface 
GLUT1 was greater than 60 min and was much slower than the half-time for the loss 
of GLUT1 which occurred when insulin was removed by the low pH washing 
procedure and which was only * 9  min. To confirm that the reduction in GLUT4 was 
due to a redistribution of these transporters within the cell and not to an irreversible 
inhibition of transport (Douen and Jones, 1988), the binding of ATB-BMPA to the 
transporters in permeabilized cells has been measured. The cells were permeabilized 
by treatment with 0.025% digitonin. This treatment can allow the membrane 
impermeant label to enter the inside of the cell and the total intracellular pool of 
glucose transporter can then be labelled. Fig. 45 shows that the total concentration of 
available GLUT4 was only slightly reduced (by *30%). This slight reduction may 
have occurred because the efficiency of labelling transporters present inside the cell 
may have been slightly less than for surface labelling. To further confirm this 
finding, Western blotting was carried out in 3T3-L1 cells. The 7 -count results are 
shown in Fig.46. This indicated that neither GLUT1 nor GLUT4 was lost from the 
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Fig.41 Comparison of the effect of 20 /*M PAO on the availability of 
GLUT1 and GLUT4 in insulin-treated 3T3-L1 adipocytes.
3T3-L1 cells in 35 mm dishes were fully stimulated by treatment with 100 nM 
insulin for 30 min at 37°C. The cells were then maintained at 37°C for a further 60 
min in the presence (O ) and the absence ( • )  of 20 phenylarsine oxide. The
cells were then photolabelled with 100 nCi of ATB-BMPA and then the GLUT1 (a) 
and GLUT4 (b) were immunoprecipitated with anti-C-terminal peptide antibodies. 
The protein was then subjected to electrophoresis and the radioactivity was 
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Fig.42 Time course of the PAO-induced loss of cell-surface GLUT1 in 
3T3-L1 adipocytes.
3T3-L1 adipocytes were stimulated with 100 nM insulin for 30 min at 37° C. 
At zero time (A) insulin was removed and 20 jcM PAO was added for 10 min (A), 
15 min (v), 25 min (□), 35 min (O) and 60 min (■). At indicated time the 20 ^cM
PAO was removed and the cells were photolabelled with 100 /xCi o f ATB-BMPA. 
Following labelling the cells were washed four times in KRH buffer and then 
directly solubilized in 012^9  detergent buffer. The GLUT1 were 
immunoprecipitated with anti-(C-terminal peptide) antibodies. The protein was then 
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Fig.43 Time course of the PAO-induced loss o f cell-surface GLUT4 in 
3T3-L1 adipocytes.
3T3-L1 adipocytes were stimulated with 100 nM  insulin for 30 min at 37°C. 
At zero time (A) insulin was removed and 20 fiM PAO was added for 10 min (A), 
15 min (v), 25 min (□), 35 min (O) and 60 min (■). At indicated time the 20 fiM
PAO was removed and the cells were photolabelled with 100 /zCi of ATB-BMPA. 
Following labelling the cells were washed four times in KRH buffer and then 
directly solubilized in C 12E9 detergent buffer. The GLUT4 were 
immunoprecipitated with anti-(C-terminal peptide) antiibodies. The protein was then 
subjected to electrophoresis and the radioactivity was estimated by cutting out and 
counting gel slices.
(b) Semi-log plots of -ln(f) against time, f  is tlhe fraction of the maximum 
stimulation. The tVi =  7.8 ±  0.8 min. The results w ere from 2 experiments. The 
\}h values were calculated according to the equation: tn/2 = (ln2-a)/b where a is the 
intercept on the -ln(f) axis and b is the slope.
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Fig.44 Time course for the PAO-induced loss of cell-surface transporters 
and transport activity.
20 fiM PAO treatment of fully insulin-stimulated 3T3-L1 cells was carried out 
as described in Fig.42 and Fig. 43. The total radioactivity associated with 
photolabelled GLUT1 (■) in Fig.42 and GLUT4 (A) in F ig .43 was compared with 
the loss of 2-deoxy-D-glucose transport activity ( # )  in Fig.40. The results are the 


























1612 148 1062 40
Slice number
Fig.45 Experiment to determine whether the PAO-induced decrease in 
cell-surface GLUT4 is due to a redistribution to the cell interior.
3T3-L1 adipocytes cells were fully stimulated by treatment with 100 nM 
insulin for 30 min at 37°C. The cells were then maintained at this temperature for a 
further 50 min in the absence (a) or in the presence (b) of 20 fiM PAO. The cells 
were then either photolabelled directly with 100 /xCi of ATB-BMPA (O ) or were
permeabilized in the presence of 100 /xCi of ATB-BMPA by treatment with 0.025% 
digitonin for 8 min at 18°C ( • ) .  GLUT4 was then immunoprecipitated with anti-C-
terminal antibody. The protein was then subjected to electrophoresis and the 


































Fig.46 To test if GLUT1 and GLUT4 internalization to the light-
microsome fraction was increased by the PAO treatment compared 
with insulin alone.
3T3-L1 adipocytes were fully stimulated with 100 nM insulin for 30 min at 
37°c. The cells were then maintained at 37°C for a further 60 min in the presence 
(open symbols) or absence (closed symbols) of 20 /xM PAO. 50 /xg protein from 
Crude plasma membrane (O ) and microsome (A) were subjected to SDS-PAGE.
Proteins were transferred to nitrocellulose paper and incubated with a 1:500 
dilution of anti-GLUTl and anti-GLUT4 antibody. Blots were developed with ^ 5 j  
labelled protein A and quantified by gamma counting.
1 3 0
insulin and then 20 /xM PAO. The more striking effect of PAO treatment was to 
reduce just the GLUT4 at the cell-surface. In the cells treated with insulin alone 
*60% of the available transporter was at the cell surface. In the cells treated with 
PAO *20% of the available transporters were at the surface. In addition, by 
measuring ATB-BMPA photolabelling in permeabilized cells, it was found that the 
total available GLUT1 concentration was only slightly reduced following PAO 
treatment. Approximately 60% of the available GLUT1 transporters were at the 
surface both in the presence and in the absence of PAO.
A possible interpretation of this differential effect on GLUT1 and GLUT4 
cell-surface availability is that in the presence of PAO both transporters are removed 
from the cell-surface at the same rate but their recycling is differentially perturbed. 
Thus both GLUT1 and GLUT4 could be endocytosed even in the presence of PAO 
but inhibition of GLUT4, but not GLUT1, re-emergence and re-exposure to the 
photolabel at the cell-surface could then have resulted in the observed fall in its 
detected surface concentration.
3.8.4. Effect of PAO on internalization of GLUT1 and GLUT4
To examine the possibility that both transporters were internalized in the 
presence of PAO, the cell-surface transporters in fully insulin-stimulated cells was 
labelled with ATB-BMPA and then treated with PAO and insulin for a further 60 
min. The cells then were homogenised and a crude plasma membrane fraction was 
separated from the light-microsome fraction. After 60 min in the continuous presence 
of insulin the light-microsome level of photolabelled GLUT1 and GLUT4 was 
increased above that observed at zero time ( Fig. 47 and Fig. 48). This indicates that 
internalization of transporters occurred even in the continuous presence of insulin 
(Table 2). The percentages of photolabelled transporter found in the light microsome 
fraction are consistent with the results of Calderhead et al. (1990) who determined by





















Fig.47 Redistribution of photolabelled GLUT1 to subcellular membrane 
fractions of 3T3-L1 adipocytes.
3T3-L1 adipocytes were fully insulin stimulated by treatment with 100 nM 
insulin for 30 min at 37°C. They were then photolabelled with 100 /xCi of ATB- 
BMPA and then maintained with (O ) and without (□) 100 nM insulin for a further
60 min. Crude plasma membrane (closed symbols) and light-microsome membranes 
(open symbols) were prepared from 2 dishes for each condition. These fractions 
were solubilized in C 12E9 detergent buffer. GLUT1 was then immunoprecipitated 
with anti-C-terminal peptide antibody and subjected to electrophoresis and the 























Fig.48 Redistribution of photolabelled GLUT4 to subcellular membrane 
fractions of 3T3-L1 adipocytes.
3T3-L1 adipocytes were fully insulin stimulated by treatment with 100 nM 
insulin for 30 min at 37°C. They were then photolabelled with 100 ^Ci of ATB- 
BMPA and then maintained with (O ) and without (□) 100 nM insulin for a further
60 min. Crude plasma membrane (closed symbols) and light-microsome membranes 
(open symbols) were prepared from 2 dishes for each condition. These fractions 
were solubilized in C 12E9 detergent buffer. GLUT4 was then immunoprecipitated 
with anti-C-terminal peptide antibody and subjected to electrophoresis and the 
radioactivity was estimated by cutting and counting gel slices.
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western blotting that *50% of the total recovered GLUT1 and GLUT4 were present 
in the light microsome pool of basal cells and that this was reduced to *25% in 
insulin treated cells. However results from digitonin-permeabilized cells suggest 
different results and that in the presence of insulin *50% of the transporters are at 
the surface and 50% are in the light microsome pool. The light microsome 
association of GLUT1 was slightly less than that which occurred for the GLUT4 
isoform. This probably reflects the greater tendency of GLUT1 to be re-exocytosed 
under these conditions.
Table 2. also shows that the internalization of GLUT1 and GLUT4 also 
occurred in cells treated with PAO. However, in PAO-treated cells the additional 
GLUT4, above that found with insulin alone, that was lost from the cell-surface was 
not recovered in the light-microsomes but partitioned with the plasma membrane 
fraction during homogenization. The total recovered photolabel was unaltered by the 
PAO treatment. Western blotting confirmed that neither GLUT4 nor GLUT1 
internalization to the light microsome fraction was increased by the PAO treatment 
compared with insulin alone (Fig. 46). This result was consistent with the result from 
cell fractionation experiments ( see Fig. 49). This result shows that *35% of 
GLUT4 transporters that were photolabelled in the insulin-stimulated state were 
transferred to the light-microsome fraction after 60 min. This proportion was not 
altered by the PAO treatment.
3.9 COMPARISON OF GLUT1 AND GLUT4 SUBCELLULAR 
TRAFFICKING IN BASAL AND INSULIN-STIMULATED 3T3-L1 
ADIPOCYTES
Kinetic, rather than steady-state distribution, studies of transporter cycling 
should be able to directly determine and quantify the site of insulin action on 
trafficking.
1 3 4
Percentage of radioactivity in light-microsome fraction
Transporter... GLUT1 GLUT4
Time Individual Individual
Addition (min) Expt. results Mean +  S.E.M. results M ean+s.E.M .







4 11.0 . 13.2 .







4 16.2 . 18.2 .




20.6 23.2 + 1.8
35.4
29.8 32.0 ±1 .2
4 20.9 . 29.5 .
Table 2 Internalization of glucose transporters in 3T3-L1 cells
Fully-insulin-stimulated 3T3-L1 cells were photolabelled with ATB-BMPA 
and then either homogenized immediately (0 min) or maintained at 37°C with 
insulin (60 min) or insulin -I- 20 /xM-PAO (60 min) before homogenization. Crude 
plasma-membrane and light-microsome fractions were prepared and solubilized in 
C 12E9 detergent buffer. GLUT1 and GLUT4 were then immunoprecipitated and 
subjected to electrophoresis. The radioactivity in the transporter peaks was 
estimated, and the results are expressed as a percentage of radioactivity recovered in 
the light-microsome fraction compared wit the sum of the radioactivity recovered in 
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Fig.49 Redistribution of photolabelled GLUT4 to subcellular membrane 
fractions of 3T3-L1 adipocytes.
3T3-L1 adipocytes were fully insulin stimulated by treatment with 100 nM 
insulin for 30 min at 37°C. They were then photolabelled with 100 /xCi of ATB- 
BMPA and then maintained with (A) and without (O ) 20 /zM PAO for a further 60
min. Crude plasma membrane (closed symbols) and light-microsome membranes 
(open symbols) were prepared from 2 dishes for each condition. These fractions 
were solubilized in detergent buffer. GLUT4 was then immunoprecipitated
with anti-C-terminal peptide antibody and subjected to electrophoresis and the 
radioactivity was estimated by cutting and counting gel slices
136
The impermeant glucose transporter photolabel-ATB-BMPA has been used to 
tracer-tag cell-surface GLUT1 and GLUT4 in 3T3-L1 cells. The removal of these 
transporters from the plasma membrane of cells maintained in either basal or insulin- 
stimulated states has then been followed. The maintenance of a steady state of non­
labelled transporter distribution was confirmed by comparing the amounts of 
immunodetectable GLUT1 and GLIJT4 at the initial labelling time and following a 
further 40 min of incubation at 37°C. Fig. 50 shows an SDS-PAGE profile obtained 
by labelling and immunoprecipitating GLUT4 in insulin-treated 3T3-L1 cells. The 
label recovered in the post plasma membrane fraction of cells which were 
homogenized immediately was very low. This is an improvement over the results 
from the PAO study described above because of an improvement in the 
homogenization procedure. This suggests that tracer-tagged GLUT4 was not 
significantly transferred to the low-density microsomes during the processing period. 
This results contrast with those of Jhun et al. (1992) who have reported that in rat 
adipose cells approximately one third of the labelled GLUT4 was recovered in the 
post plasma membrane fraction in samples which were processed immediately after 
labelling.
Following 40 min of incubation of the cells at 37°C the label in the plasma 
membrane was reduced to approximately one-half its initial value. The label that was 
lost from the plasma membrane was recovered in the low-density microsome fraction. 
The material transferred to the low-density microsome fraction was not routinely 
analyzed because of the need to simultaneously process multiple immunoprecipitated 
samples obtained for estimating GLUT1 and GLUT4 in the plasma membrane. 
Previous studies have demonstrated that constitutive turnover of transporters occurs 
(Satoh., et al. unpublication results; Holman et al., 1988;) and that label which is 
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Fig. 50 Equilibration of tracer-tagged GLUT4 with the intracellular 
membrane pool in 3T3-L1 adipocytes.
3T3-L1 cells (two 35mm dishes) were stimulated for 30 min with 100 nM 
insulin and then labelled with 500 fiC'i of ATB-[2-3H]-BMPA. Following labelling, 
the dishes were either homogenized immediately (a) or were maintained at 37°C in 
the continuous presence of insulin for a further 40 min and then homogenized (b). 
GLUT4 was immunoprecipitated from either the plasma membrane ( • )  or the post 
plasma membrane supernatant (low-density microsomes) (O ) and was then analyzed 
by electrophoresis.
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In basal cells, the labelling of GLUT1 and GLUT4 was low (Fig. 51 and Fig. 
52) and following 40 min of incubation of the labelled cells at 37 °C the level of 
tracer-tagged transporter in the plasma membrane was reduced to background levels.
The least squares curve fitting to directly estimate exocytosis and endocytosis 
rate constants from time courses of loss of tracer-tagged GLUT1 (Fig. 53) and 
GLUT4 (Fig. 54) from the plasma membrane has been used. For analytical purposes 
the rate of loss of label from the plasma membrane is assumed to be dependent on 
just two rate constants; one describing the exocytosis (kex) and one the endocytosis 
(ken). The rate of loss of labelled transporters is then:
d Lp= kex. (1 -Lp) - ken . Lp (Eq. 2)
d t
where Lp is the fraction of the label in the plasma membrane.
Integration of Eq. 2 with lp =  1.0 at t= 0  gives:
Lp= kex +  ken exp( -t. (kex +  ken)) (Eq. 3)
(kex +  ken)
In the experiments described here this equation has been used to analyze the 
redistribution of label under steady-state conditions but (Eq. 3) is equally applicable 
to an analysis of label equilibration under non-steady-state conditions. All that is 
required is that the total pool of transporters is conserved. It is only necessary to 
consider the concentration of unlabelled transporters if there are saturation steps in 
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Fig. 51 Equilibration of tracer-tagged GLUT1 in basal 3T3-L1 adipocytes.
3T3-L1 cells (two 35 mm dishes) were labelled in the basal state with 500 /iCi 
o f ATB-[2-3H]-BMPA. Following labelling the dishes were either homogenized 
immediately (A) or were maintained at 37 °C for a further 40 min and then 
homogenized (A). GLUT1 was then immunoprecipitated from the plasma membrane 





























Fig. 52 Equilibration of tracer-tagged GLUT4 basal 3T3-L1 adipocytes.
3T3-L1 cells (two 35 mm dishes) were labelled in the basal state with 500 /xCi 
of ATB-[2-3H]-BMPA. Following labelling the dishes were either homogenized 
immediately ( • )  or were maintained at 37°C for a further 40 min and then 
homogenized (O)- GLUT4 was then immunoprecipitated from the plasma 
membrane fractions and were then analyzed by electrophoresis.
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In the continuous presence o f insulin both tracer-tagged GLUT1 and GLUT4 
were rapidly removed from the plasma membrane. The values of kex and ken derived 
from the mean results of 3 separate experiments are shown in Table 3. The estimated 
rate constants were similar for both GLUT1 and GLUT4. In addition, the end points 
of the equilibration of the tracer-tagged transporters were not significantly different. 
At 40 min the levels of tracer-tagged GLUT1 and GLUT4 remaining in the plasma 
membrane were 53 ±  1.2% (n =  3) and 51.1 ±  1.7% (n =3) respectively, of the 
initial values. The maintenance o f the insulin steady-state in which approximately 
one-half of the total transporter pool is at the surface thus occurs because the 
exocytosis of transporters (dependent on kex) matches an equal rate of endocytosis 
(dependent on ken).
In the basal state, tracer-tagged GLUT4 was more extensively removed from 
the plasma membrane than in the Insulin-stimulated state. At 40 min the fraction of 
the tracer-tagged GLUT4 remaining in the plasma membrane was only 8.4 ±  2.0% 
(n =4) of the initial value. In contrast, the fraction of the tracer-tagged GLUT1 
remaining in the plasma membrane was 20.8 ±  1.3% (n =  3) of the initial value. 
Analysis of the time course of tracer-tagged GLUT1 and GLUT4 redistribution in the 
basal state (Table 3) showed that the endocytosis rate constants were only *40%  
faster than in the insulin-stimulated state. However, the GLUT4 exocytosis rate 
constant was 8 . 6  times lower. In contrast to the low exocytosis rate constant of 
GLUT4, exocytosis of GLUT1 was only 3-times lower in the basal compared with 
the insulin-stimulated state (Table 3).
Although the curve fitting to directly obtain the rate constants kex and ken has 
been used, the half-time for label equilibration can also be easily calculated from least 






GLUT4 0.010 ±  0.001 0.116 ±  0.006 5.6 ±  0.3
GLUT1 0.035 ±  0.009 0.121 ±  0.020 4.4 ±  0.6
Insulin
GLUT4 0.086 ±  0.011 0.080 ±  0.007 4.2 ±  0.3
GLUT1 0.096 ±  0.023 0.093 ±  0.017 3.7 ±  0.6
Table 3 Kinetic parameters for glucose transporter trafficking in 3T3-L1 
cells
Kinetic parameters were calculated from the mean data shown in Fig. 44 and 
Fig. 45. These data were from three separate experiments (insulin) and three 
separate experiments (basal) except in the case of GLUT4 in basal cells where the 
results were from four separate experiments. The data were fitted to Equation 5 
using least squares analysis (weighted for relative error)
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ti/ 2 =  In 2 / {kex +  ken) (Eq. 4)
The values for the half-times for equilibration of tracer-tagged transporter 
were therefore calculated from summing the rate constants kex and ken as in (Eq. 4 
and are shown in Table 3. The half-times for GLUT1 and GLUT4 equilibration in 
basal cells were 4.4 and 5.6 min respectively. These values are similar to, but 
slightly faster than, the half-times (6.5 min) for the decrease in glucose transport 
activity in 3T3-L1 cells following removal of insulin. The calculated half-times for 
loss of tracer-tagged transporters in the continuous presence of insulin were slightly 
faster than in its absence because of the greater contribution of the re-exocytosis, the 
kex term in (Eq. 4), to the equilibration rate.
Kinetic parameters were calculated from the mean data shown in Fig.53 and 
54. These data were from three separate experiments (Insulin) and three separate 
experiments (Basal) except in the case of GLUT4 in basal cells where the results were 
from four separate experiments. The data were fitted to (Eq. 3) using least squares 
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Fig.53 Time courses for equilibration of tracer-tagged GLUT1 in 3T3-L1 
adipocytes.
3T3-L1 cells were labelled either in the basal ( • )  or insulin-stimulated (A) 
states and were then maintained in these steady states for the indicated times before 
homogenization to obtain the plasma membrane fraction. GLUT1 was then 
immunoprecipitated and analyzed by electrophoresis. The lines through the data 
were derived from least squares fitting to Eqn. 5. (see "Results" 3.6). The results 
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Fig.54 Time courses for equilibration of tracer-tagged GLUT4 in 3T3-L1 
adipocytes.
3T3-L1 cells were labelled either in the basal ( • )  or insulin-stimulated (A) 
states and were then maintained in these steady states for the indicated times before 
homogenization to obtain the plasma membrane fraction. GLUT4 was then 
immunoprecipitated and analyzed by electrophoresis. The lines through the data 
were derived from least squares fitting to Eqn.5. (see MResults” 3.6). The results 
are the mean and S.E.M . from 3 separate experiments in insulin treated cells and 4 
experiments in basal cells.
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PART IV INVESTIGATION OF DIFFERENT pH ON INSULIN-STIMULATED 
TRANSLOCATION OF GLUT1 AND GLUT4
3.10 DOSE-RESPONSE OF INSULIN-STIMULATED TRANSLOCATION OF 
GLUT1 AND GLUT4 AT pH 7.4
Using the ATB-BMPA photolabeling technique, the time course for 
translocation was determined by incubating cells in the presence of a maximal insulin 
concentration (100 nM) for variable times at 27 °C and it has been shown that the 
half-times for the appearance of GLUT1 and GLUT4 at the cell surface were 5.7 and 
5.4 min respectively. To compare with this result, the effect of different 
concentration of insulin has been examined in 3T3-L1 adipocytes. At the same time, 
the GLUT1 and GLUT4 in purified plasma membrane was determined by quantitative 
immunoblotting.
The 3T3-L1 adipocytes were treated with zero, 0.025, 0.05, 0.1, 1, and 100 
nM insulin and incubated in pH 7.4 KRH buffer for 30 min at 37°C. The 2-deoxy-D- 
glucose transport activity were measured (see Fig. 12) and the cell-surface glucose 
transporter were labelled with 100 c^Ci ATB-BMPA at pH 7.4 KRH buffer. The 
ATB-BMPA labelled GLUT1 is shown in Fig. 55, the GLUT4 is shown in Fig. 56. 
The half effective dose (ED5 0 ) for GLUT1 was 0.12 nM, for GLUT4 was 0.3 nM.
Using the Western blotting technique to examine the dose response of insulin- 
stimulated glucose transporter levels in plasma membrane, the cells were treated with 
same concentration of insulin and incubated in pH 7.4 KRH buffer and then the cells 
were homogenized and the purified plasma membrane was assessed by SDS-PAGE, 
gel transfer, and Western blotting using an anti-GLUTl and anti-GLUT4 C-terminal 
peptide antiserum and [ ^ 1]-protein A. The amount of purified plasma membrane 
was measured by the BCA protein assay and the protein was loaded onto a 1.5 mm
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Fig.55 Dose response of translocation of GLUT1 at pH 7.4 by ATB- 
BMPA photolabelling in 3T3-L1 adipocytes.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.05, 0.1, 1 and 100 nM of 
insulin in KRH buffer (pH 7.4) at 37°C for 30 min. The cells then were labelled 
with 100 jtCi o f ATB-[2-3H]-BMPA in 250 jtl of KRH buffer at 18°C. Following 
labelling the cells were washed four times in KRH buffer (pH 7.4) and solubilized 
in C 1 2 E9  detergent buffer. GLUT1 was then immunoprecipitated with anti-(C- 
terminal peptide) antibodies. The protein was then subjected to electrophoresis and 










1 1 0 1 0 00 . 10.01
Fig.56 Dose response of translocation of GLUT4 at pH 7.4 by ATB- 
BMPA photolabelling in 3T3-L1 adipocytes.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.05, 0.1, 1 and 100 nM of 
insulin in KRH buffer (pH 7.4) at 37°C for 30 min. The cells then were labelled 
with 100 /tCi of ATB-[2-3H]-BMPA in 250 of KRH buffer at 18°C. Following 
labelling the cells were washed four times in KRH buffer (pH 7.4) and solubilized 
in C 12E9 detergent buffer. GLUT4 was then immunoprecipitated with anti-(C- 
terminal peptide) antibodies. The protein was then subjected to electrophoresis and 
the radioactivity was estimated by cutting out and counting the gel slices.
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gel at 30 /xg protein/lane. Fig. 57 shows the Western blotting result of GLUT1 and 
GLUT4. The 7 -counts result of GLUT1 in the basal state was 4311 cpm and in the 
insulin (100 nM) stimulated state it was 12546 cpm. The insulin increase the counts 
about 3 fold compared to the basal level. The 7 -counts result of GLUT4 in basal state 
was 1901 cpm and in insulin (100 nM) stimulated state it was 8221 cpm. The insulin 
increase the counts about 4 fold compared to the basal level. The half effective dose 
(ED5 0 ) is 0.041 nM for GLUT1 and 0.046 nM for GLUT4. The comparison of the 
cell surface ATB-BMPA results, the Western blotting results and the 2-deoxy-D- 
glucose transport activity of GLUT1 is shown in Fig. 58, GLUT4 in Fig. 59. These 
results clearly indicated that the plasma membrane glucose transporter detected by 
Western blotting was higher than the ATB-BMPA labelled cell surface glucose 
transporter levels and these were both higher than the 2-deoxy-D-glucose transport 
activity.
3.11 DOSE-RESPONSE OF INSULIN-STIMULATED TRANSLOCATION OF 
GLUT1 AND GLUT4 AT pH 8.0
Ismail-Beigi et al. (1990) have reported that the rate of carrier-mediated 
glucose transport in a nontransformed rat liver cell line (Clone 9) is markedly 
stimulated by incubation at pH 8.5. A stimulation of glucose transport by incubation 
at alkaline pH has also been reported in rat adipocytes and an apparent translocation 
of glucose transporters to plasma membranes has been suggested as a possible 
mechanism (Sonne et al. , 1981; Toyoda et al. , 1986).
To examine the effect of alkaline pH on insulin-stimulated translocation of 
glucose transporter, the 3T3-L1 adipocytes were treated at zero, 0.025, 0.05, 0.1, 1 
and 100 nM of insulin and incubated at pH 8.0 KRH buffer for 30 min at 37 °C. The 
2-deoxy-D-glucose transport activity was measured, and was compared with results 
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Fig.57 To test the dose response of translocation of GLUT1 and GLUT4
at pH 7.4 by Western blotting.
3T3-L1 adipocytes w ere incubated with 0, 0 .025 , 0 .05 , 0 .1 , 1 and 100 nM  o f 
insulin and KRH buffer (pH 7.4) at 37°C . The cells then w ere hom ogenized and 
purified plasm a m em brane (30 /*g) was subjected to SD S-PA G E . Proteins w ere 
transferred to nitrocellulose paper and incubated with a 1:500 dilution o f  anti- 
GLUT1 (a) and anti-G LU T4 (b) antibody. Blots w ere developed w ith ^ 5 j  labelled 
protein A and this photo was taken from x-ray films.
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Fig.58 Comparison the dose response of translocation of GLUT1 and 2- 
deoxy-D-glucose transport activity at pH 7.4.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.05, 0.1, 1 and 100 nM of 
insulin in KRH buffer (pH 7.4) at 37°C for 30 min. The fractions of maximum 2- 
deoxy-D-glucose transport Fig. 12 ( o ) ,  ATB-BMPA labelling Fig.55 (□) and
immunoblotting Fig. 57 (A) of GLUT1 were compared.
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Fig.59 Comparison the dose response of translocation of GLUT4 and 2- 
deoxy-D-glucose transport activity at pH 7.4.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.05, 0.1, 1 and 100 nM of 
insulin in KRH buffer (pH 7.4) at 37°C for 30 min. The fractions of maximum 2- 
deoxy-D-glucose transport Fig. 12 (O ), ATB-BMPA labelling Fig.56 (□) and
immunoblotting Fig. 57 (A) of GLUT4 were compared.
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deoxy-D-glucose transport activity is shown in Fig.60. At this pH, the basal transport 
rate is 39.1 pmole/min/35 mm dish. The transport rate of insulin (100 nM) stimulated 
cells was increase to 542.3 pmole/min/35 mm dish. The insulin increased transport 
activity about 17 fold compared with the basal state. The half effective dose (ED5 0 ) 
is 0.077 nM. This is compared with the ED5 0  at pH 7.4 which is 1.9 nM. The 
transport activity at pH 8.0 is stimulated by lower insulin concentrations than the 
transport activity at pH 7.4.
This result indicates that the pH 8.0 markedly activated the insulin stimulated 
glucose transport activity.
In the same pH condition and the same insulin concentration, 100 /xCi of 
ATB-BMPA was used to detect the changes in the cell-surface glucose transporter 
levels. The ATB-BMPA labelled cell surface glucose transporter levels of GLUT1 are 
shown in Fig. 61. The half effective dose (ED5 0 ) for GLUT1 is 0.09 nM. The 
GLUT4 ATB-BMPA labelling result is shown in Fig. 62. The half effective dose 
(ED5 0 ) for GLUT4 is 0.16 nM. The ATB-BMPA labelling results have shown that 
the half effective doses (ED5 0 ) for stimulation of GLUT1, GLUT4 and 2-deoxy-D- 
glucose transport activity are very close. This indicates that the transport activity and 
cell-surface glucose transporter levels are very similar.
Fig. 63 demonstrates Western blotting results of GLUT1 and GLUT4. The 
purified plasma membranes were loaded at 10 fig protein per well (1.5 mm gel). The 
half effective dose (ED5 0 ) for GLUT1 is 0.09 nM, and for GLUT4 it is 0.05 nM. 
The basal level 7 -counts of GLUT1 is 4720 cpm and insulin (100 nM) stimulated 
state is 7980 cpm (the increase is about 2 fold). The basal level 7 -counts of GLUT4 
is 992 cpm and insulin (100 nM) stimulated state is 4228 cpm. (The increase is about 
4 fold). In contrast with the pH 7.4 results, at pH 8.0 both stimulation of cell surface 
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Fig.60 Dose response of translocation of 2-deoxy-D-glucose transport 
activity at pH 8.0.
3T3-L1 adipocytes were treated with 0, 0.025, 0.05, 0.1, 1, and 100 nM of 
insulin in KRH buffer (pH 8.0) for 30 min at 37°C. The 50 /*M 2-deoxy-[2,6-^H]- 
D-glucose was then measured over 5 min. After washing four times with KRH 
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Fig.61 Dose response of translocation of GLUT1 at pH 8.0 by ATB- 
BMPA photolabelling in 3T3-L1 adipocytes.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.05, 0.1, 1 and 100 nM of 
insulin in KRH buffer (pH 8.0) at 37°C for 30 min. The cells then were labelled 
with 100 /iCi of ATB-[2-3h]-BMPA in 250 jil o f KRH buffer at 18°C. Following 
labelling the cells were washed four times in KRH buffer (pH 7.4) and solubilized 
in C 12E9 detergent buffer. GLUT1 was then immunoprecipitated with anti-(C- 
terminal peptide) antibodies. The protein was then subjected to electrophoresis and 
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Fig.62 Dose response of translocation of GLUT4 at pH 8.0 by ATB- 
BMPA photolabelling in 3T3-L1 adipocytes.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.05, 0.1, 1 and 100 nM of 
insulin in KRH buffer (pH 8.0) at 37°C for 30 min. The cells then were labelled 
with 100 p C io f  ATB-[2-3H]-BMPA in 250 pi o f KRH buffer at 18°C. Following 
labelling the cells were washed four times in KRH buffer (pH 7.4) and solubilized 
in C 12E9 detergent buffer. GLUT4 was then immunoprecipitated with anti-(C- 
terminal peptide) antibodies. The protein was then subjected to electrophoresis and 
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Fig.63 To test the dose response of translocation of GLUT1 and GLUT4 
at pH 8.0 by Western blotting.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.05, 0.1, 1 and 100 nM of 
insulin and KRH buffer (pH 8.0) at 37°C. The cells then were homogenized and 
purified plasma membrane 10 fig were subjected to SDS-PAGE. Proteins were 
transferred to nitrocellulose paper and incubated with a 1:500 dilution of anti- 
GLUT1 (a)and anti-GLUT4 (b) antibody. Blots were developed with labelled 
protein A and this photo was taken from x-ray films.
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blotting results of GLUT1 and GLUT4 show no difference from the 2-deoxy-D- 
glucose transport activity (Fig. 64 for GLUT1 and Fig. 65 for GLUT4).
3.12 DOSE-RESPONSE OF INSULIN STIMULATED TRANSLOCATION OF 
GLUT1 AND GLUT4 AT pH 6.5
At pH 6.5, the insulin concentration dependency on 2-deoxy-D-glucose 
transport activity has been studied. At this pH, the glucose transport rate is much 
lower than in the pH 7.4 and pH 8.0 buffer. When the cells were treated with 100 
nM insulin, the transport rate at pH 6.5 is 357.9 pmole/min/35 mm dish. When the 
cells were treated at pH 7.4 with the same insulin concentration (100 nM), the 
transport rate is 509.5 pmole/min/35 mm dish. When the insulin concentration was 
increased to 500 nM the transport rate was 465.4 pmole/min/35 mm dish. Increasing 
the insulin concentration to 10 (iM increased the transport activity very little. The 
maximum insulin concentration in the follow investigation at pH 6.5 was chosen as 
500 nM. The transport assay result on pH 6.5 is shown in Fig. 6 6 . The half effective 
dose (ED5 0 ) is 140.6 nM.
Using ATB-BMPA labelling and Western blotting techniques, the 3T3-L1 
adipocytes were studied at this low pH condition. The cells were incubated with 0, 
0.025, 0.1, 1, 10 and 500 nM of insulin at pH 6.5 for 30 min at 37°C. 100 /*Ci of 
ATB-BMPA was used for labelling the cell-surface GLUT1 and GLUT4. ATB- 
BMPA labelled GLUT1 is shown in Fig. 67 and GLUT4 is shown in Fig. 6 8 . The 
half effective dose (ED5 0 ) for GLUT1 is 16.36 nM and for GLUT4 it is 64.66 nM. 
Both GLUT1 and GLUT4 ATB-BMPA labelling were stimulated more effectively 
than the transport activity.
At same concentrations and pH condition, the Western blotting result of 
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Fig.64 Comparison the dose response of translocation of GLUT1 and 2-
deoxy-D-glucose transport activity at pH 8.0.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.05, 0.1, 1 and 100 nM of 
insulin in KRH buffer (pH 8.0) at 37°C for 30 min. The fractions of maximum 2- 
deoxy-D-glucose transport Fig. 60 (O), the ATB-BMPA labelling Fig.61 (□) and
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Fig.65 Comparison the dose response of translocation of GLUT4 and 2- 
deoxy-D-glucose transport activity at pH 8.0.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.05, 0.1, 1 and 100 nM of 
insulin in KRH buffer (pH 8.0) at 37°C for 30 min. The fractions of maximum 
2-deoxy-D-glucose transport Fig. 60 (O ), the ATB-BMPA labelling Fig.62 (□) and
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Fig.66 Dose response of translocation of 2-deoxy-D-glucose transport 
activity at pH 6.5.
3T3-L1 adipocytes were treated with 0, 0.025, 0.1, 1, 10, 100, 500 nM, 1 
/xM and 10 /xM insulin in KRH buffer (pH 6.5) for 30 min at 37°C. The transport 
of 50 /xM 2-deoxy-[2,6-^H]-D-glucose was measured over 5 min . The cells were 
washed four times with KRH buffer (pH 6.5) and then dissolved in 0.1 M NaOH. 
The radioactivity was counted (A).
The 2-deoxy-D-glucose transport at pH 7.4 (O) was compared with pH 6.5.
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at 10 ^g/well onto 1.5 mm gel. At basal state the 7 -counts for GLUT1 was 2837 cpm 
and for GLUT4 it was 741 cpm. At 500 nM insulin concentration, the 7 -counts result 
for GLUT1 was 8506 cpm, for GLUT4 it was 2189 cpm. Insulin increased both the 
basal state for GLUT1 and GLUT4 by about 3 fold. The half effective dose (ED5 0 ) 
for GLUT1 was 1.04 nM and for GLUT4 was 4.22 nM. The comparison of transport 
activity, the ATB-BMPA labelling and Western blotting results are shown in Fig. 70 
(GLUT1) and Fig. 71 (GLUT4).
3.13 THE EFFECT OF DIFFERENT pH ON INSULIN BINDING
It is well known that binding of [125I]iodoinsulin to several cell types is 
markedly dependent on pH with a maximum in the range 7.5 to 8.2 (Cuatrecasas, 
1971; Gavin et al., 1973; Pederson and Beck-Nielsen, 1976; Ginsberg et al. 1976; 
Sonne and Gliemann, 1980). Sonne et al. (1981) reported that the amount of tracer 
bound at steady state at pH 7.8 was 6  times that at pH 6 .8 , the fractional degradation 
of receptor-bound iodoinsulin remained the same. The decreased binding at acidic pH 
could be accounted for by a decrease in the affinity.
De Meyts et al. (1976) have studied insulin binding in cultured human 
lymphocytes(IM-9) at 15°C and have shown that the dissociation rate constant at low 
receptor occupancy is markedly increased at acidic pH as compared to pH 7.8. In 
addition, these studies suggested that a high concentration of unlabelled insulin in the 
wash out medium had a more pronounced effect at pH 7.8 than at pH 7.0. It is 
therefore inferred from the work of De Meyts et al. that the receptors are in a low 
affinity state at acidic pH mainly because the dissociation rate constant is increased.
By contrast, Van Putten et al. (1985) reported that lowering of physiologic pH 
(pH 7.4) to pH 6.9 induced a decrease in insulin binding (50%) in cultured 3T3 
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Fig.67 Dose response of translocation of GLUT1 at pH 6.5 by ATB- 
BMPA photolabelling in 3T3-L1 adipocytes.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.1, 1, 10 and 500 nM of 
insulin in KRH buffer (pH 6.5) at 37°C for 30 min. The cells then were labelled 
with 100 jtCi o f ATB-[2-3H]-BMPA in 250 of KRH buffer at 18°C. Following 
labelling the cells were washed four times in KRH buffer (pH 7.4) and solubilized 
in C 12E9 detergent buffer. GLUT1 was then immunoprecipitated with anti-(C- 
terminal peptide) antibodies. The protein was then subjected to electrophoresis and 
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Fig.68 Dose response of translocation of GLUT4 at pH 6.5 by ATB-
BMPA photolabelling in 3T3-L1 adipocytes.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.1, 1, 10 and 500 nM of 
insulin in KRH buffer (pH 6.5) at 37°C for 30 min. The cells then were labelled 
with 100 f i d  of ATB-[2-3H]-BMPA in 250 #tl of KRH buffer at 18°C. Following 
labelling the cells were washed four times in KRH buffer (pH 7.4) and solubilized 
in C 1 2 E9  detergent buffer. GLUT4 was then immunoprecipitated with anti-(C- 
terminal peptide) antibodies. The protein was then subjected to electrophoresis and 
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Fig.69 To test the dose response of translocation of GLUT1 and GLUT4 
at pH 6.5 by Western blotting.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.1, 1, 10 and 500 nM of 
insulin and KRH buffer (pH 6.5) at 37°C. The cells then were homogenized and 
purified plasma membrane (10 ng) was subjected to SDS-PAGE. Proteins were 
transferred to nitrocellulose paper and incubated with a 1:500 dilution of anti- 
GLUT1 (a) and anti-GLUT4 (b) antibody. Blots were developed with 125j labelled 
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Fig.70 Comparison the dose response of translocation of GLUT1 and 2- 
deoxy-D-glucose transport activity at pH 6.5.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.1, 1, 10 and 500 nM of  
insulin in KRH buffer (pH 6.5) at 37°C for 30 min. The fractions of 2-deoxy-D- 
glucose transport Fig . 6 6  (O ), the ATB-BMPA labelling Fig.67 (□) and
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Fig.71 Comparison the dose response of translocation of GLUT4 and 2- 
deoxy-D-glucose transport activity at pH 6.5.
3T3-L1 adipocytes were incubated with 0, 0.025, 0.1, 1, 10 and 500 nM of 
insulin in KRH buffer (pH 6.5) at 37°C for 30 min. The fractions of 2-deoxy-D- 
glucose transport F ig.66 (O ), the ATB-BMPA labelling F ig.68 (□) and
immunoblotting Fig. 69 (A) of GLUT4 were compared.
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To examine the effect of different pH on insulin binding at 3T3-L1 
adipocytes, the [125I]-insulin binding assay was performed at pH 6.5, pH 7.4, pH 
8.0. The displacement curve of [125I]-insulin binding at these three pH shown in Fig. 
72. These results correspond well with the result that De Meyts and Van Putten. This 
result indicates that high pH (pH 8.0) increases the insulin binding to 3T3-adipocytes. 
At low pH (pH 6.5) a decrease insulin binding occurs.
The half effective dose of insulin binding at pH 7.4 and pH 8.0 are very 
similar. At pH 7.4 the half effective dose for insulin binding was 0.26 nM. At pH
8.0 the half effective dose for insulin binding was 0.39 nM. The Kd values for 
insulin binding and ED5 0  values for glucose transport stimulation are summarized in 
Table 4. These results indicate that the high transport activity at pH 8.0 is not due the 
change on insulin binding. Possibly the high pH opens the vesicles in the cell surface 
which are occluded in the normal pH buffer. Further investigation will need to be 

















Fig. 72 Displacement curve of ^^^I-insulin binding.
3T3-L1 adipocytes were incubated at pH 6.5 (O ), pH 7.4 (□) and pH 8.0 (A)
with 30 fmol ^ 5 j_ insuiin ancj increasing amounts of unlabelled insulin for 3 hours 
at 20 °C. The results are from 4 determinations.
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Table 4 ED5 0  for glucose transporter stimulation and Kd values for 
insulin binding at different pH 
3T3-L1 adipocytes were incubated with 0, 0.025, 0.05, 0.1, 1 and 100 nM of 
insulin in KRH buffer (pH 7.4 and pH 8.0) and some cells were incubated with 0, 
0.025, 0.1, 1, 10 and 500 nM of insulin in KRH buffer (pH 6.5) at 37°C for 30 min. 
The half effective dose of 2-deoxy-D-glucose transport, the ATB-BMPA labelling 
and immunoblotting at these pHs were compared. The Kd values for insulin binding 




The transport of glucose in insulin-sensitive tissues is mediated by two 
transporter isoforms, GLUT1 and GLUT4. GLUT4 is the major isoform present in 
fat and muscle and its expression is restricted to insulin sensitive tissues (James et al., 
1989; Bimbaum, 1989; Charron et al., 1989; Fukumoto et al., 1989). GLUT1 is 
expressed in many cell types, including those that do not normally exhibit insulin- 
sensitive glucose transport (Mueckler et al., 1985; Bimbaum et al., 1986; Filer et al., 
1987; Fukumoto et al., 1988).
It is well documented that insulin stimulates hexose transport in 3T3-L1 
adipocytes rapidly and typically by 10-fold or more (Frost and Lane., 1985; 
Calderhead and Lienhard., 1988). Because of this large effect, this cell line has been 
used as a good model for investigations of the basis for insulin action on glucose 
transport.
It has been known that both GLUT1 and GLUT4 transporters are present in 
3T3-L1 adipocytes. Unlike the rat adipocytes, the GLUT1 is a major transporter in 
3T3-L1 cells. However, the increase in GLUT1 at the cell surface in response to 
insulin, which has been assessed by quantitative immunoelectron microscopy (Blok et 
al., 1988), by labelling of surface GLUT1 with galactose oxidase and 
borohydride (Calderhead et al., 1988), and by relative GLUT1 content of a plasma 
membrane fraction (Gould et al., 1989), is only 2-3 fold; while the increase in 
GLUT4 is about 11 fold. The results presented in this thesis have shown that upon 
insulin stimulation, ATB-BMPA labelled GLUT1 was increased about 3-5 fold 
compared to basal, and GLUT4 was increased 15-20 fold. This indicated that GLUT4
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is also a major isoform that responds to insulin stimulation of glucose transport on 
3T3-L1 adipocytes. An increase in GLUT4 mRNA and protein has been shown to be 
associated with the differentiation of the adipocyte phenotype (Kaestner., et al 1989). 
It is the concentration of this novel glucose transporter in adipose cells which is 
lowered in streptozotocin-induced diabetes (Kahn et al., 1989; Berger et al., 1989). 
Both the mRNA and the intracellular pool of this glucose transporter are strikingly 
lowered, while the level of the GLUT1 transporter is unchanged. These studies show 
that the large stimulations by insulin of glucose transport in 3T3-L1 cell are clearly 
related to the presence of the GLUT4 isoform.
Clark and Holman (1990) have shown that the bis-D-mannose compound 
ATB-BMPA can photolabel the glucose transporter isoform GLUT1. In erythrocytes 
ATB-BMPA labels a single band of protein which when analysed by SDS-PAGE has 
an apparent molecular mass of 45-66 kDa. Holman et al (1990) reported this 
compound can also photolabel GLUT4. In adipocytes, the ATB-BMPA labels a *  55 
kDa protein. It has been demonstrated that the label is specifically binding to a 
glucose transporter protein-GLUTl, by displacing ATB-BMPA labelling totally with 
100 mM D-glucose (Clark and Holman, 1990). In adipocytes, the ATB-BMPA 
labelling of GLUT4, is also completely displaceable with D-glucose (Holman et al., 
1990). The label therefore specifically binds to these two glucose transporters.
The anti-GLUTl antibody immunoprecipitates 70-80% of the ATB-BMPA 
photolabelled GLUT1 in intact erythrocytes (Clark and Holman, 1990). The anti- 
GLUT4 antibody immunoprecipitates 70-80% of the labelled transporter peak 
obtained in membranes which are isolated from insulin-treated adipose cells but 
which are not subjected to immunoprecipitation (Holman et al., 1990). Although this 
comparison does not directly compare GLUT1 and GLUT4 in the same cell type, it 
does suggest that the antibodies probably immunoprecipitate GLUT1 and GLUT4 
with similar efficiencies and that photolabelling with ATB-BMPA does not reduce the
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precipitation efficiency.
Calderhead et al. (1990) have shown that when GLUT1 and GLUT4 were 
immunoprecipitated from 3T3-L1 adipocytes and then each immunoprecipitate was 
immunoblotted for both transporters, only GLUT1 was detected in the 
immunoprecipitate with antibodies against GLUT1 and only GLUT4 was detected in 
the immunoprecipitate with antibodies against GLUT4.
Palfreyman et al. (1992) have observed that the Kj for ATB-BMPA is »  250 
/xM in acutely and chronically insulin-treated 3T3-L1 cells. These results are similar 
to those in which transport is inhibited by ATB-BMPA in erythrocytes. In those cells 
a GLUT1 Kj *  250 /xM has been reported (Clark and Holman, 1990). Transport 
inhibition by ATB-BMPA in rat adipocytes (where GLUT4 is the predominant 
isoform) has shown a GLUT4 Kj «  250 jxM (Holman et al., 1990). The GLUT2 
isoform in liver membranes also has a for ATB-BMPA of about 200 /xM (Jordan 
and Holman, 1992). Thus the binding of ATB-BMPA (a non-transported ligand) is 
approximately equal for all the mammalian isoforms tested (GLUT1,GLUT4 and 
GLUT2). This suggests that the ATB-BMPA binding site, in contrast to the 
cytochalasin B binding site, is conserved in all glucose-transporter isoforms. Recent 
studies indicate that, on irradiation, ATB-BMPA labels the exofacial region of the 
helix 8  and that helices 7. 8  and 9 are important in exofacial ligand binding (Davies 
et al., unpublished work).
4.2 DEVELOPMENT OF AN INTRACELLULAR POOL OF GLUCOSE 
TRANSPORTERS IN 3T3-L1 CELLS
The sequestration of glucose transporters in an intracellular pool is likely to be 
a general mechanism by which cells regulate the supply of glucose to metabolic 
enzymes in line with the growth demands and cellular-metabolism requirements of
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the cell. The phenomenon of intracellular transporter sequestration was first 
demonstrated in insulin-sensitive rat adipose cells by Cushman and Wardzala, (1980) 
and Suzuki and Kono, (1980) and has subsequently been found in other insulin
responsive tissues such as brown adipose tissue (Slot et al., 1991a), heart muscle
(Watanabe et al., 1984, Slot et al., 1991b), diaphragm muscle (Wardzala and 
Jeanrenauld, 1983) and skeletal muscle (Klip et al., 1987; Hirshman et al., 1990; 
Klip et al., 1990). In addition it has been shown that virus infection of BHK cells 
(Widnell et al., 1990) leads to a redistribution of internalized GLUT1 transporters to 
the cell surface. Widnell et al., 1990 have also shown that in BHK cells the 
sequestered GLUT1 transporters redistribute to the cell-surface in response to stress 
stimuli such as arsenite and heat shock. Haspel et al, (1986) have shown that in 
fibroblasts GLUT1 redistribution can occur in response to glucose starvation. 
Although the cellular redistributions of glucose transporters can be followed by 
subcellular fractionation and separation of plasma membrane from the light 
microsome membranes (Slot et al., 1991a,b; Smith et al., 1991), this is not a
technique that can be readily applied to cells and tissues that are difficult to
successfully homogenize and fractionate such as skeletal muscle (Klip et al., 1987) 
and cultured cells (Calderhead et al., 1990).
Immunochemical techniques (Blok et al., 1988; Slot et al., 1991a,b; Smith et 
al., 1991, Widnell et al., 1990, Tordjman et al., 1990) circumvent the need to obtain 
subcellular membrane fractions but these methods are not easily adaptable to 
investigations of the kinetics of transporter regulation.
As an alternative to these methods, impermeant photolabel ATB-BMPA has 
been used to measure both the cell-surface and total-cellular levels of transporters. 
The method, when applied to differentiated 3T3-L1 adipocytes, gives results which 
are consistent with those obtained by Gould et al, (1986) who used Western blotting 
of isolated membrane fractions to determine that about half of the cell GLUT1 was at
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the cell-surface in the insulin-stimulated state.
ATB-BMPA has been used to investigate at what stage during growth and 
differentiation of 3T3-L1 cells the transporter sequestration develops. Initially, it was 
assumed that the cellular mechanisms necessary for transporter sequestration was 
most likely to develop during the period of differentiation from fibroblasts to 
adipocytes. It was surprising to find that GLUT1 transporters were down-regulated 
from the cell surface as the cells reached confluence as fibroblasts. The sequestration 
mechanism seems capable of internalizing over 75% of the total GLUT1 transporter 
both in confluent fibroblasts and in differentiated adipocytes. At both the fibroblast 
and adipocyte stage insulin produced a redistribution of about half of the available 
GLUT1 to the cell surface. Additional sequestration capability may have also 
developed as additional GLUT1 transporters were synthesized during differentiation. 
Alternatively, there may have been spare capacity available in fibroblasts that could 
potentially sequester any new GLUT1 or GLUT4 that was introduced into fibroblasts 
or produced in subsequent differentiation.
Gould et al. (1989) have shown that in 3T3-L1 cells transfected with human 
GLUT1 *50% of both the transfected and endogenous murine GLUT1 were 
sequestered in intracellular membranes and that both human GLUT1 and endogenous 
GLUT1 responded equally to insulin stimulation of translocation.
Joost et al.{1992) have shown that during growth of the fibroblasts to 
confluence, basal transport activity decreased to 2 0 % of that in non-confluent cells. 
Corresponding with the reduction in transport activity, the abundance of GLUT1 in 
plasma membranes as normalized per cell decreased by 75% during growth of the 
cells to confluence. They suggested that this effect was mainly due to a reduction of 
total cellular GLUT1. In addition, the portion of GLUT1 located in intracellular 
vesicles (low-density microsomes) was moderately increased in confluent cells. The
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reason for the difference between the results in this thesis and the results of Joost et 
al may be that they did not recover all the membrane protein after homogenization. 
Therefore it is an advantage to label permeabilized cells as membrane losses are 
minimized.
Other investigators have shown that there is either no change in the basal 
transport activity throughout differentiation (Kaestner, 1989) or that basal activity 
falls in the first few days after the initiation of differentiation (Weiland et al., 1990; 
Harrison et al., 1990). The results in this thesis show that basal activity can fall 
markedly if cells are maintained at full confluence for several days without the 
initiation of differentiation. Thus the studies cited above can be reconciled if there 
was a variable time after confluence was reached and before the differentiation 
regime was initiated. Thus if the initiation programme was started earlier than in 
these experiments the basal rate would have fallen during the first few days of 
differentiation. However, the results in this thesis suggest that the increase in 
transporter sequestration and the fall in the transport activity is not a direct 
consequence of the differentiation regime but develops because cells are in a growth 
arrested phase of the cell cycle.
The results from this thesis and those of other investigators (Kaestner et al., 
1989; Garcia de Herreros and Bimbaum 1989; Weiland et al, 1990), show that 
insulin-stimulated transport activity in adipocytes is much higher than in fibroblasts. 
Joost et al, (1992) have shown that in the differentiated adipocytes, insulin stimulated 
a 1 0 -fold increase in glucose transport activity, the maximum levels approaching 
basal transport rates of non-confluent cells; both GLUT1 and GLUT4 were 
translocated in response to insulin.
The discrepancy between transport activity and labelled-transporter level when 
comparing fibroblasts with differentiated adipocytes in the basal state has also been
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observed in this studies. In this thesis, the ratio of transport activity to GLUT1 
labelling in fibroblasts can be calculated as 130 pmoles/10^ cells/min divided by 
GLUT1 labelling of 970 dpm/1 0  ^ cells or 0.044 pmoles/10^ cells (the specific 
activity is 10 Ci/mmole). This intrinsic activity ratio is 41 pmoles/10^ cells/min 
divided by GLUT1 labelling of 590 dpm/10^ cells or 0.026 pmoles/10^ cells in 
differentiated cells. Thus during the transition from preconfluent fibroblasts to 
differentiated adipocytes the intrinsic activity ratio falls from 2954 min-1 in 
fibroblasts to 1576 min-1 in adipocytes in the basal state. Any GLUT4 present at the 
surface of basal adipocytes would lower this ratio. These results suggest that the 
activity of GLUT1 and probably GLUT4 is suppressed by 40-50% and are consistent 
with estimates of the intrinsic activity of GLUT1 and GLUT4 previously reported for 
the basal state (Holman et al., 1990; Kozka et al., 1991; Clark et al., 1991; 
Palfrey man et al., 1992; present studies).
Several studies using the photolabel (as cited above) have shown an *  2-fold 
discrepancy between photolabelling and transport and have shown a lag between the 
appearance of transporters that can be photolabelled and the increase in transport 
activity following insulin stimulation of rat adipocytes (Clark et al., 1991; Satoh et 
a l ,  1991) and 3T3-L1 cells (present studies). These studies show that ATB-BMPA 
binds to transporters that are inactive in transport catalysis. These studies have 
suggested that it is this form of the transporter that may be associated with modifier 
proteins such as those involved in trafficking events in the normal translocation 
pathway. In addition, there is a further discrepancy between transporters that are 
detected by labelling compared with Western blotting, as in isoproterenol treated 
insulin-stimulated rat adipocytes (Vannucci et al., 1992) and phenylarsine oxide- 
treated insulin-stimulated 3T3-L1 cells (present studies). This may be due to the 
formation of plasma membrane associated, but occluded, vesicles. These results 
suggest that the transport-inactive form at the plasma membrane is a relatively small 
fraction of the total plasma membrane pool, that these forms represent intermediates
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in normal transporter trafficking and that translocation is the major mechanism by 
which glucose transport is stimulated in insulin-sensitive cells.
The experiments in which digitonin have been used suggest that the photolabel 
interacts with equal amounts of transporter in the basal and insulin-stimulated states 
and that this provides additional evidence, to that previously described (Calderhead et 
al., 1990; Holman et al., 1990), which suggests that basal and insulin-stimulated 
transporters do not have differing affinities for the photolabel. If an inhibitory protein 
were present in basal cells which produced a large increase in the proportion of 
transporters in a catalytically inactive state, then this association would be expected to 
reduce the apparent labelling of the total cellular transporter pool of basal cells. Thus 
these experiments in which cells are digitonin permeabilized also suggest that the 
proportion of transporters with suppressed activity is small and that the low surface- 
levels of transporters detected by labelling of cells in the basal state is due to 
transporter sequestration within the intracellular pool.
During the process of 3T3-L1 cell differentiation over 95% of the total 
cellular GLUT4 in the intracellular pool was sequestered. This is similar to the level 
of sequestration of GLUT4 seen in other insulin-responsive tissues (Slot et al., 
1991 a,b). The greater sequestration of GLUT4 may be related to the targeting of this 
isoform to separate intracellular vesicles (Zorzano et al., 1989), although Calderhead 
et al. (1990) have reported that GLUT1 and GLUT4 were detected in the same 
vesicles. It seems likely that the two isoforms leave the cell surface by the same 
endocytosis route as it has been shown that both isoforms are endocytosed with the 
same half-time when insulin is removed and the calculated rate constant Ken is 
similar. This has been observed in rat adipocytes (Clark et al., 1991) and in 3T3-L1 
cells (present studies). However, in insulin-stimulated 3T3-L1 cells which are treated 
with the vicinal dithiol inactivating reagent phenylarsine oxide, there may be some 
separation of the transporter vesicle processing as GLUT4 re-exocytosis appeared to
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be blocked by this reagent but GLUT1 re-exocytosis was not. Cellular mechanisms 
for the separate localization and processing of GLUT4 must be very dependent on the 
GLUT4 protein structure as GLUT4 transfected into expression systems tends to 
become localized inside the cell rather than at the plasma membrane (Gould et 
al., 1991).
The studies on the use of the photolabel in permeabilized 3T3-L1 cells 
described here have shown that transporter sequestration can occur before 
differentiation is initiated and that transporters produced in differentiation probably 
enter a pre-formed sequestration process.
4.3 DETERMINATION OF THE RATES OF APPEARANCE AND LOSS OF 
GLUCOSE TRANSPORTERS AT THE CELL SURFACE IN 3T3-L1 
ADIPOCYTES
The acute activation of glucose transport into fat and muscle cells by insulin is 
probably the best-known biochemical action of this hormone, but until recently little 
was understood about its chemical basis.
Cushman and Wardzala (Cushman and Wardzala, 1980) and Suzuki and Kono 
(Suzuki and Kono, 1980) proposed in 1980 that glucose transporters, like receptors 
and other membrane proteins, were translocated from light-microsome vesicles to the 
plasma membrane of adipose cells in response to insulin.
Recently, two different but complementary approaches to investigating this 
membrane trafficking phenomenon have provided very strong support for their 
hypothesis. Slot et al. (1991b) have used antibodies specific for the insulin- 
regulatable glucose transporter (GLUT4) to immunolocalize this protein in brown 
adipose tissue from basal and insulin-treated rats. They showed under basal
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conditions that 99% of the GLUT4 labelling was located within the cell. Labelling 
was predominantly in the trans-Golgi reticulum and tubulo-vesicular structures 
elsewhere in the cytoplasma. In insulin-stimulated cells about 40% of the GLUT4 
labelling was at the cell surface. Upon insulin stimulation the GLUT4 located in the 
plasma membrane was increased by 40-fold.
The second approach that has provided strong supportive evidence for the 
translocation hypothesis has involved use of the bis-mannose photolabel-ATB-BMPA 
in trafficking kinetic experiments. ATB-BMPA can provide quantitative information 
on the abundance of glucose transporter isoforms at the plasma membrane (Clark et 
al., 1990; Holman et al., 1990; Calderhead et al., 1990). This label is a good probe 
to examine the kinetic of the cellular trafficking, as it can selectively label 
transporters when they appear and are removed from the cell surface.
Satoh et al. (1991) have shown, in trafficking experiments using the ATB- 
BMPA photolabel, that transporters are recycled between plasma membrane and 
light-microsome pools. Fully insulin-stimulated cells were photolabelled with ATB- 
BMPA and then insulin was removed by collagenase treatment. Labelled transporters 
were shown to be transferred to the light-microsome membranes. Equilibration of 
cell-surface labelled transporters with the light-microsome pool also occurred when 
cells were maintained, after labelling, in the continuous presence of insulin. In the 
presence of insulin, the level of transporters in the light-microsomes reached a lower 
steady-state level than that which occurred following insulin removal. These 
experiments have thus provided direct evidence that transporters move between the 
plasma-membrane and light microsome pools. Furthermore, restimulation 
experiments have directly shown that internalized transporters are re-exocytosed to 
the plasma membrane. Insulin stimulation was shown to be due to an enhancement of 
exocytosis rather than due to an inhibition of the endocytosis of transporters (Clark et 
al., 1991; Satoh, eta l., 1991).
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Use of the ATB-BMPA photolabelling reagent has also allowed an assessment 
of the magnitude of translocation to be made in intact adipose cells. Insulin has been 
shown to increase cell-surface GLUT4 by 15-20-fold while GLUT1 is only increased 
by *  5-fold. The use of this in-situ labelling procedure has circumvented the need to 
use subcellular fractionation of cells which is considered to underestimate the 
magnitude of the translocation effect due to the cross-contamination of plasma 
membrane and light-microsome membrane fractions. (Holman et al., 1990; Kozka et 
a l , 1991; Clarketa l., 1991).
The redistribution of the two transporters from the intracellular to the plasma 
membrane-containing fractions of the sucrose gradient in response to insulin provides 
further evidence for the translocation of each transporter. The fact that the insulin 
induced increase in translocation to the plasma membrane-containing fractions is 
considerably less (2-and 4-fold, respectively, for GLUT1 and GLUT4) than that 
found by the ATB-BMPA labelling method may be due to the contamination of these 
fractions with intracellular membrane containing the transporters (Calderhead et al. , 
1990).
The photolabel ATB-BMPA has been used to compare the time-courses for 
appearance and loss of transporters in rat adipocytes with the time course for change 
in glucose transport activity. Clark et al. (1991) have found that the time course of 
GLUT4 and GLUT1 appearance at the cell surface showed no lag and a half time of 
about 2.3 min for both isoforms. The time course for insulin stimulation of glucose 
transport activity occurred with a slight lag period of 47 sec and a half time of 3.2 
min. Thus at early times after insulin stimulation there was a discrepancy between 
transporter abundance and transport activity. The lag period in the stimulation of 
transport activity may represent the time required for about 2  fold stimulation of 
transport intrinsic activity. The decrease in transport activity after insulin removal 
occurred with a very high activation energy of 159kJ.mol. There was thus no
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significant decrease in transport or loss of cell-surface transport over 60 min at 18°C. 
The decrease in transport activity occurred with a half time of 9-11 min at 37°C. The 
ATB-BMPA labelled experiment showed that the loss of GLUT4 and GLUT1 
occurred with half time values of about 12 min. This study has shown that on insulin 
addition the arrival of GLUT1 and GLUT4 transporters at the cell-surface slightly 
precedes the increase in transport activity, but that the loss of these transporters from 
the cell-surface on insulin removal correlated well with transport. Results presented 
in this thesis show that these effects also occur in 3T3-L1 cells. At 27°C the half- 
time for the appearance of GLUT1 and GLUT4 at the cell surface were 5.7 and 5.4 
min respectively and were slightly shorter than that for the observed stimulation of 
transport activity (half-time 8 . 6  min). These studies are consistent with the 
observations of Kamielli et al. (1981), who have shown that the appearance of 
cytochalasin B-binding sites in plasma membrane fractions isolated from insulin 
treated adipose cells preceded transport stimulation. In addition Gibbs et al. (1988) 
showed that the arrival of GLUT1 at the surface of 3T3-L1 cells preceded the 
stimulation of transport. This lag may occur because transporters are still associated 
with trafficking-proteins at early time points following insulin addition to the cells. 
Thus the translocation may precede the transport activation due to the requirement for 
a dissociation from these proteins.
When fully insulin stimulated cells were subjected to a low-pH washing 
procedure to remove insulin at 37°C, the cell-surface levels of GLUT1 and GLUT4 
decreased, with half-time of 9.2 and 6 . 8  min respectively. These times correlated 
well with a decrease in 2-deoxy-D-glucose-transport activity that occurred during this 
washing procedure (half-time 6.5 min).
The loss of transporters from the cell-surface occurs with half-times which 
are very similar to the half-time for internalization of other membrane proteins and 
receptors such as the transferrin and the asialoglycoprotein receptors (Goldstein et
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al., 1985; Stoorvogel et al., 1987; Gibbs et al., 1986) suggesting that this 
internalization step occurs by receptor mediated endocytosis (Lienhard, 1983). The 
high activation energy for reversal of transport stimulation and the almost complete 
cessation of glucose transporter internalization at 18°C (Clark et al., 1991) are also 
consistent with this possibility.
The transporter immuno-localisation study of Slot et al. (1991b) have found 
that in the basal state GLUT4 is concentrated in tubulo-vesicular structures in the 
trans-Golgi region and elsewhere throughout the cytoplasm. Upon insulin treatment 
there is a marked shift in GLUT4 from these sites to the plasma membrane, such that 
the amount of GLUT4 at the cell-surface increases by at least 40-fold; moreover, 
GLUT4 is seen to enter the coated pit/coated vesicle/early endosome pathway typical 
for receptor-mediated endocytosis. These findings indicate that the translocation of 
GLUT4 is the major mechanism by which insulin stimulates glucose transport in 
brown adipocytes, and they provide evidence that this multi-spanning membrane 
protein can recycle by the same route as receptors.
The evidence for the localization of GLUT4 in coated pits and early 
endosomes is particularly interesting. This indicates that a transporter undergoes 
recycling by the pathway that has been well established for cell surface receptors. 
Unlike these receptors, which contain a single transmembrane segment per 
polypeptide chain, the glucose transporter has 1 2  putative membrane-spanning 
domains (Mueckler et al., 1985; James et al., 1990). This evidence that GLUT4 is 
continuously endocytosed in insulin-treated adipocytes points to a tentative conclusion 
concerning the locus of insulin action. GLUT4 could be effectively excluded from the 
membrane in the basal state by intracellular sequestration or by an efficient 
internalization process. Thus, the redistribution of GLUT4 to the cell-surface in 
response to insulin could be due either to an increased rate of exocytosis of the 
transporter or to decreased rate of its endocytosis.
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The association of this transporter in clathrin-vesicles was increased by insulin 
treatment of the cells. Other trafficking-proteins that may be involved include small 
G-proteins. It is now known that these are intricately involved in many vesicle- 
trafficking events (Bourne et al., 1991). Beckers and Balch (1989) have reported that 
Calcium and GTP are essential components in vesicular trafficking between the 
endoplasmic reticulum and Golgi apparatus. Transport was inhibited rapidly and 
irreversibly in the presence of micromolar concentrations of the nonhydrolyzable 
GTP analogue, GTP7 S. The transport block in the presence of GTP7 S was found to 
be distal to a post-endoplasmic reticulum, pre-Golgi compartment where proteins 
accumulate during incubation at 15°C. Transport was also completely inhibited in the 
absence of free Ca^+ . A sharp peak defining optimal transport between the 
endoplasmic reticulum and the c/s-Golgi was found to occur in the presence of 0.1 
/xM free Ca^+ . G-protein involvement in glucose transporter trafficking has been 
clearly implicated by the discovery of Baldini et al (Baldini et al., 1991) that the non- 
hydrolysable GTP analgue 7 -GTP stimulates translocation of GLUT4 from the light- 
microsome pool to the plasma membrane of rat adipocytes. The GTP itself is 
ineffective, thus, a GTP-binding protein might be involved in translocation of 
GLUT4 from the LDM to the plasma membrane. Many ras-like GTP-binding 
proteins are involved in intracellular vesicular traffic and /or cell growth.
Other proteins that are likely to be involved in the trafficking include 
adaptins. These have been implicated in the enhancement of receptor association with 
clathrin (Robinson, 1987) and their involvement in the trafficking of other membrane 
proteins is likely. A reasonable interpretation of some features of the trafficking 
kinetics of glucose transporters in 3T3-L1 cells that have been observed here is that a 
dissociation from trafficking-proteins occurs before the transporters can fully 
participate in transport.
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4.4 EFFECT OF PHENYLARSINE OXIDE ON GLUT1 AND GLUT4 
TRAFFICKING
The effects of PAO on the trafficking of membrane proteins have generally 
been reported to be due to inhibition of fluid-phase endocytosis by this reagent 
(Knutson, et al., 1986; Wiley and Cunningham, 1982; Frost et al., 1989). However, 
the resolution of an effect on endocytosis or exocytosis is difficult. It is possible for 
example that receptors are internalized and reappear at the surface but then fail to 
dissociate from the trafficking proteins because this process is blocked by PAO. 
Receptor abundance at the surface would remain high due to a single cycle of 
internalization and re-exocytosis and the whole cycling process would halt. The net 
result would be that endocytosis would appear to be inhibited. There is evidence 
against the possibility that a simple block of endocytosis occurs. PAO has been 
shown (Gould et al., 1989) to reduce surface transferrin receptors as measured by 
transferrin binding to whole cells but to increase the level of plasma membrane 
associated receptors measured in an isolated membrane fraction. It was proposed 
(Gould et al., 1989) that this effect may have occurred because recycled vesicles 
containing the receptors could not fuse with the plasma membrane but many remained 
associated with it during sub-cellular fractionation.
The GLUT1 contribution to transport is about one third of that of GLUT4 in 
fully insulin stimulated cells (Holman et al., 1990; Calderhead et al., 1990; Kozka et 
al., 1991). Yet when the insulin stimulation was reversed with PAO the fall in 
transport followed the fall in GLUT4 and the remaining cell-surface GLUT1 
appeared to make only a minimal contribution to transport. Thus GLUT1 may be 
internalized and recycled to the surface but many remain associated with trafficking- 
proteins which suppress its transport capability. This association with trafficking 
proteins may be similar to that which occurs in the lag-phase of insulin activation 
(Clark et al., 1991; Satoh et al., 1991; Gibbs, et al., 1988; Kamielli et al., 1981;
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and the present study) and may account for the low contribution of cell-surface 
GLUT1 to the transport activity in basal cells (Calderhead et al., 1990; Clancy and 
Czech, 1990).
Harrison et al. (1990) have proposed that GLUT1 activity is suppressed in 
transfected 3T3-L1 cells. Kozka, et al (1991) have shown that it is difficult to remove 
GLUT1 from the cell-surface following chronic-insulin treatment but that this cell- 
surface GLUT1 appears to have low transport capability. The location of transporters 
of suppressed activity may be in surface-attached vesicles. These may be 
intermediates in the insulin-stimulated trafficking pathway (Satoh et al., 1991). If 
some of the surface-attached vesicles are surface-exposed then glucose transporters in 
these vesicles would be photolabelled but would possibly not be able to participate in 
transport if they were still associated with trafficking proteins.
If the effect of PAO is mainly due to an inhibition of exocytotic vesicle fusion 
with the plasma membrane and/or inhibition of transporter dissociation from 
trafficking-proteins then this inhibition could also account for the fall in cell-surface 
GLUT4 that is detectable with the ATB-BMPA photolabel. A proportion of the 
GLUT4 transporters which are removed from surface accessibility to the photolabel 
in PAO treated cells appear to fractionate with the plasma membrane. The percentage 
of transporters recovered in the light microsomes was similar to that obtained with 
insulin alone. This effect is being further investigated but it may be similar to that 
observed with transferrin receptors where a PAO-induced failure of recycled vesicles 
to fuse with the plasma membrane was proposed (Gould et al., 1990). A similar 
effect was observed when insulin-stimulated rat adipocytes were treated by 
isoproterenol (Joost,H.G e ta l.,  1987).
187
4.5 COMPARISON OF GLUT1 AND GLUT4 SUBCELLULAR 
TRAFFICKING IN BASAL AND INSULIN-STIMULATED 3T3-L1 
ADIPOCYTES
The studies on the steady-state distribution of GLUT1 and GLUT4 strongly 
support the recruitment hypothesis described by Cushman and Wardzala (Cushman 
and Wardzala, 1980) and Suzuki and Kono (Suzuki and Kono, 1980). An additional 
approach to studying insulin action on this system is to selectively tracer-tag plasma 
membrane localized transporters and then to follow the kinetics of label redistribution 
to the low-density microsomes.
Use of bis-hexoses with photoreactive substitutes (Clark et al., 1991) has 
shown that GLUT4 constitutively recycles between the plasma membrane and the 
intracellular vesicle pool of rat adipose cells and in 3T3-L1 adipocytes (present 
studies). In the continuous presence of insulin the GLUT1 and GLUT4 isoforms 
recycle at similar rates and redistribute to the intracellular pool so that at equilibrium 
only approximately one-half of the labelled transporters remain in the plasma 
membrane. This is to be expected if all the cellular transporters are involved in the 
recycling process and is consistent with studies on the photolabelling of the cell- 
surface and total-cellular pools of glucose transporters in 3T3-L1 cells that 
approximately one-half of the total cellular pool of GLUT1 and GLUT4 transporters 
are located at the cell surface of insulin-stimulated cells.
In the basal state a much greater proportion of labelled GLUT4 transporters 
are lost from the plasma membrane. This is the result that would be expected if over 
90% of the transporters were intracellularly localized. However, the half-time for 
removal of these labelled transporters in the basal state is somewhat slower than is 
observed in the insulin steady-state. These results contrast with those of Jhun et al 
(1992) who have reported that in basal rat adipose cells the half-time for tracer-
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tagged GLUT4 equilibration is faster than that observed in insulin-stimulated cells. 
This discrepancy may be related to the need to rapidly process samples to determine 
the fraction of label removed from the plasma membrane. This is particularly 
important in the basal state where the fraction of the label removed from the plasma 
membrane is more extensive.
The data in this thesis show that the calculated endocytosis rate constants 
(ken) are similar for GLUT1 and GLUT4 and that these endocytosis rate constants are 
only *30% slower in the insulin-stimulated compared with the basal state. These 
findings are consistent with observations on the rate of loss of cell-surface 
transporters from 3T3-L1 cells under conditions in which insulin was removed by a 
low pH buffer. In those experiments, the proportions of transporters remaining at the 
cell-surface can be estimated simply by labelling at different time points following 
insulin removal. The cell-surface levels of GLUT1 and GLUT4 decreased at a similar 
rate. The fractional loss of GLUT1 was slightly less than GLUT4 and suggested that 
this was due to a greater re-exocytosis of this isoform.
From this thesis, it has been shown quantitatively that insulin increases the 
rate constant (hex) for glucose transporter exocytosis. The exocytosis of the GLUT4 
isoform is 8 .6 -fold faster in insulin-stimulated compared with basal cells. The basal 
exocytosis rate constant may be over-estimated because of some plasma-membrane 
contamination from label which transfers to the intracellular pool. However, the 
observed level of stimulation of GLUT4 exocytosis is almost sufficient to account for 
the » 12-15-fold stimulations of cell-surface appearance of GLUT4 previously 
observed using ATB-BMPA (Calderhead et al., 1990; Holman et al., 1990; Clark et 
al., 1991; Kozka et al., 1991). In turn, this level of recruitment of GLUT4 is almost 
sufficient to account for the increase in glucose transport activity in these cells ( » 15- 
20-fold). Insulin also stimulates GLUT1 exocytosis but only to » 3-fold above basal 
levels. Again, this level of stimulation of exocytosis accounts for the smaller, 3-5-
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fold increases in cell-surface GLUT1 accessible to the photolabel.
The major difference between the trafficking of the GLUT1 and GLUT4 
isoforms is the much slower exocytosis of GLUT4 in the basal state. However, in the 
presence of insulin, both isoforms are processed in the same way. This suggested that 
in basal cells intracellular processing steps remove GLUT4 from the normal 
endosome recycling pathway; possibly to a specialized compartment within the 
tubulo-vesicular system (Slot et al., 1991). Insulin may then re-commit or re-target 
these transporters from the tubulo-vesicular system to the plasma membrane and 
thence to the early endosome system. Both intracellular transporter pools would then 
be in rapid equilibrium with each other in the insulin-stimulated state as the 
photolabel equilibration data shows that the cells entire complement of glucose 
transporters are involved in the recycling process both in 3T3-L1 cells (this study) 
and in rat adipose cell (Clark et al., 1991).
The half-time for the initial stimulation of glucose transporter translocation by 
insulin is faster than the half-time for steady-state recycling of transporters and the 
half-time for loss of transporters when insulin is removed (Clark et al., 1991; present 
studies). This may occur because, immediately following insulin addition, 
transporters are rapidly committed to the plasma membrane at a vesicle docking and 
fusion step and that once transporters are committed in this way they are then 
recycled at a slower rate through the early endosomes. The kinetic effects expected 
from this type of multiple-pool-trafficking system have been analyzed and have been 
shown to account for the observed disparity between the half-times for insulin 
stimulation of the initial translocation and the steady-state rates of transporter 
recycling (Holman, unpublished results).
4.6 DOSE RESPONSE OF INSULIN-STIMULATED TRANSLOCATION OF 
GLUT1 AND GLUT4 IN DIFFERENT pH BUFFERS
1 9 0
To better understand the differences in the intracellular distribution between 
GLUT1 and GLUT4, reported in this thesis, the dose response curves for insulin- 
stimulated translocation of these two glucose transporters has been studied.
The half effective dose of insulin for stimulation of 2-deoxy-D-glucose 
transport activity at pH 7.4 has been found to be 1.9 nM. This half effective dose 
corresponds well with the result that Piper et al. (1992) reported (1 nM). The dose 
responses of insulin-stimulated translocation of GLUT1 and GLUT4 (detected by 
Western blotting) have indicated that the half effective dose for stimulation of 
GLUT1 is 0.041 nM and GLUT4 is 0.046 nM. The half effective dose for 
stimulation of these two isoforms are not significantly different. These results are 
slightly different from those described by Piper et al. (1992). They found the half 
effective doses for stimulation of GLUT1 and GLUT4 (both detected by Western 
blotting) are both 1 nM. This difference may be due to the concentration range of 
insulin they used. The maximum concentration they used is 10 nM while results in 
this thesis show that this concentration does not give a maximum effect.
The half effective doses for stimulation of GLUT1 and GLUT4 as measured 
by Western blotting are lower than the half effective dose measured by ATB-BMPA 
labelling and by the transport assay. These findings are consistent with the hypothesis 
that there may be an occluded state in the plasma membrane. Some vesicles 
containing glucose transporters in the plasma membrane may not be opened and these 
transporters may not be detectable by the ATB-BMPA labelling and transport assay. 
Some vesicles may fused with plasma membrane but because the glucose transporter 
is still associated with trafficking protein, the glucose transporter can not participate 
in glucose transport. This may possibly explain the slightly higher half effective dose 
obtained from the transport assay compared with ATB-BMPA labelling assay.
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Kamielli et al. (1981a) have postulated that there may be four plasma 
membrane intermediate states in the subcellular trafficking pathway. There is an 
occluded state that may be present in the plasma membrane. In this state, the 
membrane vesicles are not fused with the plasma membrane and therefore occlude 
the glucose transporter proteins from photolabelling and participating in glucose 
transport. Using ATB-BMPA to elucidate insulin-regulated GLUT4 subcellular 
trafficking kinetics in rat adipose cells, Satoh et al. (1993) have reported that those 
docking and fusion intermediate steps are critical sites of insulin action.
Alkaline pH stimulates glucose transport in rat adipocytes and the rat liver cell 
line (Sonne et al., 1981; Toyoda et al., 1986 and Ismail-Beigi et al., 1990). The 
results from this thesis also show that the half effective dose for stimulation of 2 - 
deoxy-D-glucose transport at pH 8.0 is lower than at pH 7.4. A very similar level of 
half effective dose of insulin is required to stimulate translocation as detected by 
Western blotting, ATB-BMPA labelling and 2-deoxy-D-glucose transport at pH 8.0. 
This indicates that an alkaline pH may have opened the occluded vesicles which have 
been postulated to be present at pH 7.4.
Sonne et al. (1981) have reported that, although the amount of tracer insulin 
bound at steady state at pH 7.8 was 6  times that at pH 6 .8 , the fractional degradation 
of receptor-bound iodoinsulin remained the same.
The dose response of iodoinsulin binding described in this thesis has shown 
that the half effective dose at different pH is not significantly different but that the 
maximum binding is reduced at low pH. This is consistent with the result that Sonne 
et al (1981) have reported. This indicates that the differences in the half maximum 
dose of insulin required for stimulation of translocation as detected by Western 
blotting, ATB-BMPA labelling and transport assay are not due to an altered dose 
response for insulin binding. It may be that the alkaline pH opens vesicles which at
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pH 7.4 are occluded.
To support the hypothesis that the alkaline pH may be opening occluded 
vesicles at the plasma membrane, more direct evidence needs to be obtained.
A technique of preparation of adipocytes plasma membrane vesicles has been 
reported by McKeel and Jarett (1970). This technique has been successfully used to 
measure the uptake of different concentration of D-glucose at rat adipocytes (Busza, 
Ph.D thesis 1983). A measurement of the 2-deoxy-D-glucose transport activity of 
these plasma membrane vesicles at different pH conditions will give more directly 
evidence to help us understand the effect of alkaline pH on glucose transport 
stimulation. The 2-deoxy-D-glucose transport activities in these vesicle preparations 
at pH 7.4 and pH 8.0 could be determined in future studies.
Sandvig et al. (1987) found that acidification of the cytosol of several cell 
types perturbed endocytosis of transferrin and epithelia growth factor by inhibiting 
invaginated coated pits from pinching off. Hansen et al. (1993) have shown that 
acidification of the cytosol leads to a significant decrease in surface area of both 
plasma membrane and trans Golgi network populations of clathrin-coated domains. 
Their findings also indicate that cytosol acidification prevents invaginated clathrin- 
coated domains from pinching off. Further studies are required to investigate the 
effect of pH 8.0 on internalization of GLUT1 and GLUT4 which may require clathrin 
association.
The effect of akaline pH on the levels of these two glucose transporters may 
be due to either an effect on endocytosis or on exocytosis. The occluded vesicles may 
therefore be intermediates in endocytosis or exocytosis. Future studies should aim to 
give more information on the effect of pH 8.0 on glucose transporter trafficking.
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Trafficking of glucose transporters in 3T3-L1 cells
Inhibition of trafficking by phenylarsine oxide implicates a slow dissociation of transporters from 
trafficking proteins
Jing YANG , Avril E. CLARK, Roger HARRISON, Izabela J. KOZKA and Geoffrey D. HOLM AN*
Department of Biochemistry, University o f Bath, Claverton Down, Bath BA2 7AY, Avon, U.K.
We have compared the rates of insulin stimulation of cell-surface availability of glucose-transporter isoforms (GLUT1 
and GLUT4) and the stimulation of 2-deoxy-D-glucose transport in 3T3-L1 cells. The levels of cell-surface transporters 
have been assessed by using the bismannose compound 2-JV-[4-(l-azi-2,2,2-trifluoroethyl)benzoyl]-l,3-bis-(D-mannos-4- 
yloxy)propyl-2-amine (ATB-BMPA). At 27 °C the half-times for the appearance of GLUT1 and GLUT4 at the cell 
surface were 5.7 and 5.4 min respectively and were slightly shorter than that for the observed stimulation of transport 
activity (h 8.6 min). This lag may be due to a slow dissociation of surface transporters from trafficking proteins responsible 
for translocation. When fully-insulin-stimulated cells were subjected to a low-pH washing procedure to remove insulin at 
37 °C, the cell-surface levels o f GLUT1 and GLUT4 decreased, with half-times of 9.2 and 6.8 min respectively. These 
times correlated well with decrease in 2-deoxy-D-glucose-transport activity that occurred during this washing procedure 
(h 6.5 min). When fully-insulin-stimulated cells were treated with phenylarsine oxide (PAO), a similar decrease in 
transport activity occurred (h 9.8 min). However, surface labelling showed that this corresponded with a decrease in 
GLUT4 only (n 7.8 min). The cell-surface level o f GLUT1 remained high throughout the PAO treatment. Light- 
microsome membranes were isolated from cells which had been cell-surface-labelled with ATB-BMPA. Internalization of 
both transporter isoforms to this pool occurred when cells were maintained in the presence of insulin for 60 min. In 
contrast with the surface-labelling results, we have shown that the transfer to the light-microsome pool of both 
transporters occurred in cells treated with insulin and PAO. These results suggest that both transporters are recycled by 
fluid-phase endocytosis and exocytosis. PAO may inhibit this recycling at a stage which involves the re-emergence of 
internalized transporters at the plasma membrane. The GLUT1 transporters that are recycled to the surface in insulin- 
and PAO-treated cells appear to have low transport activity. This may be because of a failure to dissociate fully from 
trafficking proteins at the cell surface. GLUT4 transporters appear to have a greater tendency to remain internalized if 
the normal mechanisms that commit transporters to the cell surface, such as dissociation from trafficking proteins, are 
uncoupled.
INTRODUCTION
The large insulin stimulations of glucose transport in adipose 
cells [1-3] and in 3T3-L1 cells [4] are now known to be due to the 
presence of the GLUT4 isoform of the glucose transporter. This 
isoform has been cloned and sequenced by five independent 
laboratories [5-9]. The study of the cellular-trafficking pathways 
of GLUT4 is of great importance in the understanding of the 
effect o f insulin on the translocation of this isoform to the cell 
surface. A recent, very elegant, study by Slot et al. [10] has clearly 
shown that insulin produces a very large increase in GLUT4 in 
the plasma membrane of brown adipose tissue as detected by 
immunogold electron microscopy. The increase in plasma-mem- 
brane transporter was paralleled by a decrease in glucose 
transporter in a cytoplasmic pool associated with tubulo-ves­
icular structures. An alternative approach to studying glucose- 
transporter trafficking that we have developed is to use a cell- 
impermeant photoaffinity label. The photolabel, 2-V-[4-(l- 
azi-2,2,2-trifluoroethyl)benzoyl]-1,3-bis-(D-mannos-4-yloxy)-2- 
propylamine (ATB-BMPA), is a bis-D-mannose derivative sub­
stituted with an (azitrifluoroethyl)benzoyl group. This only labels 
those transporters that are present at the cell surface of intact 
cells [11-14], However, photolabelling of glucose transporters in 
light-microsome membranes can occur if the reagent has access
to these, as it does in permeabilized cells (J. Yang, A. E. Clark, 
I. J. Kozka, S. W. Cushman & G. D. Holman, unpublished 
work) or in membrane fractions [16].
In experiments using the bismannose photolabel we have 
studied the kinetics of trafficking in rat adipocytes at 37 °C [16] 
and have found that GLUT1 and GLUT4 appeared rapidly on 
the cell surface with half-times of a  2 min, which were slightly 
shorter than that for the stimulation of glucose transport. The 
losses of cell-surface GLUT1 and GLUT4 occurred with half- 
times of a  12 min. These results suggested that the larger insulin 
stimulation of cell-surface availability o f GLUT4 ( «  15-20-fold) 
compared with GLUT1 ( x  5-fold) was due to a lower rate of 
exocytosis of GLUT4 in the basal state. In addition to the cell- 
surface detection of transporters, Satoh et al. [17] have shown 
that the reagent can be used to monitor the internalization of 
transporters directly. Thus, after labelling, the cells can be 
maintained at 37 °C to allow cell processing to occur and then 
plasma membrane and light-microsome fractions can be isolated. 
By measuring transporter redistribution in this way we have 
obtained direct evidence that glucose transporters are recycled 
between the plasma membrane and the light microsomes, even in 
the continuous presence of insulin. In the presence of insulin the 
cell-surface level o f transporters was shown to be constant, but 
photolabelled transporters were internalized and equilibrated
Abbreviations used: ATB-BMPA, 2-Ar-[4-(l-azi-2,2,2-trifluoroethyl)benzoyl]-l,3-bis-(D-mannos-4-yloxy)propyl-2-amine; PAO, phenylarsine oxide; 
DMEM, Dulbecco’s modified Eagle medium; KRH, Krebs-Ringer/Hepes; GLUT1 and GLUT4, glucose-transporter isoforms 1 and 4; 
C12E9, nona(ethylene glycol) dodecyl ether; G-protein, guanine-nucleotide-binding protein.
* To whom correspondence should be sent.
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Fig. 1. Insulin stimulation of the cell-surface appearance of GLUT1 and GLUT4 in 3T3-L1 cells
3T3-L1 cells in 35 mm-diameter dishes were stimulated with 100 nM-insulin at 27 °C and then at zero time (A). 2.5 min (A). 5 min (V ), 7.5 min 
(□ ), 12 min (O ) and 30 min (■ )  the insulin was removed by washing twice in KRH buffer at 18 °C. The cells were then labelled at 18°C with 
100 /iC i of ATB-BMPA in 250 //I of KRH buffer. After labelling the cells were washed four times in KRH buffer and then directly solublized in 
CiaE9 detergent buffer. GLUT 1 (a) and GLUT4 (b) were then immunoprecipitated with anti-(C-terminal peptide) antibodies. The protein vas then 
subjected to electrophoresis and the radioactivity was estimated by cutting out and counting the gel slices.
with the light-m icrosom e pool. Studies on internalized ATB- 
BM PA-labelled G L U T4 have shown that insulin increases the 
rate o f exocytosis o f this isoform [17]. A similar conclusion was 
reached by Slot et al. [10] in their electron-m icroscopic study, 
which analysed the steady-state distribution o f  transporters in 
brown adipose tissue.
The kinetic studies suggest that som e trafficking o f  GLUT1 
and G L U T 4 occurs via a com m on pathway, but that G LU T4  
can be excluded from the com m on pathway in the absence o f 
insulin and sequestered in a distinct vesicle pool. An approach to 
examining the possibly separate processing o f  the two trans­
porters is to inhibit their trafficking. Phenylarsine oxide (PAO) is 
known to inhibit receptor endocytosis [18,19] and fluid-phase 
endocytosis in 3T3-L1 cells [20], but has been shown to inhibit 
the insulin stimulation o f glucose transport in 3T3-L1 cells and 
in adipocytes [4,21] an exocytotic process [17]. Thus, in the study 
described here, we have kinetically monitored the insulin- 
stimulated translocation o f  GLUT1 and G L U T 4 to the cell 
surface o f  3T3-L1 cells and have, in addition, addressed the 
question o f  the site o f  action by PAO by m onitoring the 
appearance and loss o f  these transporters in cells whose vesicle- 
processing pathways have been perturbed with this reagent.
M ATERIALS AND M ETH O D S 
M aterials
A TB-BM PA  and ATB-[2-:iH]BM PA (sp. radioactivity 
% 1 0 C i/m m ol) were prepared as described [ 11], 2 -deoxy-D- 
[2,6-:iH]glucose was from Amersham International. D ulbecco’s 
modified Eagle medium (D M E M ) was from Flow laboratories. 
Foetal-bovine serum was from Gibco. M onocom ponent porcine 
insulin was a gift from Dr. Ronald Chance, Eli Lilly Corp.
Dexam ethasone, isobutylm ethylxanthine, Protein A - 8epharose 
and phenylarsine oxide were from Sigma. N onafethyleie glycol) 
dodecyl ether (C 12E9) was from Bochringer.
Cell culture
3T3-L1 fibroblasts were cultured in D M EM  and difftrentiated 
to adipocytes by treatment with insulin, dexamethaione and 
isobutylm ethylxanthine as described in [4,13]. Fully difftrentiated 
cells were washed with phosphate-buffered saline (154 mM- 
N aC l/12 .5  mM-sodium phosphate, pH 7.4) and were then in­
cubated for 2 h in serum-free medium containing 25 mM-D- 
glucose. This was followed by three washes in K rebs-R inger/ 
Hepes buffer (K R H  buffer; 136 m M -N aC /4.7 mM- 
KC1/1.25 mM-CaCl2/ l  .25 mM-MgSO4/1 0  mM-Hepes, pH 7.4) 
before use in experiments to determine 2 -deoxy-D-glucise trans­
port activity or cell-surface transporters.
Insulin stimulation experiments
N orm ally cell m onolayers in 35 mm-diameter diffies were 
maintained at 37 °C with 100 nM porcine m onocom pontnt insulin 
to produce fully stimulated cells. However, the half-time for 
stim ulation o f  transport at 37 °C was found to be % 3 min, 
which was considered to be too short a time for accurate 
com parisons with the time course o f  cell-surface phoblabelling  
(/i % 2 min). In rat adipocytes we were able to measurt the time 
course for stimulation at 37 °C because the stim ulatioi o f  these 
cells could be blocked at short time points by the acdition o f  
K CN. We have found, however, that the stim ulation oftransport 
in 3T3-L1 cells was not blocked by K C N . Instead, to compare 
the time course for insulin stimulation o f  transport and cell- 
surface availability o f  transporters in these cells we stinulatcd at 
27 °C and then washed the cells at 18 °C before neasuring
(b ) GLUT4(a) GLUT1
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Fig. 2. Time course for insulin stimulation of cell-surface availability of 
glucose transporters and for stimulation of 2-deoxy-D-glucose 
transport
3T3-L1 cells were stimulated with 100 nM-insulin at 27 °C and then 
cell-surface GLUT1 (# ) ,  cell-surface GLUT4 (A) and 2-deoxy-D- 
glucose transport activity (□ )  were determined at 18 °C. The 
immunoprecipitated transporters were subjected to electrophoresis 
and the total radioactivity associated with each transporter peak 
was determined. The levels of transporter labelling and transport 
activity at the indicated times were then calculated as a fraction of 
the maximum determined from the samples which were stimulated 
with insulin for 30 min. Two additional experiments showed the 
same result, and the average half-time for stimulation was calculated 
as described in the Materials and methods section.
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Fig. 3. Time course for the reversal of insulin stimulation
3T3-L1 cells in 35 mm-diameter dishes were stimulated with 100 n M -  
insulin for 30 min at 37 °C and then insulin was removed by washing 
twice with MES buffer and by maintaining the cells in this buffer for 
the indicated times. The cells were washed in KRH buffer at 18 °C 
and then photolabelled with 100 //Ci of ATB-BMPA. After labelling, 
the levels of the GLUT1 ( # )  and GLUT4 (□ )  transporters were 
determined by immunoprecipitation and electrophoresis. Some cells 
were used for estimation of 2-deoxy-D-glucose transport activity (A) 
as described in the Materials and methods section. The results 
shown are the means for two photolabelling experiments and for 
three experiments in the case of transport-activity determination.
glucose tran sp o rte rs  in 3T3-L1 cellsTrafficking o f
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transport and the am ounts o f  photolabelled transporters. The 
uptake was measured by incubating the 35 mm dishes with 
50 //M-2-deoxy-D-glucose in 1 ml o f  KRH buffer for 1-5 min at 
18 °C. We have found that no further insulin stimulation occurs 
once insulin is removed and the dishes are washed at 18 °C. The 
rates o f  stimulation were determined from sem i-log plots o f  
— In (1 —f )  against time, where / ' is  the fraction o f  the maximum  
stimulation. N orm ally the slope o f  such a plot gives the activation  
rate constant, but because a lag phase occurred before the 
transport activation, the t\ values were calculated according to 
the equation:
h  — (In 2 — a ) /b
where a is the intercept on the — In (1 —f )  axis and b is the slope.
Reversal of insulin stimulation
Cell monolayers were stimulated with 100 nM-insulin at 37 °C 
for 30 min. The insulin stimulation was then reversed by washing 
cell m onolayers twice with a M ES buffer (136 m M -NaCl/4.7 mM- 
KC1/1.25 mM M gSO .,/1.25 mM-CaCl2/1 0  itim-M ES, pH 6.0) and 
then maintaining them in this buffer at 37 °C. At the times 
indicated in the Figure legends the dishes were washed twice in 
KRH at 18°C  and then either used for 2-deoxy-D-glucose- 
uptake determ inations (as described above) or in cell-surface 
photolabelling experiments.
ATB-BM PA photolabelling
Plates (35 mm diameter) o f  the 3T3-L1 cells were washed in 
KRH buffer and were irradiated at 18 °C for 1 min in the 
presence o f  100 //Ci o f  A TB-[2-3H]BM PA as described in [13,14]. 
The irradiated cells were washed four times in KRH buffer and
solubilized in 1.5 ml o f  detergent buffer containing 2%  C 12E9, 
5 mM-sodium phosphate and 5 mM-EDTA, pH 7.2, and with the 
proteinase inhibitors antipain, aprotinin, pepstatin and leupeptin, 
each at 1 //g /m l. After centrifugation at 2 0 0 0 0 # max for 20 min, 
the supernatant was carefully separated from unsolubilized pellet 
and the insoluble fat-cake and then subjected to im m uno­
precipitation to determine the am ounts o f  photolabelled GLUT1 
and G L U T 4 transporter.
Cell fractionation
For each condition, two 35 mm dishes o f  fully-insulin- 
stimulated cells were photolabelled with 100 //Ci each o f  ATB- 
[2-;,H]BM PA. The labelling was carried out with the lids on the 
35 mm dishes so that radiation damage to the cells was minimized. 
After four washes o f  the dishes in KRH to remove excess label, 
the cells were then incubated at 37 °C for a further 60 min with 
insulin or with insulin and 20 //m-PAO. The cells from each dish 
were scraped into 0.5 ml for each dish o f  TES buffer (255 m M -  
sucrose/10 m M -T ris/H C l/0.5 mM-EDTA, pH 7.2). The pooled  
material from the two dishes were then hom ogenized at 
900 rev./m in in a 2 ml tight-fitting Teflon hom ogenizer (clearance 
^ 0 .1 5  mm) with ten com plete strokes. The hom ogenate was 
then centrifuged at 20000 # rnax for 20 min. The pellet, containing  
the crude plasma-membrane fraction, was dissolved in 0.5 ml o f  
6 % -C 12E9 detergent buffer and diluted with 1m l o f  5 mM- 
sodium phosphate buffer. The 20000 g mAx supernatant from  
above, containing the crude light-m icrosom e fraction, was mixed 
with 0.5 ml o f  6 % -C12E9 detergent buffer. Both detergent- 
solubilized samples were kept at 0 -4  °C for 30 min and then re­
centrifuged at 20000 # max for 20 min. The supernatants were 
then subjected to immunoprecipitation with anti-G L U T l and 
anti-G L U T4 antibodies. In some experiments cells were
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Fig. 4. Comparison of the effects of PAO and insulin on the cell-surface photolabelling of GLUT1 and GLIJT4
3T3-L1 cells in 35 mm-diameter dishes were maintained either with no additions (O). with 100 nM-insulin ( # )  or with 10 //m-PAO (A) for 30 min 
at 37 °C. The cells were then labelled with 150 //Ci of ATB-BMPA. After labelling, GLUT1 (a) and GLUT4 (b) were immunoprecipitated with 
anti-(C-terminal peptide) antibodies. The protein was then subjected to electrophoresis and the radioactivity was estimated by cutting out and 
counting gel slices.
hom ogenized in a KC1 buffer (150 mM -KCl/2 mM-MgCl2/  
20 mM-Hepes, pH 7.4) and a 16000 g m&x plasma-membrane and 
supernatant fraction were isolated as described in [22], The 
results obtained were the same as those obtained using the Tes 
buffer.
Immunoprecipitation and electrophoresis
The detergent-solubilized samples, either from solubilized cells 
or from crude plasma-membrane or crude light-m icrosom e 
fractions prepared as described above, were subjected to sequen­
tial im m unoprecipitation with 3 0 //I o f  Protein A+Sepharose 
coupled with 100//I o f  anti-G L U T l or 50 fi\ o f  anti-G LU T4  
antiserum. These antisera were raised against C-terminal peptides 
as described in [12,16]. After incubation for 2 h at 0 -4  °C and 
w ashing o f  the immunoprecipitates three times with 1.0 %- 
and once in 0.1 % -C 12E9 detergent buffer, the labelled glucose 
transporters were released from the antibody com plexes with 
10%  (w /v ) S D S / 6  M -urea/10%  (v/v)-m ercaptoethanol electro­
phoresis sample buffer and subjected to electrophoresis on 1 0 %- 
(w /v)-acrylam ide gels. The radioactivity on the gel was extracted 
from gel slices and estimated by liquid-scintillation counting. 
The radioactivity in transporter peaks was corrected for back­
ground radioactivity which was based on the average radio­
activity o f the slices on either side o f  the peak [13].
RESULTS
Insulin stimulation of glucose transport and the availability of 
cell-surface transporters
The insulin stimulation o f  the cell-surface availability o f
glucose transporters was found to be very rapid at 37 °C 
(/i % 2 min). This was considered to be too rapid for comparison  
with the stimulation o f  2-deoxy-D-glucose transport activity at 
this temperature (+ % 3 min). Instead, we followed the approach 
o f  Gibbs et at. [23], who studied the time course for insulin 
stimulation at 27 °C. At 27 °C the increase in cell-surface GLUT1 
and G L U T 4 occurred in parallel. Fig. 1 shows that a large 
increase above basal levels (as 45%  o f  maximum) in cell-surface 
labelling o f  these two isoform s occurred with only 5 min o f  
stimulation by 100 nM-insulin. The cell-surface levels o f  both 
isoform s then rose progressively and reached a maximum level o f  
stimulation in % 12 min. The cell-surface GLUT1 increases with 
ti o f 5 .7 + 1 .5  min (two experim ents), which was similar to the
rate o f  increase in cell-surface G L U T 4 (t< 5.4 +  0.7 min; two2 .-
experiments). In Fig. 2 the time course for this stimulation o f  the 
cell-surface availability o f  transporters is shown to slightly 
precede the time course for insulin stim ulation o f  2-deoxy-D- 
glucose transport activity (+ 8 .6 +  1.5 min; three experiments).
Reversal of insulin action on glucose transport and loss of cell- 
surface glucose transporters
We examined the time course for the loss o f cell-surface 
glucose transporters and compared this with the decrease in 2 - 
deoxy-D-glucose transport activity (Fig. 3). The cells were fully 
stimulated by treatment with 100 nM-insulin for 30 min at 37 °C, 
and then the insulin was removed by washing and incubation 
with M ES buffer at pH 6.0 for the indicated times. This p-ocedure 
was developed by Gibbs et al. [24], who showed that this low-pH  
buffer resulted in insulin dissociation and a consequent decrease 
in transport activity. The rate o f  loss o f  2-deoxy-D-glucose-
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Fig. 5. Comparison of the effect of PAO on the availability of GLUT1 and GLUT4 in insulin-treated 3T3-L1 cells
3T3-U cells in 35 mm-diameter dishes were fully stimulated by treatment with 100 nM-insulin for 30 min at 37 °C. The cells were then maintained 
at 37 <7 for a further 60 min in the presence (O) and the absence ( • )  of 20 //m-PAO. The cells were then photolabelled with 100//Ci of ATB- 
BMPX and then the GLUT1 (a) and GLUT4 (6) were immunoprecipitated with anti-(C-terminal peptide) antibodies. The protein was then 
subjeced to electrophoresis and the radioactivity was estimated by cutting out and counting gel slices.
transpo t activity that we have observed (Fig. 3) agrees with their 
results. The calculated half-time for the decrease in 2-deoxy-D- 
glucose transport activity was 6.5 +  0.4 min (three experiments). 
This correlates well with loss o f  cell-surface GLUT1
(ti 9.2 ±0.8 m in ; two experiments) and G L U T 4 (/i 6.8  ±  1.7 m in ;
2 . 2  
two experiments). The decrease in cell-surface G L U T 4 was
slightly more extensive than for G L U T 1, possibly reflecting the
greater endency o f  GLUT1 to be re-exocytosed in the absence o f
insulin.
Effect of PAO on glucose-transporter trafficking
A number o f effects o f  PAO on the glucose-transport activity 
in basal 3T3-L1 cells have been noted. Frost & Lane [4] reported 
that PAO decreased the insulin stim ulation o f  transport activity, 
but had no effect on the transport activity o f  basal cells. However, 
Gould (t al. [25] reported that, at low concentrations o f  PAO  
( <  20  //vi), a stimulation o f  the basal rate o f  transport occurred. 
Surprisingly, at concentrations o f  PAO where a transport stim u­
lation was noted they found a decrease in cell-surface transporters 
(as detected by cell-surface labelling with N aB 3H 4 o f  galactose 
oxidase-treated cells) and a rise in plasma-m embrane-associated  
GLUT1 as detected by Western blotting. We therefore examined 
the effect o f  5 -10  //m-PAO on basal transport activity and found 
a ^  1.5-fold increase in 2-deoxy-D-glucose transport. As shown 
in Fig. 4, 10 //m-PAO gave no detectable rise in either the 
concentration o f  GLUT1 or G L U T4. It is clear from this Figure, 
however, that any effect o f  PAO on basal levels o f  transporters 
is very small in com parison with the stimulatory effect o f  insulin.
Treatment o f  fully-insulin-stim ulated 3T3-L1 cells with 20 / / m- 
PAO for 60 min markedly decreased the cell-surface level o f  the
G L U T 4 isoform (Fig. 56). However, the level o f  the GLUT1  
isoform was only slightly decreased (Fig. 5a). The time course for 
the PAO-induced loss o f  cell-surface transporters is compared  
with the decrease in 2-deoxy-D-glucose-transport activity in Fig. 
6 . The loss o f  transport activity and G L U T 4 occurred with half- 
times o f  9.8 ± 1 .6  and 7 .8 ± 0 .8  min respectively (two experi­
ments), which were similar to the half-time for the decrease in 
transport activity that occurred when insulin was removed by the 
low -pH -w ashing procedure (Fig. 3). In contrast with this, the 
level o f  cell-surface GLUT1 remained high during the PAO  
treatment. During the PAO treatment the half-time for the 
decrease in cell-surface GLUT1 was greater than 60 min and was 
much longer than the half-time for the loss o f  GLUT1 that 
occurred when insulin was removed by the low -pH -w ashing  
procedure and which was only % 9 min. To confirm that the 
decrease in G L U T 4 was due to a redistribution o f  these trans­
porters within the cell and not to an irreversible inhibition o f  
transport [21], we have measured the binding o f A TB-BM PA  to 
the transporters in cells which had been permeabilized by 
treatment with 0.025%  digitonin. Figs. 7(a) and 7(6) show that 
the total concentration o f  available G L U T 4 was only slightly 
decreased (by % 30% ). This slight decrease may have occurred 
because the efficiency o f  labelling transporters present inside the 
cell may have been slightly less than for surface labelling. We also 
confirmed that neither GLUT1 nor G L U T 4 was lost from the 
cell by W estern-blotting crude membrane fractions obtained  
from cells treated with insulin and then 20 //m-PAO (J. Yang, 
A. E. Clark, R. Harrison, I. J. Kozka & G. D. H olm an, un­
published work). The more striking effect o f  PAO treatment was 
to decrease just the G L U T 4 at the cell surface. In the cells treated
(b ) GLUT4
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Fig. 6. Time course for the PAO-induced loss of cell-surface transporters 
and transport activity
PAO treatment of fully-insulin-stimulated 3T3-L1 cells was carried 
out as described in Fig. 5. The total radioactivity associated with 
photolabelled GLUT I (■ )  and GLUT4 (A ) was compared with the 
loss of 2-deoxy-D-glucose transport activity (# ) .  The results are the 
means for two photolabelling experiments and, in the case of the 
transport-activity measurements, three experiments.
with insulin alone, % 60 % o f the available transporter was at the 
cell surface. In the cells treated with PAO, % 20%  o f  the 
available transporters were at the surface (two experiments). In 
addition we have found, by measuring A TB-BM PA  p hoto­
labelling in permeabilized cells, that the total available GLUT1 
concentration was only slightly decreased after PAO treatment. 
Approx. 60%  o f the available GLUT1 transporters were at the 
surface both in the presence and in the absence o f  PAO.
A possible interpretation o f  this differential effect on GLU T1  
and G L U T 4 cell-surface availability is that, in the presence o f  
PAO, both transporters are removed from the cell surface at the 
same rate, but their recycling is differentially perturbed. Thus 
both G L U T l and G L U T 4 could be endocytosed even in the 
presence o f  PAO, but inhibition o f G L U T4, but not G L U T 1, re- 
emergence and re-exposure to the photolabel at the cell surface 
could then have resulted in the observed decrease in its detected  
surface concentration.
T o examine the possibility that both transporters were in­
ternalized in the presence o f  PAO, we labelled the cell-surface 
transporters in fully-insulin-stim ulated cells with A TB -B M PA  
and then treated them with PAO and insulin for a further 60 min. 
We then homogenized the cells and separated a crude plasma 
membrane fraction from the light-m icrosom e fraction. After 
60 min in the continuous presence o f  insulin, the light-m icrosom e 
level o f  photolabelled GLUT1 and G L U T 4 was increased above 
that observed at zero time. This indicates that internalization o f
transporters occurred even in the continuous presence o f  insulin 
(Table 1). The percentages o f  photolabelled transporter found in 
the light-m icrosom e fraction are consistent with the results o f  
Calderhead et al. [13], who determined by Western blotting that 
«  50%  o f the total recovered GLUT1 and G L U T 4 were present 
in the light-m icrosom e pool o f  basal cells and that this was 
•§ decreased to % 25 % in insulin-treated cells. The light-m icrosom e
■£ association o f  GLUT1 was slightly less than that which occurred
■% for the G L U T 4 isoform. This probably reflects the greater
® tendency o f  GLUT1 to be re-exocytosed under these conditions,
c Table 1 also shows that the internalization o f  G LUT1 and
J. G L U T 4 also occurred in cells treated with PAO. H owever, in
f  PAO-treated cells the additional G L U T 4, above that found with
insulin alone, which was lost from the cell surface was not
0 recovered in the light m icrosom es, but partitioned with the 
plasma-membrane fraction during hom ogenization. The total
~  recovered photolabel was unaltered by the PAO treatment.
Western blotting confirmed that neither G L U T 4 nor GLUT1  
J  internalization to the light-m icrosom e fraction was increased by
1 the PAO treatment compared with insulin alone (J. Yang, 
A. E. Clark, R. Harrison, I. Kozka & G. D. H olm an, un-
S published work). Fig. 8 show s that «  35%  o f G L U T 4 trans-
64 porters that were photolabelled in the insulin-stim ulated state
were transferred to the light-m icrosom e fraction after 60 min. 
This proportion was not altered by the PAO treatment.
D ISCUSSION
Cushman & Wardzala [26] and Suzuki & K ono [27] proposed  
in 1980 that glucose transporters, like receptors and other 
membrane proteins, were translocated from light-m icrosom e 
vesicles to the plasma membrane o f  adipose cells in response to 
insulin. Recently two different, but com plem entary, approaches 
to investigating this membrane-trafficking phenom enon have 
provided very strong support for their hypothesis. Slot et al. [10] 
have shown that, in brown adipose tissue, im m unodetectable 
G L U T 4 was localized to a cytosolic-vesicle pool with very low  
transporter levels in the plasma membrane o f  basal cells. U pon  
insulin stimulation, the G L U T 4 located in the plasma membrane 
was increased 40-fold. The second approach that has provided 
strong supportive evidence for the translocalion hypothesis has 
involved use o f  the bis-D-mannose photolabel A TB-BM PA  in 
trafficking kinetic experiments [16,17], Satoh et al. [17] have 
shown, in trafficking experiments using the A TB-BM PA  photo­
label, that transporters are recycled between plasma-membrane 
and light-m icrosom e pools. Fully-insulin-stim ulated cells were 
photolabelled with A TB -B M PA  and then insulin was removed 
by a collagenase treatment. Labelled transporters were shown to 
be transferred to the light-m icrosom e membranes. Equilibration 
o f  cell-surface-labelled transporters with the light-m icrosom e 
pool also occurred when cells were maintained, after labelling, in 
the continuous presence o f  insulin. In the presence o f  insulin, the 
level o f  transporters in the light m icrosom es reached a lower 
steady-state level than that which was reached after insulin 
removal. These experiments have thus provided direct evidence 
that transporters move between the plasma-membrane and light- 
m icrosom e pools. Furthermore, re-stim ulation experiments have 
directly shown that internalized transporters are re-exocytosed  
to the plasma membrane. Insulin stim ulation was shown to be 
due to an enhancement o f  exocytosis rather than due to an 
inhibition o f  the endocytosis o f  transporters [16,17],
U se o f the A TB -B M PA  photolabelling reagent has also 
allowed an assessment o f  the magnitude o f  translocation to be 
made in intact adipose cells. Insulin has been shown to increase 
cell-surface G L U T 4 15-20-fold , whereas GLUT1 is only  
increased *  5-fold. The use o f  this ‘ in s itu ’ labelling procedure
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Fig. 7. Experiment to determine whether the PAO-induced decrease in cell-surfaee GLUT4 is due to a redistribution to the cell interior
3T3-L1 cells in 35 mm-diameter dishes were fully stimulated by treatment with 100 nM-insulin for 30 min at 37 °C. The cells were then maintained 
at this temperature for a further 50 min in the absence (a) or in the presence (b) of 20 //m-PAO. The cells were then either photolabelled directly 
with 100 //Ci of ATB-BMPA (O ) or were permeabilized in the presence of 100 /<Ci of ATB-BMPA by treatment with 0.025 % digitonin for 8 min 
at 18 °C and then irradiated (# ) . GLUT4 was then immunoprecipitated with anti-(C-terminal peptide) antibody. The protein was then subjected 
to electrophoresis and the radioactivity was estimated by cutting out and counting gel slices.
Table 1. Internalization of glucose transporters in 3T3-L1 cells
Fully-insulin-stimulated 3T3-L1 cells were photolabelled with ATB-BMPA and then either homogenized immediately (0 min) or maintained at 
37 °C with insulin (60 min) or insulin-I-20 //m-PAO (60 min) before homogenization. Crude plasma-membrane and light-microsome fractions were 
prepared and solubilized in C12E„ detergent buffer. GLUT1 and GLUT4 were then immunoprecipitated and subjected to electrophoresis. The 
radioactivity in the transporter peaks was estimated, and the results are expressed as a percentage of radioactivity recovered in the light-microsome 
fraction compared with the sum of the radioactivity recovered in the plasma-membrane and the light-microsome fractions.
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Fig. 8. Redistribution of photolabelled GLUT4 to subcellular membrane 
fractions of 3T3-L1 cells
3T3-L1 cells in 35 mm-diameter dishes were fully insulin-stimulated 
by treatment with 100 nM-insulin for 30 min at 37 °C. They were 
then photolabelled with 100 (iCi of ATB-BMPA and then main­
tained with (circles) and without (triangles) 20 //m-PAO for a further 
60 min. Crude plasma membrane (closed symbols) and light-micro- 
some membranes (open symbols) were prepared from two dishes for 
each condition. These fractions were solubilized in C12E9 detergent 
buffer. GLUT4 was then immunoprecipitated with anti-(C-terminal 
peptide) antibody and subjected to electrophoresis; radioactivity 
was estimated by cutting out and counting gel slices.
has circumvented the need to subject the cells to subcellular 
fractionation, a procedure that is considered to underestimate 
the magnitude o f  the translocation effect, owing to the cross­
contam ination o f  plasma-membrane and light-m icrosom e frac­
tions. The photolabel has been used to compare the time courses 
for appearance and loss o f  transporters in rat adipocytes with the 
time course for a change in glucose-transport activity [16]. This 
study has shown that, on insulin addition, the arrival o f  GLUT1 
and G L U T 4 transporters at the cell surface slightly precedes the 
increase in transport activity, but that the loss o f  these trans­
porters from the cell surface on insulin removal correlated well 
with transport. We have confirmed here that these effects also 
occur in 3T3-L1 cells. The loss o f  transporters from the cell 
surface occurs with half-times that are very similar to that for the 
internalization o f  other membrane proteins and receptors [28-30], 
suggesting that this internalization step occurs by fluid-phase 
endocytosis [31]. The high activation energy for reversal o f  
transport stimulation and the alm ost com plete cessation o f  
glucose-transporter internalization at 18 °C [16] are also con­
sistent with this possibility.
N ow  that the essential predictions o f  the translocation hy­
pothesis have been confirmed, questions concerning the mech­
anistic details o f  the trafficking pathways can be addressed. The 
transporter-im m unolocalization study o f  Slot et al. [10] has 
provided evidence that the GLUT4-trafficking pathway involves 
clathrin-coated vesicles. The association o f  this transporter in 
clathrin vesicles was increased by insulin treatment o f  the cells. 
Other trafficking proteins that may be involved include small 
guanine-nucleotide-binding proteins (G-proteins). It is now  
known that these are intricately involved in many vesicle- 
trafficking events [32], G-protein involvement in glucose-trans­





Baldini et al. [33] that the non-hydrolysable GTP analogue 
guanosine 5'-[y-thio]triphosphate stimulates translocation o f  
G L U T 4 from the light-m icrosom e pool to the plasma membrane 
o f rat adipocytes. Other proteins that are likely to be involved in 
the trafficking include adaptins. These have been implicated in 
the enhancement o f  receptor association with clathrin [34], and 
their involvem ent in the trafficking o f  other membrane proteins 
is likely. A reasonable interpretation o f  som e features o f  the 
trafficking kinetics o f  glucose transporters in 3T3-L1 cells that we 
have observed here is that a dissociation from trafficking proteins 
occurs before the transporters can fully participate in transport.
The observed lag between transporter appearance at the cell 
surface and the full stim ulation o f  transport [16,17,23.35; the 
present study] may occur because transporters are still associated  
with trafficking proteins at early time points after the addition o f  
insulin to the cells. Thus translocation may precede transport 
activation, owing to the requirement for a dissociation from  
these proteins. The effects o f  PAO on the trafficking o f  membrane 
proteins have generally been reported to be due to inhibition o f  
fluid-phase endocytosis by this reagent [18-20]. H ow e/er, the 
resolution o f  an effect on endocytosis or exocytosis is difficult. It 
is possible, for example, that receptors are internalized and 
reappear at the surface, but then fail to dissociate from the 
trafficking proteins because this process is blocked by PAO. 
Receptor abundance at the surface would remain high, cwing to 
a single cycle o f  internalization and re-exocytosis, and the whole 
cycling process would halt. The net result would be that 
endocytosis would appear to be inhibited. There is evidence 
against the possibility that a simple block o f  endocytosis occurs. 
PAO has been shown [25] to decrease surface transferrii recep­
tors, as measured by transferrin binding to whole cells, but to 
increase the level o f  plasm a-m em brane-associated receptors 
measured in an isolated membrane fraction. It was proposed [25] 
that this effect may have occurred because recycled vesicles 
containing the receptors could not fuse with the plasma mem­
brane, but remained associated with it, during subcelluar frac­
tionation. An alternative explanation is that vesicles do fuse with 
the plasma membrane, but that the receptors are associa ed with 
trafficking proteins and therefore not fully available for ligand 
binding. These two proposals are not mutually exclusive, and a 
com bination o f  both these effects may occur.
We have shown here that PAO has distinct effects on the 
trafficking o f  GLUT1 and G L U T4. The abundance o f  GLUT1 
at the cell surface remained high when fully-insulin-stinulated  
cells were treated with PAO. However, the surface level o f  
G L U T 4 decreased with a time course for redistributior similar 
to that which occurred after insulin removal by washing n  a low- 
pH buffer. This suggests they were internalized by the fluid- 
phase-endocytosis route. In contrast with the above results 
(which were obtained from surface labelling, which was carried 
out after PAO treatment) we have shown that, when photo­
labelling was carried out in fully-insulin-stim ulated cells ind cells 
were subsequently treated with PAO, then both G L IT 1 and 
G L U T 4 were internalized to the light-m icrosom e pool.
An additional observation concerning the transport activity 
o f  GLUT1 in PAO-treated cells also suggests that, although the 
GLUT1 surface-level is constant, recycling o f  this isofcrm may 
have occurred. We have calculated that the GLUT1 contribution 
to transport is about one-third o f  that o f  G L U T 4 in fully-insulin- 
stimulated cells [R. W. Palfreyman, A. E. Clark, R. M. Denton, 
G. D. Holm an & I. J. Kozka, unpublished work]. Yet vhen the 
insulin stimulation was reversed with PAO, the fall in t ansport 
paralleled the decrease in G L U T 4 and the remaining cel-surface 
GLUT1 appeared to make only a minimal contribiticn to 
transport. Thus GLUT1 may be internalized and recycltd lo the 
surface, but remain associated with trafficking proteim, which
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suppress its transport capability. This association with trafficking 
proteins may be similar to that which occurs in the lag phase of 
insulin activation [16,17,23,35; the present study] and may 
account for the low contribution of cell-surface GLUT1 to the 
transport activity in basal cells [13,37]. Harrison et al. [38] have 
proposed that GLUT1 activity is suppressed in transfected 3T3- 
L1 cells. We have shown [14] that it is difficult to remove GLUT1 
from the cell surface after a chronic insulin treatment, but that 
this cell-surface GLUT1 appears to have low transport capability. 
The location of transporters of suppressed activity may be in 
surface-attached vesicles. These may be early intermediates in the 
insulin-stimulated trafficking pathway [17]. If some of the surface- 
attached vesicles are surface-exposed, then glucose transporters 
in these vesicles would be photolabelled, but would possibly not 
be able to participate in transport if they were still associated 
with trafficking proteins.
If the effect o f PAO is mainly due to an inhibition of exocytotic 
vesicle fusion with the plasma membrane and /o r inhibition of 
transporter dissociation from trafficking proteins, then this 
inhibition could also account for the decrease in cell-surface 
GLUT4 that is detectable with the ATB-BMPA photolabel. 
GLUT4 transporter vesicles may have a greater tendency to 
remain internalized and not fully surface-exposed if the normal 
mechanisms that commit transporters to the cell surface, such as 
dissociation from trafficking proteins, are uncoupled. A pro­
portion of the GLUT4 transporters which are removed from 
surface accessibility to the photolabel in PAO-treated cells appear 
to be fractionated with the plasma membrane. The percentage of 
transporters recovered in the light microsomes was similar to 
that obtained with insulin alone. The effect requires further 
investigation, but it may be similar to that observed with 
transferrin receptors, where a PAO-induced failure of recycled 
vesicles to fuse with the plasma membrane was proposed [25]. A 
similar effect was observed when insulin-stimulated rat adipocytes 
were treated with isoproterenol [39].
The greater tendency of GLUT4 to remain internalized also 
accounts for the low levels of this isoform at the cell surface of 
basal cells [12,13,40],
In conclusion, we have shown, by measuring trafficking kinetics 
o f glucose-transporter isoforms in 3T3-L1 cells, that there is a lag 
between transporter appearance and participation in transport. 
We have provided evidence that the GLUT1 and GLUT4 
isoforms are recycled even in the presence of insulin. In addition, 
we have shown that GLUT1 and GLUT4 exhibit different 
trafficking properties when processing is perturbed with PAO. 
The above properties o f translocation indicate an involvement of 
a slow dissociation from trafficking proteins during recycling. 
This proposal implicates an involvement o f unspecified trafficking 
proteins, and further resolution of the proposed mechanism will 
depend on the identification and characterization of these pro­
teins.
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The membrane-impermeant bis-mannose photolabel 
2-iV -4 -(l-a z i-2 ,2 ,2 -tr iflu o ro eth y l)b en zo y l-l,3 -b is-  
(D-mannos-4-yloxy)-2-propylamine (ATB-BMPA) has 
been used to study the development of an intracellular 
pool of glucose transporters in 3T3-L1 cells. The sub­
cellular distributions of the transporter isoforms 
GLUT1 and GLUT4 were determined by comparing 
the labeling obtained in cells in which the impermeant 
reagent only had access to the cell surface and the 
labeling obtained in digitonin-permeabilized cells. 
ATB-BMPA labeling showed that only GLUT1 was 
present in preconfluent fibroblasts and that most of the 
transporters were distributed to the cell surface. In 
preconfluent fibroblasts, the 2-deoxy-D-glucose trans­
port activity was ~ 5  times higher than in confluent 
fibroblasts. ATB-BMPA labeling showed that the de­
crease in transport as cells reached confluence was 
associated with a decrease in the proportion of GLUT1 
distributed to the cell surface. The sequestration of 
these transporters was associated with the develop­
ment of an insulin-responsive transport activity which 
increased by «2.5-fold  compared with unstimulated 
confluent cells. ATB-BMPA labeling showed that in­
sulin stimulation resulted in an ~2-fold increase in 
surface GLUT1 so that about one-half of the available 
transporters became recruited to the cell surface. 
Measurements of the changes in the distribution of both 
GLUT1 and GLUT4 throughout the differentiation of 
confluent fibroblasts into adipocytes showed that both 
transporters were sequestered in parallel. Basal levels 
o f transport and photolabeling remained low through­
out the differentiation period when the total pool of 
transporters (GLUT1 plus GLUT4) was increased by 
~5-fold. These results suggest that the sequestration 
process was present before new transporters were syn­
thesized. Thus, the sequestration mechanism develops 
in confluent growth-arrested fibroblasts although the 
capacity to sequester additional transporters may in­
crease as differentiation proceeds.
3T3-L1 cells have been used for studying insulin action on 
glucose transport because these cells can be differentiated to 
produce a reserve of internal glucose transporters which can 
be translocated to the cell surface in response to insulin. 
When the cells are grown as fibroblasts, they produce only
* This work was supported by the Medical Research Council of the 
United Kingdom and the British Diabetic Association. The costs of 
publication of this article were defrayed in part by the payment of 
page charges. This article must therefore be hereby marked “adver­
tisement” in accordance with 18 U.S.C. Section 1734 solely to indicate 
this fact.
the glucose transporter isoform GLUT1 (Kaestner et al., 1989; 
Garcia de Herreros and Birnbaum, 1989; Tordjman et al., 
1990; Harrison et al., 1990; Reed et al., 1990; Weiland et al., 
1990). The fibroblasts are induced to differentiate using iso- 
butylmethylxanthine, dexamethasone, and insulin (Green and 
Kehinde, 1975; Frost and Lane, 1985). During the course of 
this differentiation, the cells produce the acutely insulin- 
responsive isoform GLUT4 (Kaestner et a l, 1989; Garcia de 
Herreros and Birnbaum, 1989; Tordjman et al., 1990; Weiland 
et al., 1990). It is known from these studies that both GLUT1 
and GLUT4 mRNA and total cellular protein rise in concen­
tration over 8 days, and, at 8-11 days after initiation of 
differentiation, the concentrations of these transporters 
within the cells reach a maximum.
To examine the proportion of newly synthesized transport­
ers which become available at the cell surface, we have ex­
tended the use of our bis-mannose photolabel to measure both 
cell surface and the total cellular pool of transporters. We 
have previously used this photolabel to measure the cell 
surface availability of insulin-stimulated adipose cells (Hol­
man et al., 1990; Clark et al., 1991) and differentiated 3T3-L1 
cells (Calderhead et al., 1990; Kozka et al., 1991). We show 
here that permeabilization of 3T3-L1 cells with digitonin 
allows the normally impermeant photolabel access to those 
transporters that are sequestered within the cell. We have 
therefore compared the labeling at the cell surface and the 
labeling of the total cellular transporter pool both before 
differentiation, when the 3T3-L1 cells are confluent fibro­
blasts, and during the subsequent period of the differentiation 
regime. The results suggest that mechanisms for sequestration 
of transporters develop before new transporters are synthe­
sized in the course of differentiation.
The method for examining the distribution of glucose trans­
porters that we have developed here should be a useful addi­
tion to the range of techniques that are available for studying 
transporter processing. The technique has the advantage that 
it does not depend upon homogenization and separation of 
membrane fractions and should be useful in studying systems 
where homogenization procedures are technically very diffi­
cult. In addition, it may be useful in investigations of expres­
sion systems where transporter cDNA or mRNA are intro­
duced and in which the proportion of the expressed protein 
that reaches the cell surface needs to be determined.
EXPERIMENTAL PROCEDURES
Materials—ATB-BMPA1 and ATB-[2-3H]BMPA (specific activity 
«  10 Ci/mmol) were prepared as described (Clark and Holman, 1990),
1 The abbreviations used are: ATB-BMPA, 2-AT-4-(l-azi-2,2,2-tri- 
fluoroethyl)benzoyl-l,3-bis-(D-mannos-4-yloxy)-2-propylamine; 
Hepes, 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid; C12E9, 
nonaethyleneglycol dodecyl ether; DMEM, Dulbecco’s modified Ea­
gle’s medium.
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2-deoxy-[2,6-3 H]D-glucose was from Amersham International. 
DMEM was from Flow Laboratories. Fetal bovine serum was from 
Gibco Laboratories. Monocomponent porcine insulin was a gift from 
Dr. Ronald Chance, Eli Lilly Laboratories. Dexamethasone, isobu- 
tylmethylxanthine, and protein A-Sepharose were from Sigma. Non- 
aethyleneglycol dodecyl ether (C1 2E9 ) was from Boehringer.
Cell Culture—3T3-L1 fibroblasts were seeded at a density of =0.03 
x  106 cells per 35-mm dish and cultured in DMEM with 10% newborn 
calf serum. Fibroblasts were differentiated to adipocytes in DMEM 
and 1 0 % fetal bovine serum by treatment with insulin, dexametha­
sone, and isobutylmethylxanthine as described by Frost and Lane, 
1975. Fully differentiated cells were washed with phosphate-buffered 
saline (154 m M  NaCl, 12.5 m M  sodium phosphate, pH 7.4) and were 
then incubated for 2 h in serum-free medium containing 25 m M  D -  
glucose. This was followed by three washes in Krebs-Ringer-Hepes 
buffer (KRH buffer, 136 m M  NaCl, 4.7 m M  KC1, 1.25 m M  CaCl2, 1.25 
m M  M gS04, 10 m M  Hepes, pH 7.4) before use in experiments to 
determine 2-deoxy-D-glucose transport activity or cell surface trans­
porters. Cell numbers were determined by counting, in a cytometer, 
the trypan blue excluding cells harvested from trypsin treatment of 
the cell monolayers.
Transport Activity—Cells in 35-mm dishes were maintained at 
37 °C either in the absence or presence of 100 n M  porcine monocom­
ponent insulin for 30 min. The cells were then incubated with 50 ^M 
2-deoxy-D-[2,6-3 H]glucose in 1 ml of KRH buffer at 37 °C for 5 min. 
Cells were then rapidly washed three times in KRH buffer at 0-4 °C, 
and the radioactivity was extracted into 1 ml of 0.1 M NaOH.
A TB-BM PA  Photolabeling—Cells in 35-mm dishes were main­
tained at 37 °C either in the absence or the presence of 100 n M  insulin 
for 30 min. The dishes were washed in KRH buffer and were irradi­
ated for 1  min in a Rayonet photochemical reactor in the presence of 
100 jiCi or ATB-[2-3 H]BMPA in 250 g\ of KRH buffer at 18 °C as 
described by Kozka et al., 1991. To measure labeling of the total 
cellular transporter pool, cells were permeabilized by treatment with 
0.025% (w/v) digitonin for 8  min at 18 °C in the presence of 100 gCi 
of ATB-[2-3 H]BMPA. The digitonin used (Sigma D1407 and suitable 
for use in aqueous solutions) was 50% pure, and an allowance for this 
was made in preparing the digitonin solution. The irradiated cells 
were washed four times in KRH buffer and solubilized in 1.5 ml of 
detergent buffer containing 2% Ci2 E9, 5 m M  sodium phosphate, 5 m M  
EDTA, pH 7.2 and with the proteinase inhibitors antipain, aprotinin, 
pepstatin, and leupeptin, each at 1  gg/m \ and maintained at =18 °C 
for 15 min. We have found that Fibroblasts tended to detach from the 
dishes when labeled in the presence of digitonin. Therefore, in the 
case of photolabeled fibroblasts, the washing of irradiated cells was 
omitted and cells were immediately solubilized in C12E9 detergent 
buffer. Following centrifugation of the solubilized cell material at
2 0 , 0 0 0  x  gmax for 2 0  min, the supernatant was carefully separated 
from unsolubilized pellet and the insoluble fat-cake and then sub­
jected to immunoprecipitation to determine the amounts of photola­
beled GLUTl and GLUT4 transporter.
Immunoprecipitation and Electrophoresis—The detergent-solubi­
lized samples were subjected to sequential immunoprecipitation with 
30 /ul of protein A-Sepharose coupled with 100 jil of anti-GLUTl or 
50 /d of anti-GLUT4 antiserum. These antisera were raised against 
C-terminal peptides as described by Clark and Holman, 1990, and 
Holman et al., 1990. After incubation for 2  h at 0-4 °C and washing 
of the immunoprecipitates three times with 1 .0 % and once in 0 .1 % 
C 12E9  detergent buffer, the labeled glucose transporters were released 
from the antibody complexes with 10% SDS, 6  M  urea, 10% mercap- 
toethanol electrophoresis sample buffer and subjected to electropho­
resis on 10% acrylamide gels. The radioactivity on the gel was 
determined by cutting and counting gel slices. The radioactivity in 
transporter peaks was corrected for a background which was based 
on the average radioactivity of slices on either side of the peak 
(Calderhead et al., 1990).
RESULTS
We have examined the rate of 2-deoxy-D-glucose transport 
in fibroblasts at stages from initial seeding of dishes to the 
development of a confluent cell monolayer which occurs at 
about Day 5 after seeding (Fig. 1). One day after initial seeding 
of the dishes, the transport rate was 0.13 nmol/106 cells/min 
(with 0.026 x  106 cells/35-mm dish). This gradually fell over 
7 days to 0.025 nmol/106 cells/min (with 0.3 x  106 cells/35- 
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Fig . 1. 2-Deoxy-D-glucose tra n sp o rt ac tiv ity  in  3T3-L1 f i ­
brob lasts. Cells were seeded at a density of =0.03 X 106 cells per 35- 
mm dish and maintained in culture in DMEM with 10% nevborn 
calf serum for up to 13 days. On the indicated days, the cells were 
incubated in the presence of serum-free medium for 2  h anc then 
maintained at 37 °C for 30 min in either the absence (A) or prtsence 
(■) of 100 n M  insulin in 1 ml of KRH buffer. The transport of 50 g M  
2-deoxy-D-[2,6-3 H]glucose was then measured, and cell numb*r was 
determined. Results are mean and S.E. from four independent deter­
minations.
days. We have also examined the stage at which the trarsport 
rate in fibroblasts becomes insulin-responsive. From atout 7 
days after seeding, the 2-deoxy-D-glucose transport rati was 
increased by acute insulin stimulation to =2.5 times the basal 
level. However, even in the presence of insulin, the traisport 
rate (0.06 nmol/106 cells/min) was approximately on»-half 
the rate which was observed in preconfluent fibroblasts
In order to determine the subcellular distribution of Trans­
porters, we have measured the cell surface availabilty of 
transporters with our impermeant photolabel ATB-EMPA 
and compared this with labeling that was obtained ir digi- 
tonin-permeabilized cells. Fig. 2 shows the subcellular distri­
bution of GLUTl in confluent cells. No GLUT4 was de ected 
in the fibroblasts. There was an =4-fold increase in labeling 
in permeabilized cells compared with untreated cells, hsulin  
only increased the cell surface labeling by =2-fold and dd not 
increase the total pool of cellular GLUTl. The data from 
three experiments are shown in Fig. 3. This figure also shows 
that in preconfluent cells there is no significant increise in 
labeling in the presence of digitonin indicating that rrost of 
the cell transporters were at the cell surface.
Together with the transport data in Fig. 1, the labeling data 
show that in preconfluent 3T3-L1 fibroblasts the high rans- 
port rate is associated with the presence of most if the 
transporters at the cell surface. As the cells reach confhence, 
transporters are sequestered from the cell surface, aid an 
intracellular reserve pool of transporters develops. Associated 
with this sequestration is a fall in the transport activity vhich 
can then be partially restored by acute insulin treament 
which redistributes approximately one-half of the aviilable 
transporters to the cell surface.
The technique for comparing cell surface and total cdlular 
transporters has also been used to examine the distrimtion 
of the acutely insulin-sensitive isoform GLUT4 in diferen- 
tiated 3T3-L1 adipocytes. Fig. 4 shows an SDS-pobacryl- 
amide gel of ATB-BMPA-labeled and immunopreciptated 
GLUT4. As shown in previous studies by Calderheac et al. 
(1990), Kozka et al. (1991), and Yang et al. (1992), thee was 
very little GLUT4 at the cell surface in the basal state. Upon 
insulin stimulation, the GLUT4 labeling increased b? = 12- 
fold in this experiment. However, as is the case with GLUTl
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in confluent fibroblasts, only about one-half of the total 
available transporters were returned to the cell surface upon 
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Fig. 2. ATB-BMPA labeling  of cell su rface  and to ta l ce llu ­
la r  pools of GLUTl in confluen t 3T3-L1 fib roblasts. Cells were 
maintained in culture for 11 days in DMEM with 10% newborn calf 
serum and then incubated in serum-free medium for 2 h. Cells were 
then maintained at 37 °C for 30 min either in the absence (circles) or 
in the presence (triangles) of 100 nM insulin in 1 ml of KRH buffer. 
Cells were then labeled with 100 nCi of ATB-[2-3H]BMPA in 250 n\ 
of KRH buffer at 18 °C either without (open symbols) or with (closed 
symbols) of 0.025% digitonin. Labeled cells were immediately solubi­
lized in Ci2 E9 detergent buffer, and the labeled proteins were subjected 
to immunoprecipitation with GLUTl C-terminal peptide antibody 
and then analyzed by electrophoresis.
was only a slight difference between the amount of GLUT4 
labeled in the basal compared with the insulin-treated con­
dition. The small difference observed in this experiment and 
others (Fig. 5) was possibly due to a difference in efficiency 
of labeling of the intracellular pool compared with the cell 
surface GLUTL This small difference was not observed in all 
experiments, and, over seven experiments, the mean was only 
slightly lower than that observed with insulin-treated cells. 
However, Fig. 5 also shows that the S.E. was larger for the 
labeling of the total cellular pool of both GLUTl and GLUT4 
in the basal cells. The greater variability of labeling of the 
intracellular pool (which constitutes a greater proportion of 
the total in the basal state) was probably a consequence of 
variations between cell batches in the susceptibility to digi­
tonin permeabilization or the efficiency with which the uv 
light could penetrate to intracellular sites of transporter lo­
calization. Fig. 5 also shows that in the insulin-stimulated 
state approximately half of the total of both GLUTl and 
GLUT4 was recruited to the plasma membrane. However, as 
previously shown by Calderhead et al. (1990) and Yang et al. 
(1992), the GLUT4 has a greater tendency to be internalized 
in the absence of insulin, and the cell surface labeling of 
GLUT4 is about one-third of the GLUTl level in this basal 
state.
We next examined the time course for changes in the 
glucose transport activity and subcellular transporter distri­
bution during the transition from confluent fibroblasts to 
fully differentiated adipocytes (Fig. 6). This figure shows that 
the basal level of 2-deoxy-D-glucose transport remained low 
throughout the differentiation period. The transport rate in 
basal cells was ~8  pmol/dish/min in confluent fibroblasts 
(with 0.3 X 106 cells/dish) increased to ~25 pmol/dish/min in 
fully differentiated cells where the cell number had also in­
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Fig. 3. Com parison of GLUTl ce llu lar d istribu tion  in preconfluen t and  confluen t 3T3-L1 fib ro ­
b lasts. In a, 3T3-L1 fibroblasts were harvested and plated into two 35-mm dishes to give a total of 0.28 x  106  
subconfluent cells after 1  day in culture. Cells in each dish were incubated in serum-free medium for 2  h and then 
labeled with 100 fiCi of ATB-[2-3 H]BMPA in 250 of KRH buffer at 18 °C either in the absence, B(sur), or 
presence, B(tot), of 0.025% digitonin. Labeled cells from the two dishes were then immediately solubilized in C12E9  
detergent buffer, and labeled proteins were subjected to immunoprecipitation with G LUTl C-terminal peptide 
antiserum followed by electrophoresis. Results are the mean and S.E. from four experiments. In b, 3T3-L1 
fibroblasts were maintained in culture for 11 days and at confluence reached a density of 0.28 x  106 cells/35-mm  
dish. The cells were incubated for 2  h in serum-free medium and then maintained at 37 °C for 30 min either 
without (B) or with (I) 100 nM insulin in 1 ml of KRH buffer. Cells were then labeled with 100 nCi of ATB-[2- 
:iH]BMPA in 250 /d of KRH buffer at 18 °C either in the absence (sur) or presence (tot) of 0.025% digitonin, and 
GLUTl immunoprecipitated as described in the Fig. 2  legend. Results are the mean and S.E. of three experiments.
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creased to 0.6 x  106 cells/dish. During the differentiation, the 
amount of protein per 35-mm dish increased enormously from 
88 Mg/dish to 1.1 mg/dish. The insulin-stimulated rate of 
transport was approximately double the basal rate for about 
4 days after the initiation of differentiation. By 6 days, there 
was a very marked increase in the insulin-stimulated rate of 
transport to reach by 11 days, a rate which was ~20 times the 
basal rate.
Fig. la  shows the distribution of GLUTl throughout this 
differentiation period. During the first 4 days, the cells be­
haved in a manner similar to that observed in confluent 










Fig. 4. ATB-BM PA labeling  of cell su rface  and to ta l cellu­
la r  pools of GLUT4 in 3T3-L1 adipocytes. Fully differentiated 
3T3-L1 adipocytes in 35-mm dishes were incubated in serum-free 
medium for 2 h and were then maintained at 37 °C for 30 min either 
in the absence (circles) or presence ( triangles) of 100 nM insulin in 1 
ml of KRH buffer. Cells were then labeled with 100 ^Ci of ATB- 
[2- 'HjBMPA in 250 gl of KRH buffer at 18 °C either without (open 
symbols) or with (closed symbols) 0.025% digitonin. Cells were then 
washed twice in KRH buffer and then solubilized in Ci2E9 detergent 
buffer, and the labeled proteins were subjected to immunoprecipita­
tion with GLUT4 C-terminal peptide antiserum and then analyzed 
by electrophoresis.
fold lower than the insulin-stimulated level. The total cellular 
levels were approximately double the level found at the cell 
surface in the insulin-stimulated state. Between 6 and 11 
days, there was a marked rise in the total cellular GLUTl. 
The cell surface GLUTl in the basal cells rose slightly 
throughout this period, and this may have been a consequence 
of the increased cellular level of this transporter. The GLUT4 
was produced in parallel with the rise in GLUTl (Fig. lb). 
Thus, there was little detectable GLUT4 over the first 2 days 
of differentiation and then this rose steeply between days 6 
and 11.
In contrast with the rise in the basal level of labeled 
GLUTl, labeling showed that the GLUT4 that was newly 
synthesized was very effectively sequestered inside the cell. 
The basal GLUT4 labeling remained consistently low from 
days 4-11 after the initiation of differentiation while the total 
cellular GLUT4 rose by >10-fold over this period.
DISCUSSION
The sequestration of glucose transporters in an intracellular 
pool is likely to be a general mechanism by which cells regulate 
the supply of glucose to metabolic enzymes in line with the 
growth demands and cellular metabolism requirements of the 
cell. The phenomenon of intracellular transporter sequestra­
tion was first demonstrated in insulin-sensitive rat adipose 
cells by Cushman and Wardzala (1980) and Suzuki and Kono 
(1980) and has subsequently been found in other insulin- 
responsive tissues such as brown adipose tissue (Slot et al., 
1991a), heart muscle (Watanabe et al., 1984; Slot et al., 1991b), 
diaphragm muscle (Wardzala and Jeanrenauld, 1983), and 
skeletal muscle (Klip et al., 1987; Hirshman et al, 1990; Klip 
et al,  1990). In addition, it has been shown that virus infection 
of BHK cells (Widnell et al., 1990) leads to a redistribution 
of internalized GLUTl transporters to the cell surface. Wid­
nell et al. (1990) have also shown that in BHK cells the 
sequestered GLUTl transporters redistribute to the cell sur­
face in response to stress stimuli such as arsenite and heat 
shock. Haspel et al., 1986 have shown that in fibroblasts 
GLUTl redistribution can occur in response to glucose star­
vation. Although the cellular redistributions of glucose trans­
porters can be followed by subcellular fractionation and sep­
aration of plasma membrane from the light microsome mem­
branes, this is not a technique that can be applied readily to 
cells and tissues that are difficult to successfully homogenize 
and fractionate such as skeletal muscle (Klip et al., 1987) and 
cultured cells (Calderhead et al., 1990). Immunochemical tech­
GLUT1 GLUT4
Fig. 5. G L U T l and GLUT4 cel­
lu la r  d istribu tion  in 3T3-L1 adipo­
cytes. Cells were fully differentiated in 
35-mm dishes and then subjected to the 
labeling procedure described in the Fig. 
4 legend. The total disintegrations/min 
under the gel peaks were calculated for 
GLUTl (a) and GLUT4 (b) either with­
out or with 0.025% digitonin to obtain 
cell surface (sur) or total cellular (tot) 
levels of labeling for basal cells (B) or 
cells treated with 100 nM insulin (I).  The 
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Day o f d ifferentiation
Fig . 6. T im e course for d iffe ren tia tio n  of h ighly insulin- 
responsive glucose tra n sp o rt in 3T 3-L 1 cells. Confluent 3T3- 
L1 cells in 35-mm dishes were treated with dexamethasone, isobutyl- 
methylxanthine, and insulin in DMEM with 10% fetal bovine serum 
to initiate differentiation. On the indicated days, cells were incubated 
in serum-free medium for 2 h and then maintained at 37 °C for 30 
min in the absence (A) or presence (■) of 100 n M  insulin in 1 ml of 
KRH buffer. This was followed by determination of the rate of uptake 
of 50 /zM 2-deoxy-D-[2,6-’H]glucose. Results are the mean of two 
experiments.
niques (Blok et al., 1988; Slot et al., 1991a, 1991b; Smith et 
al., 1991; Widnell et al., 1990; Tordjman et al., 1990) circum­
vent the need to obtain subcellular membrane fractions, but 
these methods are not easily adaptable to investigations of 
the kinetics of transporter regulation.
As an alternative to these methods, we have extended the 
use of our impermeant photolabel ATB-BMPA to measure 
both the cell surface and total cellular levels of transporters. 
We have shown here that the method when applied to differ­
entiated 3T3-L1 adipocytes gives results which are consistent 
with those obtained by Gould et al. (1989a) who used Western 
blotting of isolated membrane fractions to determine that 
about one-half of the cell GLUTl was at the cell surface in 
the insulin-stimulated state. The new method has also been 
used successfully to measure the distribution of GLUTl in 
BHK cells2 and in CHO cells transfected with the GLUTl 
gene.3
Here we have extended the use of this method to investigate 
at what stage during growth and differentiation of 3T3-L1 
cells the transporter sequestration develops. We initially as­
sumed that the cellular mechanisms necessary for transporter 
sequestration were most likely to develop during the period 
of differentiation from fibroblasts to adipocytes. We were 
surprised to find that GLUTl transporters were down-regu­
lated from the cell surface as the cells reached confluence as 
fibroblasts. The sequestration mechanisms seem capable of 
internalizing over 75% of the total GLUTl transporter both 
in confluent fibroblasts and in differentiated adipocytes. At 
both these stages, insulin produced a redistribution of about 
one-half of the available GLUTl to the cell surface. Addi­
tional sequestration capability may have also developed as 
additional G LUTl transporters were synthesized during dif­
ferentiation. Alternatively, there may have been spare capac­
ity available in fibroblasts that could potentially sequester 
any new G LUTl or GLUT4 that was introduced into fibro­
2 C. A. Pasternak, I. J. Kozka, A. E. Clark, and G. D. Holman, 
unpublished results.
3 A. E. Clark, M. Hashiramoto, T. Kadowaki, G. D. Holman, and
M. Kasuga, unpublished results.
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blasts or produced in subsequent differentiation. Gould et al. 
(1989b) have shown that 3T3-L1 cells transfected with human 
GLUTl, that «50% of both the transfected and endogenous 
murine GLUTl were sequestered in intracellular membranes, 
and that both human GLUTl and endogenous GLUTl re­
sponded equally to insulin stimulation of translocation.
Other investigators have shown that there is either no 
change in the basal transport activity throughout differentia­
tion (Kaestner et al., 1989) or that basal activity falls in the 
first few days after the initiation of differentiation (Weiland 
et al., 1990; Harrison et al., 1990). Our results show that basal 
activity can fall markedly if cells are maintained at full 
confluence for several days without the initiation of differ­
entiation. Thus, the studies cited above can be reconciled if 
there is a variable time after confluence was reached and 
before the differentiation regime was initiated. Thus, if the 
initiation program was started earlier than in our experi­
ments, the basal rate would have fallen during the first few 
days of differentiation. However, our results suggest that the 
increase in transporter sequestration and the fall in the trans­
port activity is not a direct consequence of the differentiation 
regime but develops because cells are in a growth-arrested 
phase of the cell cycle.
Harrison et al. (1990,1991a, 1991b) and Clancy et al. (1991) 
have recently described evidence that the intrinsic activity of 
glucose transporters in 3T3-L1 cells and particularly that of 
GLUTl is suppressed during differentiation. Their evidence 
is based on an apparent higher insulin-stimulated glucose 
transport activity in fibroblasts where GLUTl is present, 
compared with differentiated 3T3-L1 cells where both 
GLUTl and GLUT4 are present. Our results, and those of 
other investigators (Kaestner et al., 1989; Garcia de Herreros 
and Birnbaum, 1989; Weiland et al., 1990), show, however, 
that insulin-stimulated transport activity in adipocytes is 
much higher than in fibroblasts. In addition, however, Har­
rison et al. (1990, 1991a, 1991b) argue that as the binding of 
their exofacial GLUTl antibody, the 5-antibody, is increased 
2.6-fold in adipocytes in the basal state compared with fibro­
blasts while the transport activity is reduced by ss2.5-fold, the 
GLUTl intrinsic activity is suppressed by 90%. They suggest 
that inactivation is due to interaction with an inhibitory 
protein (Harrison et al., 1991b; Clancy et al., 1991). Our results 
also show a discrepancy between transport activity and la­
beled transporter level in comparing fibroblasts with differ­
entiated adipocytes in the basal state but suggest that the 
discrepancy is smaller than the 90% (10-fold) discrepancy 
calculated by Harrison et al., 1990. The ratio of transport 
activity to GLUTl labeling in fibroblasts can be calculated as 
130 pmol/106 cells/min divided by GLUTl labeling of 970 
dpm/106 cells or 0.044 pmol/106 cells (the specific activity is 
10 Ci/mmol). This intrinsic activity ratio is 41 pmol/106 cells/ 
min divided by GLUTl labeling of 590 dpm/106 cells or 0.026 
pmol/106 cells in differentiated cells. Thus, during the tran­
sition from preconfluent fibroblasts to differentiated adipo­
cytes, the intrinsic activity ratio falls from 2954 min-1 in 
fibroblasts to 1576 min-1 in adipocytes in the basal state. Any 
GLUT4 present at the surface of basal adipocytes would lower 
this ratio. Thus these results suggest that the activity of 
GLUTl and probably GLUT4 is suppressed by 40-50% or by 
1.5-2-fold and are consistent with estimates of the intrinsic 
activity of GLUTl and GLUT4 previously reported for the 
basal state (Holman et al., 1990; Kozka et al., 1991; Clark et 
al., 1991; Palfreyman et al., 1992).
Harrison et al. (1991b) have suggested that the exofacial 
probe that we have used may react only with transporters 



















Day of differentiation Day of differentiation
Fig. 7. Tim e course for the increase  in cell su rface  and  to ta l ce llu lar pools of G L U T l and GLUT4 
in 3T3-L1 cells. Cells in 35-mm dishes were treated with dexamethasone, isobutylmethylxanthine, and insulin 
in DMEM with 10% fetal bovine serum to initiate differentiation. On the indicated days, cells were incubated in 
serum-free medium for 2 h and were then maintained at 37 °C for 30 min either in the absence (squares) or 
presence (triangles) of 100 n M  insulin in 1 ml of KRH buffer. In GLUTl (a) and GLUT4 (b), distribution was 
determined by labeling with 100 nCi (closed symbols) or total cellular levels in cells permeabilized with 0.025% 
digitonin (open symbols). Cells were washed twice in KRH buffer and then solubilized in Ci2E9 detergent buffer 
except Day 0 cells which were immediately solubilized in detergent buffer. The isoforms were then immunoprecip­
itated with anti-C-terminal peptide antibodies and analyzed by electrophoresis to obtain the total disintegrations/ 
min under the gel peaks. Results are the mean from two experiments.
a pool of transporters exists which has suppressed activity 
due to an inactivating modifier protein. However, several 
studies using the photolabel (as cited above) have shown an 
~2-fold discrepancy between photolabeling and transport and 
have shown a lag between the appearance of transporters that 
can be photolabeled and the increase in transport activity 
following insulin stimulation of rat adipose cells (Clark et al., 
1991; Satoh et al., 1991) and 3T3-L1 cells (Yang et al., 1992). 
These studies show that ATB-BMPA binds to transporters 
that are inactive in transport catalysis. We have suggested 
that it is this form of the transporter that may be associated 
with modifier proteins such as those involved in trafficking 
events in the normal translocation pathway (Yang et al., 
1992). In addition we have suggested that where there is a 
further discrepancy between transporters that are detected by 
labeling compared with Western blotting, as in isoproterenol- 
treated insulin-stimulated rat adipocytes4 and phenylarsine 
oxide-treated insulin-stimulated 3T3-L1 cells (Yang et al., 
1992), that this is due to the formation of plasma membrane- 
associated but occluded vesicles. Thus, we, to some extent 
concur, with the hypothesis described by Harrison et al. (1990, 
1991a, 1991b), but suggest that the transport-inactive form at 
the plasma membrane is a relatively small fraction of the 
total plasma membrane pool, that these forms represent in­
termediates in normal transporter trafficking and that trans­
location is the major mechanism by which glucose transport 
is stimulated in insulin-sensitive cells.
4 S. J. Vannucci, H. Nishimura, S. Satoh, S. W. Cushman, G. D. 
Holman, and I. A. Simpson, unpublished results.
Our experiments in which we have used digitonin suggest 
that the photolabel interacts with equal amounts o: trans­
porter in the basal and insulin-stimulated states and tiiat this 
provides additional evidence, to that previously described 
(Calderhead et al., 1990; Holman et al., 1990), which suggests 
that basal and insulin-stimulated transporters do n)t have 
differing affinities for the photolabel. If an inhibitory protein 
were present in basal cells which produced a large increase in 
the proportion of transporters in a catalytically inactive state, 
then this association would be expected to reduce the apparent 
labeling of the total cellular transporter pool of basil cells. 
Thus, these experiments in which cells are digitonin perme­
abilized also suggest that the proportion of transporters with 
suppressed activity is small and that the low surface bvels of 
transporters detected by labeling of cells in the basal state is 
due to transporter sequestration within the intracellular pool.
During the process of 3T3-L1 cell differentiation, oTer 95% 
of the total cellular GLUT4 in the intracellular pool was 
sequestered. This is similar to the level of sequestrttion of 
GLUT4 seen in other insulin-responsive tissues (Slct et al., 
1991a, 1991b). The greater sequestration of GLUT4 may be 
related to the targeting of this isoform to separate intracellular 
vesicles (Zorzano et al., 1989), although Calderheac et al., 
1990, have reported that GLUTl and GLUT4 were cetected 
in the same vesicles. It seems likely that the two iioforms 
leave the cell surface by the same endocytosis route as we 
have shown that both isoforms are endocytosed with tie same 
half-time when insulin is removed. This has been observed in 
rat adipocytes (Clark et al., 1991) and in 3T3-L1 cell) (Yang
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et al., 1992). However, we have observed that, in insulin- 
stimulated 3T3-L1 cells which are treated with the vicinal 
dithiol inactivating reagent phenylarsine oxide, there may be 
some separation of the transporter vesicle processing as 
GLUT4 re-exocytosis appeared to be blocked by this reagent, 
but GLUTl re-exocytosis was not (Yang et al., 1992). Cellular 
mechanisms for the separate localization and processing of 
GLUT4 must be very dependent on the GLUT4 protein 
structure as GLUT4 transfected into expression systems 
tends to become localized inside the cell rather than at the 
plasma membrane (Gould et al., 1991).
The studies on the use of the photolabel in permeabilized 
3T3-L1 cells that we have described here have shown that 
transporter sequestration can occur before differentiation is 
initiated and that transporters produced in differentiation 
probably enter a preformed sequestration process. Further 
studies will be required to determine whether growth arrest 
alone is sufficient to induce transporter sequestration or 
whether cell confluence and cell-cell contact phenomena re­
sult in morphological changes in the cell membrane system 
responsible for down-regulation of transporters and transport 
activity.
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Fetal bovine serum was from Gibco Laboratories. Dexamethasone, 
isobutylmethylxanthine, and protein A-Sepharose were from Sigma. 
Nonaethyleneglycol dodecyl ether (Ci2E9) was from Boehringer. 
Monocomponent porcine insulin was a gift from Dr. Ronald Chance, 
Eli Lilly Laboratories. Polyclonal antisera were raised against the C- 
terminal peptides of GLUT4 (CSTELEYGPDEND) and GLUTl 
(CGEELFHPLGADSQV) as described (22, 23).
Cell Culture—3T3-L1 fibroblasts were differentiated to adipocytes 
as described (20). Fully differentiated cells were washed with phos­
phate-buffered saline (154 mM NaCl, 12.5 mM sodium phosphate, pH 
7.4) and were then incubated for 2 h in serum-free medium containing 
25 mM D-glucose. This was followed by three washes in Krebs-Ringer- 
Hepes buffer (KRH buffer, 136 mM NaCl, 4.7 mM KC1, 1.25 mM 
CaCl2, 1.25 mM M gS04, 10 mM Hepes, pH 7.4).
A TB -B M P A  Photolabeling—Cells in 35-mm dishes were main­
tained at 37 °C either in the absence or the presence of 100 nM insulin 
in 1 ml of KRH buffer for 30 min. The buffer was removed and 
replaced by 350 /d of KRH buffer, either with or without insulin 
respectively, containing 250 nCi (insulin samples) or 500 ^Ci (basal 
samples) of ATB-[2-3H]BMPA at 18 °C. The dishes were placed 
between two 2-mm glass plates and were irradiated for 1 min in a 
Rayonet photochemical reactor equipped with eight 300-nm bulbs 
and eight 350-nm bulbs. The irradiated cells were then either washed 
rapidly and immediately homogenized in Tris-EDTA-sucrose (TES 
buffer, 10 mM Tris-HCl, 0.5 mM EDTA, 255 mM sucrose at 18 °C) or 
were maintained at 37 °C in 1 ml of KRH buffer containing 10 mM 
D-glucose for the times indicated in the figure legends before washing 
and homogenization. For each time point the combined material from 
two 35-mm dishes was pooled.
Immunoprecipitation and Electrophoresis—The 3T3-L1 cells were 
vigorously homogenized to ensure all cell material was broken. This 
was carried out in 2 ml of TES buffer, using a tightly fitting Teflon 
homogenizer operating at 1500 rpm and with 15 full strokes. Samples 
were then centrifuged at 12,500 x  gmax for 20 min. The crude plasma 
membrane and post-plasma membrane supernatants were then solu­
bilized in 1.5 ml of detergent buffer containing 2% Ci2E9, 5 mM 
sodium phosphate, pH 7.2, and with the proteinase inhibitors anti­
pain, aprotinin, pepstatin, and leupeptin, each at 1 ng/m \ (24). Any 
non-solubilized material was then removed by centrifugation at
20,000 X for 20 min. Antisera (50 /d  of anti-GLUT4 and 100 yul 
of anti-GLUTl) were premixed with 30 /ul of swollen protein A- 
Sepharose, washed in phosphate-buffered saline, and then mixed with 
the solubilized membranes for 2 h at 0-4 °C. The immunoprecipitates 
were washed four times (insulin) or five times (basal) in 0.1% then 
once in 0.01% Ci2E9 detergent buffer. The extent of washing of the 
immunoprecipitates was more extensive than previously reported (24) 
because of the low counts recovered in basal cells. The labeled glucose 
transporters were released from the antibody complexes with 10% 
SDS, 6 M urea, 10% mercaptoethanol and subjected to electrophoresis 
on 10% acrylamide gels. The radioactivity in gel slices was extracted 
with hydrogen peroxide as described (24). For the insulin-treated 
samples the background was determined by estimating the radioac­
tivity of slices on either side of the transporter peak. The background 
radioactivity in basal samples was determined by immunoprecipitat- 
ing with preimmune serum and then running this material on the 
same gel as the other basal samples. The preimmune serum did not 
produce a peak of radioactivity but allowed a correction of background 
from slices, which exactly corresponded to the position of the trans­
porter peak.
Estimation of Rate Constants—The glucose transporter levels as 
determined from electrophoresis (above) were used to calculate the 
fractional loss of plasma membrane label. These data were then fitted 
to an integrated rate equation, describing transporter recycling, by 
least squares analysis (weighted for relative error) using Fig P soft­
ware (Biosoft).
RESULTS
We have used the impermeant glucose transporter photo­
label, ATB-BMPA, to tracer-tag cell surface GLUT4 and 
GLUTl in 3T3-L1 cells. We have then followed the removal 
of these transporters from the plasma membrane of cells 
maintained in either basal or insulin-stimulated states. The 
maintenance of a steady state of non-labeled transporter 
distribution was confirmed by comparing the amounts of 
immunodetectable GLUT4 and GLUTl at the initial labeling 














S l ic e  N u m b e r S l i c e  N u m b e r
Fig. 1. E qu ilib ra tion  of trace r-tag g ed  GLUT4 w ith  the  in ­
trac e llu la r  m em brane pool in 3T3-L1 cells. Confluent 3T3-L1 
cells (two 35-mm dishes) were stimulated for 30 min with 100 n M  
insulin and then labeled with 250 #iCi of ATB-[2-3H]BMPA. Follow­
ing labeling, the dishes were either homogenized immediately (a) or 
were maintained at 37 °C in the continuous presence of insulin for 
another 40 min and then homogenized (b). GLUT4 was immunopre­
cipitated from either the plasma membrane ( • )  or the post plasma 
membrane supernatant (low density microsomes) (O) and then ana­
lyzed by electrophoresis.
37 °C.3 Fig. la  shows an SDS-polyacrylamide gel electropho­
resis profile obtained by labeling and immunoprecipitating 
GLUT4 in insulin-treated 3T3-L1 cells. The label recovered 
in the post-plasma membrane fraction of cells that were 
homogenized immediately was very low. This suggests that 
tracer-tagged GLUT4 was not significantly transferred to the 
low density microsomes during the processing period. Our 
results contrast with those of Jhun e t al. (17), who have 
reported that in rat adipose cells approximately one-third of 
the labeled GLUT4 was recovered in the post plasma mem­
brane fraction in samples which were processed immediately 
after labeling.
Following 40 min of incubation of the cells at 37 °C, the 
label in the plasma membrane was reduced to approximately 
one-half its initial value. The label that was lost from the 
plasma membrane was recovered in the low density micro- 
some fraction (Fig. lb ) .  We have not routinely analyzed the 
material transferred to the low density microsome fraction 
because of the need to simultaneously process multiple im­
munoprecipitated samples obtained for estimating GLUT4 
and GLUTl in the plasma membrane. Previous studies have 
demonstrated that constitutive turnover of transporters oc­
curs (23, 24)1 and that label which is lost from the plasma 
membrane is recovered in the low density microsome fraction.
In basal cells the labeling of GLUT4 and GLUTl was low 
(Fig. 2, a  and b), and following 40 min of incubation of the 
labeled cells at 37 °C, the level of tracer-tagged transporters 
in the plasma membrane were reduced toward background 
levels.
We have used least squares curve fitting to directly estimate 
exocytosis and endocytosis rate constants from time courses 
of loss of tracer-tagged GLUT4 and GLUTl from the plasma 
membrane (Fig. 3, a and b).  For analytical purposes the rate 
of loss of label from the plasma membrane is assumed to be 
dependent on just two rate constants; one describing the 
exocytosis (kex) and one the endocytosis (ken)• The rate of loss 
of labeled transporters is then given by Equation 1, where L p  
is the fraction of the label in the plasma membrane.
=  kex( l -  Lp) -  ken■ Lp
at
(Eq. 1)
1 J. Yang and G. D. Holman, unpublished results.




S l i c e  N u m b e r S l i c e  N u m b e r
Fig . 2. E qu ilib ra tion  of trac e r-tag g e d  GLUT4 and G L U T l 
in basal 3T 3-L 1  cells. Confluent 3T3-L1 cells (two 35-mm dishes) 
were labeled in the basal state with 500 fiCi of ATB-[2-!H]BMPA. 
Following labeling the dishes were either homogenized immediately 
( • ,  A) or were maintained at 37 °C for another 40 min and then 
homogenized (O, A). GLUT4 (a) and GLUTl (b) were then immu­
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F ig . 3. T im e courses for equ ilib ra tion  of trace r-tag g ed  
GLUT4 an d  G L U T l in 3T 3-L 1 cells. Confluent 3T3-L1 cells 
were labeled either in the basal ( • )  or insulin-stimulated (A) states 
and were then maintained in these steady states for the indicated 
times before homogenization to obtain the plasma membrane frac­
tion. GLUT4 (a) and GLUTl (b) were then immunoprecipitated and 
analyzed by electrophoresis. The lines through the data were derived 
from least squares fitting to Equation 2. (see “Results”). The results 
are the mean ± S.E. from three separate experiments, except in the 
case of GLUT4 in basal cells, where the data are from four experi­
ments.
Integration of Equation 1 with Lp = 1.0 at t = 0 gives 
Equation 2.
Lp = kex 4  hen CXp( t  ( hex 4" hen) ){hex 4* hen) (Eq. 2)
In the experiments described here we have used this equa­
tion to analyze the redistribution of label under steady-state 
conditions, but Equation 2 is equally applicable to an analysis 
of label equilibration under non-steady-state conditions. All 
that is required is that the total pool of transporters be 
conserved. It is only necessary to consider the concentration 
of unlabeled transporters if there are saturation steps in the 
flux pathway, as would be the case if one were analyzing 
equilibrium exchange by a carrier protein.
In the continuous presence of insulin both tracer-tagged 
GLUT4 and GLUTl were rapidly removed from the plasma 
membrane. The values of kex and ken derived from the mean 
results of three separate experiments are shown in Table I.
T a b l e  I
Kinetic parameters for glucose transporter trafficking in 3T3-L1 cells 
Kinetic parameters were calculated from the mean data shown in 
Fig. 3. These data were from three separate experiments (Insulin) 
and three separate experiments (Basal) except in the case of GLUT4 
in basal cells where the results were from four separate experiments. 
The data were fitted to Equation 2 using least squares analysis 




GLUT4 0.010 ±  0.001 0.116 ±  0.006 5.6 ±  0.3
GLUTl 0.035 ±  0.009 0.121 ±  0.020 4.4 ±  0.6
Insulin
GLUT4 0.086 ±  0.011 0.080 ±  0.007 4.2 ±  0.3
GLUTl 0.096 ±  0.023 0.093 ±  0.017 3.7 ±  0.6
The estimated rate constants were similar for both GLUTl 
and GLUT4. In addition, the end points of the equilibration 
of the tracer-tagged transporters were not significantly differ­
ent. At 40 min the levels of tracer-tagged GLUT4 and GLUTl 
remaining in the plasma membrane were 51.1 ±  1.7% (n = 3) 
and 53 ± 1.2% (n =  3), respectively, of the initial values. The 
maintenance of the insulin steady-state in which approxi­
mately one-half of the total transporter pool is at the surface 
(24) thus occurs because the exocytosis of transporters (de­
pendent on kex) matches an equal rate of endocytosis 
(dependent on ken).
In the basal state tracer-tagged GLUT4 was more exten­
sively removed from the plasma membrane than in the insu­
lin-stimulated state. At 40 min the fraction of the tracer- 
tagged GLUT4 remaining in the plasma membrane was only 
8.4 ±  2.0% (n =  4) of the initial value. By contrast, the 
fraction of the tracer-tagged GLUTl remaining in the plasma 
membrane was 20.8 ±  1.3% (n = 3) of the initial value. 
Analysis of the time course of tracer-tagged GLUT4 and 
GLUTl redistribution (Table I) showed that the endocytosis 
rate constants were only ss30% slower in the insulin-stimu­
lated compared with the basal state. However, the GLUT4 
and GLUTl exocytosis rate constants were 8.6 and 3 times 
higher, respectively, in the insulin-stimulated compared with 
the basal state (Table I).
Although we have used curve fitting to directly obtain the 
rate constants kex and ken, the half-time for label equilibration 
can also be easily calculated from least squares curve fitting 
using Equation 2. The half-time is only dependent on the 
exponential term, as shown by the following equation.
t x, 2  =  ln2/ (kex +  ken) (Eq. 3)
The values for the half-times for equilibration of tracer- 
tagged transporter were therefore calculated from summing 
the rate constants kex and ken as in Equation 3 and are shown 
in Table I. The half-times for GLUT4 and GLUTl equilibra­
tion in basal cells were 5.6 and 4.4 min, respectively. These 
values are similar to, but slightly faster than, the half-times 
(6.5 min) for the decrease in glucose transport activity in 
3T3-L1 cells following removal of insulin (24). The calculated 
half-times for loss of tracer-tagged transporters in the contin­
uous presence of insulin were slightly faster than in its ab­
sence because of the greater contribution of the re-exocytosis, 
the kex term in Equation 3, to the equilibration rate.
D ISCU SSIO N
Use of bis-hexoses with photoreactive substituents (17, 23)1 
has shown that GLUT4 constitutively recycles between the 
plasma membrane and the intracellular vesicle pool of rat 
adipose cells, and we have also demonstrated this phenome-
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non in 3T3-L1 cells (Ref. 24 and this study). In the continuous 
presence of insulin, the GLUT4 and GLUTl isoforms recycle 
at a similar rates and redistribute to the intracellular pool so 
that at equilibrium only approximately one-half of the labeled 
transporters remain in the plasma membrane. This is to be 
expected if all the cellular transporters are involved in the 
recycling process and is consistent with our previous studies 
on the photolabeling of the cell-surface and total-cellular 
pools of glucose transporters in 3T3-L1 cells, where we showed 
that approximately one-half of the total cellular pool of 
GLUT4 and GLUTl transporters is located at the cell surface 
of insulin-stimulated cells.
In the basal state a much greater proportion of labeled 
GLUT4 transporters are lost from the plasma membrane. 
This is the result that would be expected if over 90% of the 
transporters were intracellularly localized. However, the half- 
time for removal of these labeled transporters in the basal 
state is somewhat slower than is observed in the insulin 
steady-state. These results contrast with those of Jhun et al. 
(17), who have reported that in basal rat adipose cells the 
half-time for tracer-tagged GLUT4 equilibration is faster than 
that observed in insulin-stimulated cells. This discrepancy 
may be related to the need to rapidly process samples to 
determine the fraction of label removed from the plasma 
membrane. This is particularly important in the basal state, 
where the fraction of the label removed from the plasma 
membrane is more extensive.
Our data show that the calculated endocytosis rate con­
stants (keD) are similar for GLUT4 and GLUTl and that these 
endocytosis rate constants are only ~30% slower in the in­
sulin-stimulated compared with the basal state. These find­
ings are consistent with our previous observations on the rate 
of loss of cell-surface transporters from 3T3-L1 cells under 
conditions in which insulin was removed by a low pH buffer. 
In those experiments we simply estimated the proportions of 
transporters remaining at the cell surface by labeling at dif­
ferent time points following insulin removal. We observed 
that cell-surface levels of GLUT4 and GLUTl decreased at a 
similar rate. We observed that the fractional loss of GLUTl 
was slightly less than GLUT4 and suggested that this was 
due to a greater re-exocytosis of this isoform (24).
We have now shown quantitatively that insulin increases 
the rate constant (/eex) for glucose transporter exocytosis. The 
exocytosis of the GLUT4 isoform is 8.6-fold faster in insulin- 
stimulated cells compared with basal cells. The basal exocy­
tosis rate constant may be overestimated because of some 
plasma-membrane contamination from label, which transfers 
to the intracellular pool. However, the observed level of stim­
ulation of GLUT4 exocytosis is almost sufficient to account 
for the «12-15-fold stimulations of cell-surface appearance of 
GLUT4 previously observed using ATB-BMPA (20, 21, 24). 
In turn, this level of recruitment of GLUT4 is almost suffi­
cient to account for the increase in glucose transport activity 
in these cells (~15-20-fold). Insulin also stimulates GLUTl 
exocytosis but only to ~3-fold above basal levels. Again, this 
level of stimulation of exocytosis accounts for the smaller, 3- 
5-fold increases in cell-surface GLUTl accessible to the pho­
tolabel that we have observed in our previous studies.
The major difference between the trafficking of the GLUT4 
and GLUTl isoforms is the much slower exocytosis of GLUT4 
in the basal state. However, in the presence of insulin, both
isoforms are processed in the same way. O ur data therefore 
supports the  suggestion th a t in basal cells intracellu lar proc­
essing steps remove GLUT4 from the  norm al endosome re­
cycling pathway, possibly to  a specialized com partm ent w ithin 
th e  tubulo-vesicular system (7). Insulin  may then  re-com m it 
or re-target these transporters from th e  tubulo-vesicular sys­
tem  to the  plasm a m em brane and thence to  the early endo­
some system. B oth intracellular transpo rte r pools would then  
be in rapid  equilibrium with each o ther in the  insulin-stim u­
lated state, as our photolabel equilibration data shows th a t 
the cells entire com plem ent of glucose transporte rs are in ­
volved in the recycling process both  in 3T3-L1 cells (this 
study) and  in ra t adipose cells.1
W e have consistently observed th a t the half-tim e for the 
in itial stim ulation of glucose transporte r translocation  by 
insulin is faster th an  the half-tim e for steady-state recycling 
of transporters and  the  half-tim e for loss of transporte rs when 
insulin is removed (18, 24).1 We have suggested th a t th is  may 
occur because, imm ediately following insulin addition, tra n s ­
porters are rapidly com m itted to  the  plasm a m em brane a t a 
vesicle docking and fusion step and tha t, once transporters 
are com m itted in th is way, they are then  recycled a t a slower 
rate  w ithin the early endosomes. T he kinetic effects expected 
from th is type of multiple pool-trafficking system  have been 
analyzed and  have been shown to account for the  observed 
disparity between the  half-tim es for insulin stim ulation of the 
in itial translocation  and the steady-state rates of transporte r 
recycling.3
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